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Mitochondria are organelles present in most cells of the body responsible for the 
production of cellular energy in the form of adenosine triphosphate (ATP), through 
oxidative phosphorylation (OXPHOS). Mitochondrial function is particularly important 
in the heart due to its high requirement for ATP, and a decline in mitochondrial 
function with age is implicated in the pathogenesis of age-related cardiovascular 
disease. Exercise interventions can induce mitochondrial biogenesis and increase 
OXPHOS capacity; however, it is unknown whether such interventions are successful 
if started in later life. I wanted to investigate the effect of an endurance exercise 
intervention in 2 mouse models; 1) a model of accelerated ageing due to enhanced 
mitochondrial DNA mutagenesis (PolgAmut/mut mice); 2) C57Bl6/J mouse model of 
physiological age at 14 months of age.  
Study 1: Following baseline characterisation of PolgAmut/mut mice compared with age-
matched controls, male PolgAmut/mut mice underwent a 6-month endurance exercise 
programme from 16 weeks of age to investigate the effects of exercise on 
physiological phenotype, behavioural activity, and cardiac mitochondrial function. I 
found no improvement in clinical score, locomotor activity, cardiac hypertrophy and 
fibrosis and mitochondrial function in the exercised mice. This suggests that six 
months of endurance exercise is unable to improve the clinical phenotype and 
cardiac mitochondrial function in PolgAmut/mut mice due to the severity of the genetic 
defect. 
Study 2: To investigate whether starting an exercise programme in later life is 
beneficial, I first characterised the effect of age on cardiac function in sedentary mice. 
Between 14 and 22 months of age, I found a significant decline in neuromuscular 
coordination, decreased cardiac function (measured by cardiac MRI), and diminished 
aerobic capacity. Six months of endurance exercise improved physiological function 
and neuromuscular coordination, decreased cardiac fibrosis and apoptosis and 
improved mitochondrial OXPHOS activity. This suggests that starting an exercise 
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CC3 Cleaved caspase-3 
CHD Coronary heart disease 
CI Complex I 




cMRI Cardiac Magnetic Resonance Imaging 
CO Cardiac output 
CoA Co-enzyme A 
CoQ10 Co-enzyme Q10 
CICR Ca2+ induced Ca2+ release  
COX Cytochrome c oxidase 
CX/SDH Cytochrome c oxidase/succinate 
dehydrogenase 
CRP C-reactive protein 
CMT Charcot-Marie-Tooth disease 
CNS Central nervous system 
CT Cycle threshold 
Cyt C Cytochrome C 
CuZnSOD Copper-zinc-superoxide dismutase 
CVD  Cardiovascular disease 
CVS Cardiovascular system 
DAB 3,3’-diaminobenzidine 
DBP Diastolic blood pressure 
DISC Death inducing signal complex 
D-loop Displacement-loop 
DNA Deoxyribonucleic acid 
Drp1 Dynamin related protein 1 
DHPs Dihydropyridines  
dRP Deoxyribose phosphate residue 
ECG Electrocardiogram 
ED End-diastole 




ESV End-systolic volume 
EF Ejection fraction 
EF-Tu Mitochondrial elongation factor  
EPCs Endothelial progenitor cells 
ERR Oestrogen related receptor 
ES End-systole 
ETC Electron transport chain 
EtOH Ethanol 
FAD Flavin adenine dinucleotide 
FADH Reduced flavin adenine dinucleotide  
Fe-S Ion/Sulphur 
gDNA Genomic DNA 
GH Group-housed 
GPx Glutathione 
GSH Glutathione peroxidase  
GTP Guanosine triphosphate 
GTPases 
 
Guanosine triphosphate hydrolase 
enzyme 
H&E Haematoxylin and Eosin 
HCl Hydrochloric acid 
HMG High mobility group 
HR Heart rate 
HRP  horseradish peroxidase 
HSP Origin of heavy strand 
IBM Inner boundary membrane 
Ig Immunoglobulin 




IL-6 Interleukin-6  
IMM Inner mitochondrial membrane 
IMS Intermembrane space 
IFM Interfibrillar mitochondria 
Int + Intermediate positive 
Int - Intermediate negative 
KSS Kearns-Sayre Syndrome 
ISC Ion-sulphur cluster  
LDL Low density lipoprotein 
LSP Origin of light strand 
LVM Left ventricular mass 
L-VDCC L-type voltage dependent Ca2+ channel 
LP-BER Long-patch base excision repair 
MABP Mean arterial blood pressure  
MAP Mitogen activated protein 
mCAT Mitochondrial targeted catalase 
miRNA Micro-RNA 
Mfn1 Mitofusin 1 
Mfn2 Mitofusin 2 
MFTA Mitochondrial free radical theory of 
ageing 
MMEJ Microhomology-mediated end joining 
MMR Mismatch repair 
mPTP Mitochondrial pore transition membrane 
MRC Mitochondrial respiratory chain 
MELAS Mitochondrial encephalopathy with 




mRNA Messenger ribonucleic acid 




Termination Factor 1 
Mt-IF-2 Mitochondrial initiation factor-2 
Mt-IF-3 Mitochondrial initiation factor-3 
mtSSB 
 
Mitochondrial DNA single-stranded 
binding protein 
MTCOI Cytochrome c oxidase subunit 1 
NaCl Sodium Chloride 
NAD Nicotinamide adenine dinucleotide 
NADH Reduced nicotinamide adenine 
dinucleotide 
Neg Negative 
NBT Nitroblue tetrazolium 
NCR Non coding region 
nDNA Nuclear DNA 
NDUFB8 Ubiquinone Oxidoreductase Subunit B8 
NCX Na+/Ca2+ exchanger  
NF-B Nuclear-factor B 
NGS Normal goat serum 
NIBP Non-invasive blood pressure  
NHEJ Non-homologous end joining 
NIS Nikon imaging software 
NPC No primary control 




NMRS Nuclear magnetic resonance 
spectroscopy  
NTC No template control 
NO Nitric oxide 
OSCP Oligomycin sensitivity conferring protein 
OD Optical density 
OFT Open field testing 
OMM Outer mitochondrial membrane 
OPA1 Optic atrophy 1 
OXPHOS Oxidative phosphorylation  
OH Origin of heavy strand 
OL Origin of light strand 
PBS Phosphate buffered saline 
PDC Pyruvate dehydrogenase complex 
PCR Polymerase chain reaction 
PCr Phosphocreatine 
Pos Positive 




receptor gamma coactivator 1-alpha 
Pi Inorganic phosphate 
PI3 phosphatidylinositol 3-kinase 
PKA Protein kinase A 
PMS Phenazine methosulfate 
POLG/Polγ Polymerase gamma  
PolgA mut/mut mouse 
 





POLRMT mitochondrial RNA polymerase  
PPARα Peroxisome proliferator-activated 
receptor alpha  
Q Ubiquinone  
RER Respiratory exchange ratio 
RNA Ribonucleic acid  
ROS Reactive Oxygen Species 
rRNA Ribosomal ribonucleic acid 
RT-PCR Real time-PCR 
RGB  Red Green Blue 
RV Right ventricle  
SAN Sinoatrial node 
SBP Systolic blood pressure 










SOD Superoxide dismutase 
SR Sarcoplasmic reticulum 
SV Stroke volume 
SS Single stranded 
SSM Subsarcolemmal mitochondria 
TBS Tris-buffered saline 





TNF-α Tumor necrosis factor-α 
TCA Tricarboxylic acid cycle 
TFAM Mitochondrial transcription factor A 
Tfam -/- Homozygous knockout of TFAM gene 
TNFR1 Tumor necrosis factor receptor 1 
TFBM1 Mitochondrial transcription factor B1 
TFBM2 Mitochondrial transcription factor B2 
TIM Translocase of the inner membrane 
TIMP-1 metallopeptidase inhibitor 1 
TOM Translocase of the outer membrane 
TWINKLE mtDNA helicase enzyme 
tRNA Transfer ribonucleic acid 
UPR mt Mitochondrial unfolded protein 
response 
VAP-1 Vascular adhesion pritein-1 
VCO2 Maximum carbon dioxide production 
VDAC Voltage-gated anion channel 
VLDL Very low density lipoprotein 









Chapter 1. Introduction 
1.1 Mitochondria 
Mitochondria are rod-shaped intracellular organelles thought to be descended from a 
symbiotic relationship with α-proteobacterium (Margulis and Bermudes, 1985). 
Mitochondria exist in most eukaryotic cells and are known as the ‘power generators’ 
of cells (Detmer and Chan, 2007). The number of mitochondria varies widely by 
organism, tissue and cell type depending on the energy demand of the system. The 
mitochondrial size and shape also varies between cell types depending on their 
stage of development (Welchen et al, 2014). Like many other organelles, the 
morphology of mitochondria is crucial for its integrity and physiology, and is 
controlled by fission and fusion processes (Scott and Youle, 2010). Mitochondria are 
involved in a range of complex cellular interactions such as; cytoplasmic calcium 
homeostasis (Giorgi et al, 2012), cell growth and development (Arciuch et al, 2012), 
programmed cell death (Bras, Queenan and Susin, 2005), generation of reactive 
oxygen species (ROS) (Murphy, 2009), regulation of innate immunity (West, Shadel 
and Ghosh, 2011), stem cell regulation (Xu et al, 2013), the urea cycle, and ATP 
production through oxidative phosphorylation (OXPHOS) (Bergman and Ben-
Shachar, 2016). Mitochondria have an outer and inner membrane, enclosing the 
matrix which houses the Krebs cycle and is the main site of fatty acid oxidation. The 
inner membrane contains the respiratory chain enzymes that reduce molecular 
oxygen to water by utilising electrons passed on from a series of electron carriers. 
The redox-driven respiratory chain enzymes pump protons from the matrix to the 
inner mitochondrial membrane to establish an electrochemical gradient of protons to 
synthesise ATP from ADP and Pi (Chaban, Boekema and Dudkina, 2012). 
Mitochondria are the only organelles apart from the nuclei that contain their own 
genome, which is much smaller (~16.5Kb) than the nuclear genome. Mitochondria 
are inherited maternally and encode for 13 proteins of the electron transport chain 
(Sato and Sato, 2013). 
 
1.1.1  Mitochondrial structure 
Mitochondria have two phospholipid bilayer membranes separated by the 




mitochondrial membrane (OMM) encloses the organelle and allows for the transport 
of molecules smaller than 500Da into the IMS through integral membrane proteins 
(Flis and Daum, 2013). The OMM faces the cytosol and the IMM extends into the 
matrix which contains mitochondrial DNA (mtDNA). The IMS is the compartment 
enclosed by the IMM and the OMM (Bornhovd et al, 2006). The voltage-dependent 
anion channel (VDAC) is an outer membrane protein that facilitates the transport of 
nucleotides, ions and other metabolites from the cytosol to the IMS (Yeagle, 2016). 
The inner mitochondrial membrane (IMM) is less permeable and encloses the matrix 
with a series of invaginations on its surface called cristae (Kuhlbrandt, 2015). The 
IMM was originally believed to be a continuous membrane enclosing the cristae 
inside the matrix. However, it’s now accepted that the IMM is comprised of two 
compartments, the inner boundary membrane (IBM) and cristae membrane (CM) 
(Frey and Manella, 2000). The IMM contains four complexes of the electron transport 
chain and ATP synthase as well as proteins necessary for fission and fusion 
processes, metabolite transport proteins, redox carrying proteins and protein import 
machinery (Alberts et al, 1994). The IMM is also home to a high proportion of 
cardiolipins that make the IMM almost impermeable (Paradies et al, 2014). Unlike the 
outer membrane, the IMM does not contain porins and so molecules and ions are 
transported into the matrix via the translocase of the inner membrane (TIM) complex 
(Herrmann and Neupert, 2000). There is also a membrane potential formed across 
the IMM by the enzymes of the OXPHOS system. Invaginations of the IMM known as 
cristae expand the surface area of the IMM for greater ATP production. Cells with 
higher energy demand require a higher density of cristae to facilitate the movement 
of ions down the electrochemical gradient. A schematic diagram showing the 






Figure 1.1. Representation of mitochondrion structure. Key features include 
mitochondrial outer and inner membrane, cristae, mitochondrial DNA and matrix. 
 
1.1.2  Mitochondrial function 
1.1.2.1 Mitochondrial OXPHOS system and ATP synthesis 
ATP synthesis through OXPHOS relies on the structural integrity of the 
mitochondrion. Cellular respiration also known as aerobic respiration (in the presence 
of oxygen) is the process by which the preferred biochemical energy source, glucose, 
is converted into ATP. Glucose (C6) is broken down through the process of glycolysis 
and is converted into pyruvate (C3) generating two molecules of ATP in the process 
(Figure 1.2). Two molecules of pyruvate per glucose molecule are then transferred to 
the mitochondria and feed into the Krebs cycle or citric acid cycle where they are 
oxidised to Acetyl-Coenzyme A (Acetyl Co-A) and CO2 by the pyruvate 
dehydrogenase complex (PDC) inside the mitochondrial matrix. NAD+ is reduced to 
NADH throughout the citric acid cycle and is used as an energy source in the 
electron transport chain to generate ATP. In fact, six NADH molecules, two FADH2 
molecules and two ATP molecules as well as two molecules of H2O and CO2 as 
waste products are produced per molecule of glucose (equivalent to two molecules of 




place inside the cytoplasm and the citric acid cycle occurs in mitochondria as shown 
in figure 1.2. 
 
 
Figure 1.2. Glycolysis and citric acid cycle are linked by their end products. 
Glycolysis generates two ATP and two pyruvate molecules which are then fed into 
the citric acid cycle where pyruvate is converted to Acetyl-CoA and other metabolises 
to produce NADH and FADH substrates for the electron transport chain. 
 
NADH and FADH2 (reduced forms of electron carriers) from the citric acid cycle and 
fatty acid β-oxidation are fed into the electron transport chain (ETC) and their 
electrons are transferred to ETC complexes. The ETC comprises a set of four multi-
protein complexes (complexes I-IV) while the OXPHOS machinery comprises of 
complexes I-V. The complex series of redox reactions create an electrochemical 
proton gradient across the IMM that drives ATP synthesis as shown in figure 1.3. 
NADH is able to donate its electrons to complex I in a redox reaction to form NAD+ 
and release ATP in order to pump protons (H+) along the electrochemical gradient 
from the matrix to the IMS (Hatefi, 1985). FADH2 however isn’t as efficient at 




instead. Electrons are passed from complex I and complex II to an electron carrier 
called ubiquinone (Q) which carries electrons to complex III, pumping more protons 
across the membrane (figure 1.3). Electrons are then passed to another electron 
carrier known as cytochrome c (Cyt C) to transfer electrons to complex IV where four 
electrons then reduce molecular oxygen to form two molecules of H2O. The flow of 
electrons enables ATP synthase to catalyse the phosphorylation of ADP to form ATP 
with Pi by harnessing the flow of protons. One ATP molecule is produced in return for 
three H+ that pass through the ATP synthase (Alberts et al, 2002). Hundreds of ATP 
molecules are produced by ATP synthase in one second and these are exported via 
the adenine nucleotide translocase (ANT) to the rest of the cell (Bonora et al, 2012).  
 
 
Figure 1.3. Oxidative phosphorylation. Electrons move from complex I to complex 
IV to create energy for the transfer of protons from the matrix to the intermembrane 
space (IMS). The electrochemical gradient created is the energy that is stored for 
ATP synthesis. The protons flow back to the matrix through the ATP synthase which 
drives the phosphorylation of ADP to generate ATP. 
 
1.1.2.2 OXPHOS complexes 
OXPHOS complexes are encoded by both the mitochondrial genome and the nuclear 




before being transported into the mitochondria (Zimmerman, Von Saint-Andre, 
McLaughlin, 2011).  
Respiratory chain complex I also known as NADH dehydrogenase is the largest 
protein complex of the respiratory chain consisting of 45 subunits, seven of which are 
encoded by the mtDNA. Complex I catalyses the transfer of electrons from NADH to 
a ubiquitous coenzyme known as Coenzyme Q10 (CoQ10). This reaction 
translocates four protons across the IMM per molecule of oxidised NADH. Due to the 
inefficiency of electron transport across the IMM and the premature leakage of 
electrons to oxygen, superoxide can form, making complex I the main site of reactive 
oxygen species (ROS) production (Sharma, Lu and Bai, 2009). 
Respiratory chain complex II otherwise known as succinate dehydrogenase (SDH) 
consists of four protein subunits, two hydrophilic and two hydrophobic all encoded by 
the nuclear genome and transported into mitochondria. Complex II contributes fewer 
electrons to the chain in comparison to complex I and hence less ATP is generated 
through this pathway (Ganesh, Wong and Gorman, 2012).  
Respiratory chain complex III, or ubiquinol-cytochrome c reductase, is encoded by 
both the mitochondrial DNA and the nuclear genome. Of the 11 subunits (Xia et al, 
1997; Iwata et al, 1998), three are respiratory subunits (Rieske protein, cytochrome b 
and cytochrome C1), two are core protein subunits and six are low molecular weight 
protein subunits (Benit, Lebon and Rustin, 2009). Only one subunit is encoded by the 
mtDNA known as cytochrome b, the rest are encoded by the nuclear DNA. Complex 
III catalyses the transfer of electrons to cytochrome b and cytochrome c. Overall two 
electrons pass through complex III, four protons are passed across the IMS to 
facilitate the transfer of electrons to another electron carrier known as cytochrome c 
which carries electrons to complex IV. 
Mitochondrial Complex IV, or cytochrome c oxidase, (COX) is encoded by three 
mitochondrial genes (subunits I, II and III) and ten nuclear genes (subunits IV, Va, 
Vb, Via-Vic, VIIa-VIIc and VIII). Subunits encoded by the mtDNA form the catalytic 
core of the enzyme and nuclear-encoded subunits are involved in stability and 
assembly of the complex. Complex IV receives electrons from cytochrome c and 
transfers them to molecular oxygen to form two H2O molecules. Four protons are 




Mitochondrial Complex V or ATP synthase is the final complex, which couples ATP 
synthesis to the electrochemical gradient generated by the proton gradient across the 
mitochondrial membrane. The result is the formation of ATP by Adenosine 
diphosphate (ADP) and free phosphates. Complex V consists of 14 nuclear encoded 
and two mtDNA encoded subunits. It has two functional domains situated on the IMM 
known as Fo and F1 which are responsible for hydrolysing ATP and catalysing the 
reaction between ADP and phosphate respectively (De Meirleir et al, 2004). The 
human mitochondrial ATPase F1 domain is a soluble region in the mitochondrial 
matrix, which comprises of three copies of subunits α and β and a copy of subunits γ, 
δ and ε. The second ATPase domain Fo comprises of a subunit ring (Watt et al, 
2010) and one copies of subunits a, b, d, F6 and the oligomycin sensitivity conferring 
protein (OSCP). Two subunits of Fo domain (‘a’ and ‘A6L’) are encoded by mtDNA 
ATP6 and ATP8 genes respectively (Anderson et al, 1981).  
 
1.1.2.3  Mitochondrial calcium homeostasis 
Calcium (Ca2+) is an important modulator of signal transduction in mitochondria and 
its homeostasis is crucial for the normal functioning of mitochondria. There are 
several routes by which Ca2+ can either enter or exit the mitochondria including Ca2+ 
uniporter, Ca2+ rapid uptake mode, Ca2+/Na+ exchanger, and permeability transition 
pore (mPTP) all located on the IMM as well as VDAC on the OMM. Ca2+ homeostasis 
is significantly more important in high-energy demanding tissues such as cardiac and 
skeletal muscle as a slight change in its cytosolic concentration could result in 
significant changes in the rate of muscle contraction. Ca2+ has also a key regulatory 
role in neuronal development and function as well as cell death (Giorgi et al, 2012). 
 
1.1.2.4  Mitochondrial reactive oxygen species (ROS) generation 
Mitochondria are a major source of ROS generation primarily as a by-product of 
OXPHOS at complexes I and III (Turrens and Boveris, 1980). Balaban, Nemoto and 
Finkel (2005) have shown that excessive ROS production contributes to oxidative 
damage to macromolecular complexes including mtDNA and proteins. These toxic 




peroxide (H2O2) and hydroxyl radicals (OH-). H2O2 is generated through dismutation 
of O2●- and catalysed by superoxide dismutase (SOD) within mitochondria (Fukai and 
Ushio-Fukai, 2011). The most aggressive form of oxidative stress is through hydroxyl 
radicals due to their short half-life. OH- is generated through H2O2 and O2●- and is 
catalysed through the Haber-Weiss reaction by Fe2+. Figure 1.4 illustrates the 
production and removal of O2●-  through an enzymatic pathway. 
 
 
Figure 1.4. ROS generation and removal. O2-● dismutation is catalysed by 
superoxide dismutase (SOD) to H2O2 or through nitric oxide (NO) to form 
peroxynitrite (ONOO-) or through Haber-Weiss reaction to form hydroxyl radicals 
(OH●). H2O2 is formed directly from xanthine oxidase and reduced further to H2O and 
O2 by catalase and peroxidase. Dashed lines represent inhibition states where 
ONOO- inhibits SOD and NO inhibits OH●. 
 
Maintaining a basal level of ROS is also essential as they act as signalling molecules 
to activate biological pathways and regulate physiological functions (Mittler, 2017). 
Manivannan, Soundararajan and Jeong (2017) documented that ROS are vital 
components in regulating cellular proliferation and differentiation by modulating the 
redox status of cell components and regulating the transcription of genes associated 
with cellular proliferation. Similarly, Yarosz and Chang (2018) reported that ROS 
derived from OXPHOS, regulate T cell-mediated immunity through the AMPK 




to activation of cellular transcription factors crucial for promoting T-cell growth (Zhu et 
al, 1999).  
In order to regulate cellular redox homeostasis and prevent damage to 
macromolecules, a network of antioxidants are employed by cells to scavenge 
excessive ROS. The antioxidant defense system comprises of enzymes such as 
superoxide dismutase (SOD), catalase, glutathione (GSH) and glutathione 
peroxidase (GPx) (Poljsak, Suput and Milisav, 2013). This complex defense 
mechanism against exessive ROS should be balanced to allow cell signalling and 
redox regulation. The balance however is slightly in favour of the ROS, allowing 
continuous low-level ROS formation and damage to human body with age 
(Cheeseman and Slater, 1993). The failure of antioxidant repair mechanisms 
contributes to the accumulation of cell damage, for example lysosomal 
accummulation of lipofuscin (Terman and Brunk, 2006), ageing and age-realted 
diseases (Gems and Doonan, 2009). Non-proliferative cells such as cardiac 
myocytes are more affected by age-related oxidative damage since there is no 
opportunity to dilute the damaged structures via cell division (Terman and Brunk, 
2006). As oxidative cellular damage increases with age, an exogenous intake of 
antioxidants from the diet such as vitamins C and E as well as carotenoids and 
polyphenols are recommended to support the body’s antioxidant defense system 
(Willett, 2006).  
 
1.1.2.5  Iron/Sulphur cluster formation 
Mitochondria are also important regulators of iron homeostasis. Fe/S clusters are 
ubiquitous protein cofactors and contribute to the electron transport chain, redox 
catalysis, regulation of gene expression and protein translation, mtDNA repair and 
replication as well as tRNA modification (Johnson et al, 2005). Mitochondria contain 
the iron-sulphur-cluster (ISC) assembly machinery. Over 15 components are required 
to synthesise Fe/S proteins to be used inside and outside of mitochondria. Fe/S 
cluster formation and haem biogenesis is carried out in the mitochondrial matrix 
(Wang and Pantopoulos, 2011). Only 12 Fe/S clusters are involved in the electron 
transport chain and Fe changes its ionic state between redox reactions (Schultz and 




that domain movement is a crucial part of the enzyme reaction mechanism to 
promote the unidirectional flow of electrons. 
 
1.1.2.6  Cellular apoptosis 
Programmed cell death or apoptosis is a process of controlled cell death and is 
important during normal development and for the removal of damaged cells. Factors 
triggering apoptosis include DNA damage, viral infections, stress and ROS released 
from mitochondria. During cellular apoptosis, cells shrink in size, the cytoskeleton 
collapses, and nuclear DNA fragments following nuclear envelope disassembly 
(Alberts et al, 2002). The alteration of the cell surface during apoptosis gives signals 
to phagocytes and macrophages to initiate the engulfing processes. Apoptosis is 
mediated by proteolytic enzymes known as caspases that trigger cell death by 
cleaving proteins in the cytoplasm and nucleus. Cellular apoptosis may be induced 
by intrinsic (mitochondrial) and extrinsic pathways. In the extrinsic pathway, two 
direct mechanisms of cell death in mammals are suggested to be involved; TNF-
induced and Fas-Fas ligand mediated models (Wajant, 2002). In the TNF-induced 
model, the binding of TNF-α to TNFR-1 activates the caspase pathway whereas in 
the Fas-Fas mediated model, Fas-ligand binds to the Fas (first apoptotic signal) 
receptor; resulting in formation of the death inducing-signal complex (DISC). This 
complex contains caspase-8 and caspase-10 which trigger the execution of cellular 
apoptosis (Gu et al, 2011). 
Mitochondria play a critical role in initiating apoptosis by making its outer membrane 
more permeable to proteins especially the Bcl2 family of proteins, which regulate the 
permeability of the mitochondrial outer membrane (Wang and Youle, 2009). The two 
subtypes of this family of proteins, pro-apoptotic and anti-apoptotic, work together to 
balance the rate of cell death. Under normal healthy circumstances, the balance is in 
favour of anti-apoptotic proteins to inhibit mitochondria from initiating apoptosis. Once 
the pro-apoptotic proteins such as cytochrome c are released into the cytoplasm by 
increased permeability of the OMM, a cascade of caspases enzymes are activated. 
Caspases (family of cysteine-aspartic acid proteases) such as cleaved caspase-3 
break down proteins and degrade the large polymers inside the cells, prepare them 




Caspase-3 is involved in the final execution-phase of cellular apoptosis; hence, its 
intracellular localisation is commonly used as an immunohistochemical marker of cell 
death through apoptosis. Fragmentation of DNA is documented during cellular 
apoptosis as DNase inhibitors are removed by the activity of caspases leading to 
nuclear DNA fragmentation (Janicke et al, 1998). 
 
1.1.3  Mitochondrial dynamics 
Mitochondria are dynamic organelles and continuously undergo cycles of fission 
(division) and fusion (connection) to maintain their shape, size, distribution and to 
meet the energy demands of the cell type in which they reside (Archer, 2013). The 
structural flexibility of mitochondria allows them to form branches and filaments under 
various physiological and pathological conditions. Mitochondrial fusion is an 
integration of two mitochondria to form one mitochondrion. The fusion proteins 
include two GTPase mitofusins (Mfn1 and Mfn2) that reside on the OMM and OPA1 
that exists on IMM (Chen and Chan, 2009). The size and number of mitochondria 
varies depending on the mitochondrial regulatory fission and fusion proteins. These 
proteins balance mitochondrial number and morphology depending on the cell type 
and its function (Jornyvaz and Shulman, 2010). Mitochondrial quality control systems 
keep mitochondria functional by enabling a stable balance between fission and fusion 
proteins. Depending on the energetics state of cells, proteins are recruited on the 
mitochondrial membrane for mitophagy or repair in order to maintain the integrity of 
mitochondria (Picca et al, 2018). OPA1 overexpression leads to mitochondrial 
elongation and its loss results in mitochondrial fragmentation (Sesaki et al, 2003). 
Mitochondrial fission is defined as the division of a mitochondrion into two daughter 
mitochondria which allows the damaged mitochondria to be removed by mitophagy 
(van der Bliek, Shen and Kawajiri, 2013). Fission proteins include a dynamin-related 
proteins called Drp1 which are recruited to the mitochondrial and peroxisomal 
membranes. The loss of this cytosolic protein leads to drastic elongation of 
mitochondria and peroxisome (Koch, 2004). The balance between fission and fusion 
is an integral component of functional mitochondria. Dysregulation of fission and 
fusion processes results in a large number of round fragmented mitochondria or an 
elongated, highly connected, hyper-fused mitochondrial network (Suguira et al, 




(Eura et al, 2003) whereas Mfn-1 knockout results in fragmented mitochondria and 
Mfn-2 knockout results in enlarged spherical mitochondria (Chen et al, 2003).  
Baloh et al (2007) have reported that a mutant form of Mfn2 induces abnormal 
clusters of fragmented mitochondria in neuronal cell bodies and axons, causing an 
impairment of mitochondrial transport in neuronal axons and eventually leading to 
Charcot-Marie-Tooth disease (CMT) where peripheral sensory and motor axons are 
degenerated. Similarly, knocking out the mfn2 gene from mouse dopaminergic 
neurons result in marked mitochondrial fragmentation in neuronal cell body, reduction 
of mitochondrial mass and transport in neurons that led to reduced activity and 
rearing in mice resembling CMT type 2A disease in mice (Pham et al, 2012). 
Similarly, in a mouse model where mitochondrial fission protein Drp1 was knocked 
out in embryonic cardiomyocytes, mice displayed neonatal lethargy due to dilated 
heart, thinned heart wall and premature death (Ishihara et al, 2009). The brain 
specific knockout of Drp1 resulted in a cerebellar developmental defect, with few 
enlarged mitochondria within Purkinje cells instead of numerous tubular 
mitochondria. Knockout of Drp1 caused death within 24 hours of birth suggesting that 
Drp1 is essential for embryonic development of organs with high endogenous levels 
of Drp1 present in the heart and brain (Wakabayashi et al, 2009). 
 
1.1.4  The mitochondrial Genome 
Mitochondria are the only organelles except the nucleus that contain their own DNA 
that is located within the mitochondrial matrix. MtDNA is a double stranded ~16.5 kb 
circular molecule (figure 1.5) and each strand has different base compositions (Chial 
and Craig, 2008). It consists of the heavy strand, which is a guanine rich strand, a 
light strand which is rich in cytosine, and a noncoding region of approx. 1100 bp 
known as the D-loop. MtDNA encodes 37 genes; 13 of which are subunits of the 
OXPHOS complexes I, III, IV and V. 22 transfer RNAs (tRNAs) and two ribosomal 
RNAs (rRNA) (12s and 16s) are also encoded by mtDNA and are responsible for the 
correct translation of the OXPHOS subunit mRNAs within the mitochondria. The 
other 1000-1500 proteins necessary for the correct functioning of mitochondria are 
encoded by the nuclear DNA and are imported into mitochondria (Calvo, Calauser 




strictly maternally inherited. It has a close proximity to the site of energy production 
and oxidative stress. MtDNA does not contain any introns and the non-coding 
regions (D-loop and associated promoters) are highly involved in mtDNA replication 
and transcription (Shadel and Clayton, 1997). The human mitochondrial genome 
carries a 5-10 times higher mutation load than the nuclear genome (Siguroardottir et 
al, 2000). 
The mouse mtDNA is greatly homologous to human mtDNA in location, sequence 
and organisation of genes. The conserved regions of mouse mtDNA in descending 
order is tRNA regions, origins of replication of heavy and light strands (OH and OL 
respectively), rRNA genes protein encoding regions and finally the displacement D-
loop (Bibb et al, 1981). The mouse mtDNA is also smaller in size (16.295 kb) in 
comparison to human mtDNA, mainly due to its smaller D-loop region with 879 base 
pairs (Bibb et al, 1981). The mouse and human mitochondrial genome are 
economically organised by having their tRNA genes between rRNA and protein 
coding regions. The lack of introns in genes, absence of intergenic sequences 
excluding one regulatory region and small sizes of rRNA and tRNA molecules makes 







Figure 1.5. The human mitochondrial genome. The human mtDNA encodes for 15 
proteins of respiratory chain. Origin of heavy (OH) strand and origin of light (OL) 
strand are involved in mtDNA replication process. The genes encoding for subunits 
of each complex are colour coded according to the complex group they belong to. 
 
1.1.5  Mitochondrial DNA transcription and translation 
The mitochondrial genome is very compact in size and is present in numerous copies 
per cell. The transcription of human mtDNA is polycistronic and occurs on both 
strands to produce genome-long transcripts of mRNA and rRNA (Ojala, Montoya and 
Attardi, 1981). For successful mtDNA transcription, a number of proteins come 
together to initiate, elongate and terminate transcription of mtDNA. Initiation of 
mitochondrial transcription begins at two main transcription initiation sites within the 
D-loop; the origin of heavy strand promoter (HSP) and the origin of light strand 
promoter (LSP) which are 150 base pairs away from one another and are completely 
functionally independent. A 15 bp consensus sequence envelops the initiation sites 




transcription of H-strand commences at nucleotide 561 inside the HSP and the 
initiation of L-strand transcription commences at position 407 within the LSP. H-
strand transcription is initiated from two promoter regions; HSP1 and HSP2 which are 
approximately 100bp apart from one another in the non-coding region (NCR) 
(Montoya et al, 1982). Transcription of the L-strand is initiated from a single site that 
creates a long transcript encoding the ND6 gene and eight tRNAs. Transcription 
initiating at HSP1 results in a short transcript containing tRNAPhe, tRNAVal, 12S and 
16S rRNAs whereas transcription from HSP2 produces a near genome-length 
polycistronic RNA strand. (Dalla Rosa et al, 2017). 
Proteins essential for mtDNA transcription include the non-selective DNA-dependent 
mitochondrial RNA polymerase known as POLRMT (Fisher and Clayton, 1988) 
Milenkovic et al, 2013) which possesses a high sequence homology at the C-
terminus catalytic domain and two pentatricopeptide repeat (PPR) domains required 
for site-specific protein interactions (Ringel et al, 2011). Initiation of transcription also 
requires association of POLRMT with mitochondrial transcription factor A (TFAM), 
mitochondrial hexameric TWINKLE helicase, mitochondrial transcription factor B1 
(TFB1M) and transcription factor B2 (TFB2M). TFB2M is responsible for DNA melting 
during the initiation event and is thought to be at least twice as active in promoting 
transcription with POLRMT in vitro than TFB1M (Falkenberg et al, 2002).  
TFAM is a DNA-binding protein of 25kDa in size and is crucial for initiation of 
transcription and packaging of mtDNA in nucleoids (Kanki et al, 2004). It is made up 
of two high mobility group (HMG) domains separated by a 27 amino acid residue 
linker led by a 25 amino acid residue C-terminal tail (Taanman, 1999). The C-terminal 
tail is crucial for DNA recognition and high level specificity of transcription initiation 
(Dairaghi, Shadel and Clayton, 1995). At the upstream of HSP and LSP, TFAM forms 
a protein-DNA complex in order to recruit the modified version of POLRMT to the 
promoter via its N-terminal (Posse and Gustafsson, 2016). This also allows the 
mtDNA to form an arrangement that permits selective binding of the POLRMT. 
Mitochondrial elongation then occurs and is mediated by mitochondrial transcription 
elongation factor (TEFM) and POLRMT (Minczuk et al, 2011). Transcription 
termination occurs through mitochondrial transcription termination factor 1 (MTERF1) 
by bending the mtDNA at the junction between the HSP and tRNA Leu (UUR) terminal 




flipping and DNA unwinding (Martin et al, 2005). This was originally believed to 
explain the 50-fold increase in MTERF1-mediated rRNA synthesis. More recent 
evidence however suggest that increased rRNA abundance may be a product of 
increased stability (Terzioglu et al, 2013). MTERF1 is also documented to terminate 
LSP prematurely at 3’-end of the rRNA coding region to prevent the replication fork 
progressing into mitochondrial rRNA transcription while inhibiting rRNA antisense 
sequence transcription (Shi et al, 2016). 
Mammalian mtDNA translation take place on mitochondrial ribosomes 
(mitoribosomes) with 39S and 28S subunits plus two mitochondrially encoded rRNAs 
located inside the matrix (Smith, Smeitink and van den Heuvel, 2010). The 
mitochondrial translation machinery fully relies on nuclear-encoded regulatory 
proteins such as the initiation factor proteins mtIF2 and mtIF3 (Gaur et al, 2008). 
Initiation codons such as AUG or AUA are placed at the peptidyl site by mtlF3, while 
mtlF2 guides the assembly of the monosomes and the initiation of translation (Liao 
and Spremulli, 1990). Similar to mtDNA transcription, translation elongation follows 
the initiation event. Mitochondrial translation elongation factor EF-Tu forms a 
complex with Guanosine triphosphate (GTP) to direct the aminoacyl tRNA to base 
pair with the mRNA causing it to move along each codon (Cai et al, 2000). 
Termination of translation occurs at the A site in the presence of a stop codon 
(Frolova et al, 1999). Richter et al (2010) have shown that a -1 base frameshift in 
mammalian mitoribosomes at the AGA and AGG codons terminate the two open 
reading frames (ORFs) in MTCO1 and MTND6 genes respectively leading to 
termination of synthesis of 13 polypeptides at standard UAA and UAG stop codons. 
 
1.1.6  MtDNA replication 
Mitochondrial DNA replication occurs autonomously independently of the cell cycle 
(Bogenhagen and Clayton, 1997). The proteins involved in mtDNA replication are 
nuclear encoded and replication is controlled at the D-loop. The replication 
machinery is called the replisome and is made up of mitochondrial TWINKLE DNA 
helicase, mitochondrial DNA single-stranded binding protein (mtSSB) (13-16 kDa) 
(Falkenberg, Larsson and Gustafsson, 2007) and mtDNA polymerase γ (Polγ) which 




dependent mtDNA polymerase γ is essential for mtDNA replication, repair and 
recombination (Kaguni, 2004). Pol γ consists of a catalytic (PolγA) and two 
homodimeric accessory subunits (PolγB). PolγA has a 3’-5’ exonuclease activity and 
is 140 kDa in size, whereas PolγB is a 55kDa protein necessary for tight mtDNA 
binding and synthesis (Lim, Longley and Copeland, 1999). PolγA is responsible for 
proofreading of a newly synthesised mtDNA strand, and PolγB increases the activity, 
processivity and interaction of PolγA with the DNA template (Hudson and Chinery, 
2006). During initiation of DNA replication the double-stranded (ds) mtDNA is 
unwound to two complementary single-strands (ss) by TWINKLE in an ATP 
dependent manner in the 5’-3’ direction (Korhonen, Gaspari and Falkenberg, 2003). 
MtSSB is then used to stabilise the ssDNA, enhance the sensitivity of TWINKLE and 
trigger the activity of Polγ to initiate mtDNA synthesis (Korhonen, Gaspari and 
Falkenberg, 2003). Other enzymes required for mtDNA replication include 
ribonuclease H1 which actively removes primers from the OH and OL strands as well 
as mitochondrial topoisomerase to mitigate tension generated during replication of 
the mtDNA.  
MtDNA replication has been proposed to occur via two main mechanisms; the 
asynchronous (strand-coupled bidirectional replication model or strand displacement 
model) (Clayton,1982) and the synchronous strand coupled model (Holt, Lorimer and 
Jacobs, 2000). In the asynchronous strand displacement model mtDNA is replicated 
asymmetrically. MtDNA replication is initiated from the OH region in the D-loop and 
progresses clockwise around the two thirds of the genome until it displaces the origin 
of light strand replication (OL). Once the OL is exposed, lagging light strand synthesis 
is initiated and proceeds in the opposite direction (Clayton, 1982). A closed circular 
molecule is then formed as mtDNA daughter molecules ligate and generate a super 
helical structure known as mtDNA (Clayton, 1982). This method of mtDNA replication 
is documented to be a relatively slow process. 
In 2000, 2D gel electrophoresis analysis revealed that in addition to replication 
intermediates from the asynchronous mechanism of mtDNA replication, a second 
class of replication intermediates resistant to single-stranded nuclease degradation 
were present. These intermediates are consistent with conventional coupled leading 
and lagging strand DNA synthesis (Holt, Lorimer and Jacobs, 2000). In this model, 
replication occurs symmetrically and bi-directionally from multiple replication forks 




cytochrome b subunit of complex III and subunits 5 and 6 of NADH-ubiquinone 
oxidoreductase (Bowmaker et al, 2003).  
A more recent mtDNA replication mechanism in vertebrates was proposed by 
Yasukawa et al (2006) known as RNA-incorporation during mtDNA replication 
(RITOLS). In this model, RNAs are integrated into the lagging strand during the 
replication process leaving a time lapse between the synthesis of the leading and 
lagging strand. This model is very similar to the asynchronous replication model. 
Although the mechanisms determining which mode of replication a cell employs are 
not yet fully understood, it is thought to be dependent upon the cell type and required 
rate of mtDNA biogenesis. (Holt Lorimer and Jacobs, 2000; Reyes et al, 2004). 
 
1.1.7  Mammalian mtDNA repair mechanisms 
Mammalian mtDNA is protected from damage such as mutagenic insults to some 
extent due to the fact that is it packaged into nucleoids containing TFAM (Gouliaeva, 
Kuznestsova and Gaziev, 2006). Initially mtDNA was considered to not possess DNA 
repair capacity since alkylation damage (Miyaki, Yatagoi and Ono, 1977) and 
generation of pyrimidine dimers by UV damage (Clayton et al, 1974) were not 
removed from the mtDNA. MtDNA repair is crucial in preventing the accumulation of 
damage such as alkylation damage, hydrolytic and oxidative damage, formation of 
adducts such as photodimers, mismatches such as insertion-deletion loops (IDLs) 
and DNA strand breaks. More recent experimental evidence has revealed that 
mtDNA shares many repair mechanisms with nDNA (Blasiak et al, 2013). 
Development of techniques such as sequencing, microscopy and other molecular 
approaches have greatly advanced our knowledge of mtDNA repair over the last 
decade. 
Mammalian mtDNA repair mechanisms include base excision repair (BER) (Short-
patch and long-patch) as well as microhomology-mediated end joining (MMEJ) 
mechanisms (Zinovkina, 2018). BER pathway corrects the damaged base pairs, 
removes single base lesions and modifies nucleotides that occur with oxidative 
damage and alkylation (Bogenhagen and Clayton, 1977). BER occurs by initiation of 
specific DNA glycosylases and hydrolysis of the glycoside bond at the sugar 




Apurinic/apyrimidinic endonuclease enzyme (Tomkinson and Mackey, 1998). Polγ 
breaks and mtDNA ligase III seals and repairs the mtDNA. (Bogenhagen and 
Clayton, 1977). There are two classes of mtDNA BER glycosylases enzyme; mono-
functional and bi-functional enzymes. Mono-functional enzymes have only 
glycosylase activity, whereas bi-functional enzymes have both glycosylase and 
Apurinic/apyrimidinic lyase activity. Long-patch BER (LP-BER) is another category of 
BER for the removal of oxidised lesions of more than two nucleotides (Liu et al, 
2008). LP-BER occurs when DNA Polγ initiates polymerisation from 3’-OH adjacent 
to the deoxyribose phosphate residue (dRP) following Apurinic/apyrimidinic 
endonuclease activity. (Zheng et al, 2008). 
Other mtDNA repair mechanisms include correction of lesions on single-stranded 
mtDNA known as single-strand break repair (SSBR), mismatch repair (MMR) for the 
removal of unpaired nucleotides and repair of ds-DNA breaks by homologous 
recombination (HRR) as well as non-homologous end joining (NHEJ) as explained 
further in (Liu and Demple. 2010; Zinovkina, 2018).  
 
1.1.8  Heteroplasmy and the threshold effect 
Mitochondrial Heteroplasmy is the term given to a state in which a mix of both wild 
type mtDNA and mutant mtDNA coexist within an individual cell (Larsson and 
Calyton, 1995). Similarly, when all the mtDNA inside a cell is identical whether WT or 
mutant, this is termed homoplasmy. The level of heteroplasmy can vary between 
cells and is associated with the mosaic pattern of cells with defects in the electron 
transport chain observed in tissues in patients with mtDNA disease (Dufour et al, 
2008). The level of heteroplasmy is normally given as the percentage of mtDNA 
molecules within a cell or tissue that are mutated and indirectly determines the 
clinical phenotypes of mtDNA disease. A study on isolated skeletal muscle fibres in 
patients with 8344A>G mutation in the tRNALys gene revealed that the proportion of 
mtDNA mutation should exceed a critical threshold before a biochemical defect 
manifestation, which is typically around 60-80 percent (Boulet, Kapati and 
Shoubridge, 1992).  
MtDNA heteroplasmy levels can also shift over time by relaxed replication and 




even in non-dividing cells, and if a particular mtDNA variant is replicated more 
frequently than others, then the proportion of mutated and wild type mtDNA would 






Figure 1.6. MtDNA heteroplasmy and threshold effect. Low levels of mtDNA 
mutations is tolerated inside a single cell due to the multi-copy nature of the mtDNA. 
Defect in respiratory chain are detected when the biochemical threshold is exceeded 
a critical biochemical threshold. 
 
1.1.9  Mitochondrial DNA inheritance 
The mitochondrial genome is strictly maternally inherited and the transmission of 
maternal clinical phenotypes to the subsequent generations was also exhibited (Case 
and Wallace, 1981). During fertilisation, mixing of maternal and paternal mitochondria 
is averted by several mechanisms including ubiquitination modification (Sutovski et 
al, 2000), proteosomal degradation (Zhou, Li and Xue, 2011) and mitophagy (Al Rawi 




mitochondria still remains unclear, however it may partly be due to the higher 
population of mtDNA oocyte compared to the sperm. Paternal mtDNA however was 
observed in different species at different stages of embryogenesis, indicating the 
species-specific mechanism of eliminating sperm mitochondria (Kaneda et al, 1995). 
For example in C.elegans spermatozoon selectively prompts the recruitment of 
autophagosomes to degrade paternal mitochondria during early embryogenesis (Al 
Rawi et al, 2011). This evolutionarily conserved event also prevents the 
establishment of heteroplasmy by avoiding the paternal mtDNA transmission. Luo et 
al (2013) have reported that sperm mitochondria in mouse persisted unevenly in 
several cells until the morula stages of embryogenesis but lacked the genetic 
material, indicating that post-fertilisation elimination of sperm mitochondria in mouse 
did not occur through autophagy. 
The first human paternal transmission of mtDNA was reported in 2002 by Schwartz 
and Vissing where they have observed an existence of two various mtDNA 
haplotypes one from the mother and another from the father in the patient. The single 
male investigated had mitochondrial myopathy and exercise intolerance associated 
with a 2bp deletion in mitochondrial ND2 gene. Extensive investigation of the patient 
and his parents revealed that patient’s skeletal muscle tissue had 90% identical 
mtDNA sequence to the paternal haplotype and only 10% identical to the maternal 
mtDNA sequence. Studies by Taylor et al (2003) and Filosto et al (2003) reported a 
lack of paternal involvement in mtDNA transmission which highlights the rarity of 
paternal mtDNA inheritance and importance of inherited mtDNA disease diagnosis 
and counselling. A more comprehensive study was carried out by Luo et al (2018) on 
three unrelated multi-generation families with high levels of mtDNA heteroplasmy. 
They revealed bi-parental mtDNA inheritance in 17 members of all families. They 
have proposed that paternal mtDNA transmission was caused by a mutation in 
nuclear gene associated with paternal mtDNA elimination. 
 
1.1.10 Mitochondrial DNA bottleneck  
Rapid changes in the level of heteroplasmy were initially detected in pedigree of 
Holstein cows (1982) where a founder mother with no mtDNA polymorphism 




polymorphism (Hauswirth and Laipis, 1982). The observations led to the idea that 
genetic bottlenecking took place during the maternal transmission of mtDNA at 
oocyte maturation stage. The genetic bottleneck theory suggests that variation in 
heteroplasmy levels of offspring could be a result of reduction in mtDNA number 
during oogenesis which in turn forces rapid segregation of mtDNA heteroplasmy 
leading to high levels of variants (Zhang, Burr and Chinnery, 2018). The 
mitochondrial bottlenecks were thought to occur during oogenesis and in embryonic 
primordial germ cells (PGCs) (Jenuth et al, 1996). 
There is a strong evidence that the genetic bottleneck occurs to allow purifying 
selection throughout evolution. Muller in 1964 postulated that deleterious mutations 
accumulate over generations in asexual organism without recombination which 
ultimately leads to mutational genome meltdown. This process was termed as 
Muller’s ratchet. The mitochondrial genetic bottleneck allows purification selection 
against rapid advancement of Muller’s ratchet (Rand, 2008). Depending on the size 
of the mtDNA pool, the genetic bottleneck may allow loss or formation of 
homoplasmic mutation in the process of random and rapid genetic drift. The smaller 
the selected mtDNA pool, the higher the chances of heteroplasmy would be in a 
population of mutated and wild type alleles (Zhang, Burr and Chinnery, 2018).  
 
1.1.11 Clonal expansion  
Clonal expansion is a term used to describe the accumulation of a particular mutated 
mtDNA species within an individual cell until it reaches the threshold causing a 
mosaic pattern of respiratory chain defect (Krishnan et al, 2007; Larsson, 2010). 
Clonally expanded mtDNA deletions were initially detected biochemically in human 
muscle fibres of mitochondrial myopathy patients (Holt, Harding and Morgan-Hughes, 
1988).  
Müller-Höcker (1990) documented that clonal expansion of mtDNA mutations with 
increasing age lead to COX deficient muscle fibres. They revealed different patterns 
of mtDNA in situ hybridisation signals in ageing COX-deficient muscle fibres; a 
normal hybridisation signal, reduced signal as a result of mtDNA depletion and 
selective hybridisation as a result of a large-scale mtDNA deletion. This was the first 




skeletal muscle. Later on it was revealed that clonally expanded mtDNA deletions are 
also present in muscle fibres of healthy aged humans (Bua et al, 2006) and in 
Parkinson’s disease patients (Bender et al, 2006). Clonal expansion occurs in post-
mitotic tissues however it was also detected in colonic epithelium and crypt stem cells 
(Baines, Turnbull and Greaves, 2014) highlighting the importance of mtDNA 
mutations in functional decline during ageing. Sequential cytochrome c oxidase 
(COX)/ sodium dehydrogenase (SDH) histochemistry is used as a surrogate marker 
to detect intracellular clonally expanded mtDNA mutations. The mechanism by which 
a mutated mtDNA species clonally expands to become the dominant species within a 
cell is unknown. A number of theories to explain this have been proposed. 
In 1989, Wallace suggested the first molecular theory to explain the clonal expansion 
of mtDNA mutations with age; the survival of the smallest hypothesis. This theory 
suggests that smaller mtDNA molecules replicate faster than larger mtDNA 
molecules. Large-scale mtDNA deletions would result in smaller molecules that 
would have a replicative advantage over larger full-length wild-type mtDNA leading to 
accumulation and the spread of the deleted mtDNA in individual cells. Similarly the 
larger the deletion, the smaller the remaining genome would be and the greater 
replicative advantage it will have (Wallace, 1992). In 2014 however, Campbell et al 
demonstrated that mtDNA deletions of various sizes undergo clonal expansion in 
human skeletal muscle, suggesting that there is no replicative advantage for smaller 
genomes. In addition, point mutations that do not alter the size of the mtDNA 
molecule expand to high levels by clonal expansion confirming that clonal expansion 
isn’t driven by genome size (Picard, Vincent and Turnbull, 2016).  
A second hypothesis, the survival of the slowest theory (de Grey, 1997), postulates 
that the slower the rate of mitochondrial turnover, the higher the chances that 
dysfunctional mitochondria will persist. De Grey suggested that mitochondria with 
dysfunctional OXPHOS would actually produce fewer ROS, and have lower levels of 
ROS induced membrane damage. This would result in those mitochondria not being 
recognised as damaged and therefore degraded, allowing them to preferentially 
accumulate. However this hypothesis does not take into account the dynamic nature 
of the reticular mitochondrial network through processes of fission and fusion 
(Kowald and Kirkwood, 2011). In addition, it has been shown that dysfunctional 
mitochondria are actually preferentially degraded (Twig et al, 2008). Recently 




expansion of mtDNA deletions (Kowald and Kirkwood, 2018). The underlying 
mechanism of clonal expansion of mtDNA mutations is still largely unknown, 
although relaxed mtDNA replication can also cause intracellular random genetic drift 
in post-mitotic tissue leading to clonal expansion of single mtDNA mutation inside a 
single cell (Elson et al, 2001; Coller et al, 2002). As an example a stochastic model of 
mtDNA mutations in stem cells was developed to demonstrate random genetic drift 
(Stamp et al, 2018) and this could explain the pattern of OXPHOS defects present in 
ageing human colonic crypts. 
 
1.2 Ageing  
Ageing is an inevitable slow deterioration of body condition which is characterised by 
cumulative somatic damage and diminished cellular capacity for repair. The transition 
through the physiological decline in function with age is associated with dysregulation 
of gene expression, oxidative damage, increased mutation load, altered metabolite 
levels and increased susceptibility for developing disease, all of which are suggested 
to limit human lifespan (Gems and Partridge, 2013). In order to increase the quality of 
life with age, it’s crucial to understand the mechanisms underlying the ageing 
process. Early studies on ageing suggest that the ageing process is malleable since 
a single gene was discovered which could extend lifespan in Caenorhabditis 
elegans. Genetic manipulation of the gene daf-2 in C.Elegans result in three mutant 
strains of which had a doubling of lifespan. These mutants had reduced calorie intake 
and paralysis suggesting that ageing appeared to be controlled in a polygenic 
manner (Klass, 1983; Kenyon, 2005). Other altered pathways such as the insulin-like 
growth factor (IGF-1) pathway and protein translation modulation were identified to 
increase longevity in model organisms including nematodes, yeast, fruit-flies and 
mice in an evolutionary conserved manner (Vijg and Campisi, 2008). Hansen et al 
(2007) have shown that reducing the ribosomal protein levels known as the S6 
kinase or translation initiation factors increases the lifespan in C.elegans by shifting 
the cell’s health state to favour maintenance, longevity and repair. 
The experimental evidence to date suggest that ageing is a multi-factorial process 
which stems from a combination of different mechanisms. Different theories of ageing 





1.2.1  Evolutionary theories of ageing 
Evolutionary theories of ageing and longevity are based on the remarkable 
differences in lifespan across different biological species which evolved from the 
interplay between mutation and natural selection. Almost a century after Darwin’s 
theory of biological evolution by natural selection, evolutionary theories of ageing 
were proposed. August Weismann in 1882 envisioned ’Programmed Death’ which 
suggests that ageing is an advantageous process to replace the older population with 
younger organisms by programmed death in order to maintain population size 
(Weismann, 1882). Later Peter Medawar, in 1952, proposed the ‘accumulation of 
somatic mutation’ theory of ageing which suggests that accumulation of random 
unrepaired somatic mutations is detrimental, drives the ageing process and limits 
one’s lifespan by reducing the level of maintenance in function. George Williams 
hypothesised another theory of ageing in 1957, which suggested that natural 
selection favours the accumulation of deleterious genes in an older population that 
once had reproductive benefits early in life. This theory was known as the 
antagonistic pleiotropy theory of ageing from which the disposable soma theory of 
ageing was developed by Thomas Kirkwood in 1977. The disposable soma theory of 
ageing postulates that a gene could have both deleterious and advantageous effects. 
The initial idea arose from a hypothetical genetic mutation that led to reduced 
proofreading accuracy in somatic cells but saved and invested energy for 
reproduction and development instead, which resulted in inevitable ageing process 
(Gavrilov and Gavrilova, 2002). 
Evolutionary theories of ageing are mainly focused on the diminished force of 
selection and accumulation of mutation as a function of age whereas molecular 
theories of ageing emphasise the complexity of ageing that is influenced by genetic 
and environmental factors which is explained further in the subchapter below. 
 
1.2.2  Modern biological and molecular theories of ageing 
Modern biological theories of ageing fall into two categories which include the 




that gene expression regulates the process of ageing by switching age-associated 
genes on/off sequentially (Davidovic et al, 2010). A sub-group of the programmed 
theory includes the endocrine theory where hormones act to control the pace of 
ageing (Heemst, 2010). The observation comes from the single mutation that 
diminishes the evolutionarily conserved insulin/IGF-1 signalling pathway in C.elegans 
that resulted in their extended lifespan. Another theory was the immunological 
hypothesis (Fulop et al, 2014), where the immune system is programmed to decline 
with advancing age leading to increase vulnerability to infections, ageing and death. 
This theory was proposed following the observation that the immune system loses its 
effectiveness in combating disease as we age (Cornelius, 1972). 
Due to extensive unsatisfactory theories of ageing postulated in late 1990s, Kowald 
and Kirkwood (1996) considered interactions of different hypothesised mechanisms 
of ageing such as unrepaired damage accumulation in somatic cells, telomeres 
shortening and mitochondrial dysfunction. In 2005, Kirkwood suggested that ageing 
occurs as a result of random unrepaired molecular damage to somatic cells that 
accumulates with age. The efficiency of DNA repair mechanisms and removal of 
damage also declines with increasing age leading to tissue dysfunction (Mc Auley et 
al, 2017). Telomeres as biological clocks of the cell are neuroprotein structures that 
protect chromosomal ends against degradation except in cells with infinite 
proliferative capacity (Olovnikov, 1996). Telomeres progressively shorten with each 
cell cycle therefore reducing the amount of protection it provides to the genome with 
age (Campisi, 2000). When telomeres reach a critical length, cells stop replicating 
and enter a replicative senescence stage (Levy, 1992). Germ cells have telomerases 
to restore telomere length to the end of chromosomes ensuring cells continue to 
reproduce and promote their survival cycle. Telomere maintenance through 
telomerase is absolutely crucial to organs of extensive cell turnover such as stem 
cells (Flores, Cayuela and Blasco, 2005). Mikhelson and Gamley (2013) have 
suggested that telomere shortening is a sole mechanism of mammalian ageing. They 
have postulated that if oxidative stress was non-existent then telomeres would still 
shorten with each mitotic cell cycle due to mtDNA replication and ageing would still 
occur. DNA damage with age can also arise from post-translational and chemical 
cross-linking of proteins to intrude the normal functioning of cells (Bjorksten and 




within cells (Cuervo and Dice, 2000) may also cause the accumulation of DNA 
damage in ageing tissues. 
 
1.2.3  Mitochondrial free radical theory of ageing 
The mitochondrial free radical theory of ageing (MFTA) integrates the contributions of 
dysfunctional mitochondria, reactive oxygen species and defective proteins and 
macromolecules in the process of ageing. Denham Harman (1956) suggested that 
superoxide and hydroxyl radicals and other free radicals generated during cellular 
respiration in mitochondria can damage macromolecules such as nucleic acids, 
proteins and lipids inside cells. Since cells posses their own ROS scavenging system 
to convert harmful superoxides to a less reactive hydrogen peroxide by superoxide 
dismutase (SOD), the likelihood of damage at lower level is low (Skulachev, 2007). 
Hydrogen peroxide is usually broken down by catalase, peroxiredoxin or glutathione 
peroxide to H2O but can react with ferrous iron to form highly reactive hydrogen 
radicals which cause damage to cellular components. The body’s natural oxidative 
scavenging system declines with age, which therefore increases the risk of the 
accumulation of cellular damage. Promoting the body’s natural defence system by 
increasing anti-oxidant levels in rodents has been shown to increase longevity 
(Schulz et al, 2007). 
There is conflicting evidence regarding the role of ROS in the ageing process. For 
example, there is evidence to suggest that an endogenous increase in ROS is 
positively correlated with lifespan. In a study by Andziak and Buffenstein (2006) 
naked mole-rats demonstrate exceptional longevity despite extremely high levels of 
ROS. This led to further research on the role of ROS as cellular signalling mediator in 
immune and stress response (Labunskyy and Gladyshev, 2013). However, 
conversely it has been shown that protection against cellular ROS by ROS 
metabolising enzymes such as mitochondrial catalase (MCAT) results in increased 
longevity in mice, with delayed cardiac pathology and cataract development and 
reduced mitochondrial deletion events (Schriner and Linford, 2006). Overexpression 
of other ROS scavenging enzymes such as CuZnSOD have also been shown to 




During cellular respiration, oxygen can occasionally form superoxide by reacting with 
reduced components of the electron transport chain (ETC). This normally occurs at 
complexes I and III of the oxidative phosphorylation (OXPHOS) system (Giorgio et al, 
2005). Hiona and Leewenburgh (2008) reported that accumulation of mtDNA 
mutations caused by oxidative damage impairs the function of respiratory chain 
proteins and triggers further ROS generation and ever-increasing oxidative stress. 
This leads to a defects in mitochondrial OXPHOS capacity and eventually cell death. 
This may result in vicious cycle of mitochondrial damage known as the mitochondrial 
‘vicious cycle’ theory of ageing (Miquel et al, 1980). Supporting the mitochondrial 
theory of ageing, somatic mtDNA mutations leading to defects in OXPHOS have 
been detected in multiple mitotic (colon, stomach, small intestine, liver, oesophagus) 
and post-mitotic (skeletal muscle, brain, heart) tissues with age (Müller-Höcker, 1990, 
Cottrell et al, 2001, Taylor et al, 2003, McDonald et al, 2008, Bender et al, 2006, 
Fellous et al, 2009, Greaves et al, 2012). 
In order to test the vicious cycle theory of ageing, Greaves et al (2014) examined 
colorectal epithelium samples from young adult (<25) and aged (>70) humans using 
a methodology to quantify low level mtDNA mutations (proxy for mtDNA mutation 
rate) and clonally expanded mtDNA mutations. They showed that non-pathogenic 
mtDNA mutations exist from embryonic stages and are transmitted through the 
germline. Pathogenic mtDNA mutations are selected against in the germline, yet 
occur somatically throughout development and childhood and are detectable at low 
levels from early adulthood. They did not see any evidence of an increase in the 
frequency of low-level mtDNA mutations with age, indicating that there was no 
significant increase in basal mtDNA mutation rate. However, the frequency of cells 
with clonally expanded mtDNA mutations increased significantly over time. These 
data provided evidence refuting the vicious cycle hypothesis of ageing (Miquel et al, 
1980) and instead suggested that clonal expansion by random genetic drift was the 
driving force underlying the accumulation of mitochondrial dysfunction with age.  
Szczepanowska and Trifunovic (2017) suggested that the main source of mtDNA 
point mutation accumulation with age is the imperfect replication process mainly due 
to impaired mtDNA polymerase γ (POLG). MtDNA polymerase γ is the main protein 
involved in mtDNA synthesis. Error rates for proofreading deficient polymerase γ in 
humans is at 5.6 x10-7 (zheng et al, 2005). The high accuracy and low error rate of 




synthesis, selective extension of 3’-terminal and accurate excision of false nucleotide 
pair during a 3’-5’ exonuclease activity (Echols and Goodman, 1991; Johnson, 1993). 
There are many other studies implicating mitochondrial dysfunction in the ageing 
processes e.g. a knockout mutation in the p66Shc adaptor protein enhances 
resistance to apoptotic cell death induced by ROS. P66Shc is a cytoplasmic signal 
transducer in the transmission of mitogenic signals from activated receptors to ROS 
(Skulachev, 2000). ROS generated were thought to oxidise phosphatidyl serine in the 
inner cell membrane and cause phosphorylation of p66shc at a serine residue. 
Galomov (2010) showed that knockout mice harbouring the mutated form of this 
protein have a 30% increase in lifespan and resistance to stress apoptotic 
responses. Another example is a mutation in mitochondrial COX5 gene which 
encodes for the final subunit V of the cytochrome c oxidase complex in a filamentous 
fungus species known as Podospora anserine. The resultant mutation lead to 
inactivation of the nuclear encoded gene, multiple phenotypic properties such as 
severe malfunction in germinating mycelium and female sterility as well as a 
significant decrease in production of ROS enabling an increase in lifespan by ten-fold 
associated with stabilisation of mitochondrial chromosome (Dufour et al, 2000). 
 
1.3 Mouse models of age-related mitochondrial dysfunction 
1.3.1  TFAM knockout mouse 
A mouse model of mitochondrial diabetes was generated by knocking out TFAM in 
pancreatic beta-cells (Silva et al, 2000). TFAM knockout mice developed diabetes 
from as early as 5 weeks of age, displayed OXPHOS deficiency and mtDNA 
depletion from 7-9 weeks of age. As a result, the beta-cell population was lower, 
mitochondrial membrane potential hyperpolarisation threshold was reduced, Ca2+ 
signalling was impaired and insulin secretion was diminished upon stimulation with 
glucose, highlighting the importance of mitochondria in insulin secretion. Similarly a 
study by Sorensen et al (2001) showed that a neuron-specific TFAM knockout in the 
mitochondrial late-onset neurodegeneration mouse model (MILON) developed 50% 
reduction in mtDNA number, progressive neuronal cell loss, apoptosis and gliosis in 
their neocortex and hippocampus. Wredenberg et al (2006) conducted another study 




knockout mice. The mice were subjected to glucose tolerance tests but were found to 
not have diabetes indicating that mitochondrial OXPHOS dysfunction in skeletal 
muscle is not a primary defect inducing insulin resistance and development of 
diabetes. In 2007, Ekstrand et al have investigated the role of respiratory chain 
defects on dopaminergic (DA) neurons by creating a DA neuron specific TFAM 
knockout mouse known as MitoPark mouse. These mice developed a slow 
progressive motor function impairment, DA neuron cell death and Parkinsonism 
phenotype in adulthood highlighting the fact that respiratory chain dysfunction may 
play a critical role in pathophysiology of Parkinson’s disease. 
 
1.3.2  Mitochondrial mutator mouse 
In 2004, Trifunovic et al (2004) were the first to develop a mouse model that 
accumulates high levels of mtDNA mutations in all tissues of the body and shows an 
accelerated ageing phenotype. This mouse has a knock-in missense mutation 
causing a substitution of a critical amino acid Aspartate (D257A) to alanine in the 
proof-reading catalytic core of heterodimeric enzyme (PolgA). This amino acid 
substitution abolishes the 3’-5’ POLG exonuclease activity of the protein leading to 
progressive random somatic mtDNA mutation accumulation by 3-5 fold in a linear 
fashion with age. This leads to the development of a mosaic pattern of respiratory 
chain deficiency in tissues of high energy demand such as the heart, skeletal muscle 
and brain (Trifunovic et al, 2004). 
From 16 weeks of age the, PolgA mut/mut mice developed premature ageing 
phenotypes such as cardiac hypertrophy, kyphosis, hair loss, anaemia, osteoprosis, 
reduced fertility and reduced subcutaneous fat as well as reduced lifespan to an 
average of 48 weeks resembling normal human ageing. Kujoth et al (2005) reported 
that these mice do not develop increased ROS generation and oxidative damage at 
the tissue level providing evidence against the mitochondrial vicious cycle theory. In 
contrast with this study, more recent technological advances have shown evidence of 
elevated hydrogen peroxide levels in the muscle of aged PolgAmut/mut mice, 
suggesting that there is a role of oxidative damage in the phenotype of these mice at 
older age (Kolesar, 2014). Also Niu et al (2007) showed that accelerated and 




as 6 months of age equivalent to wild type mice of 25 months of age. The hearing 
loss was associated with cell death in the inner ear with the highest density of 
mitochondrial accumulation. Interestingly, analysis of isolated mitochondria from both 
spleen and livers of PolgA mut/mut mice revealed age-dependent development of 
abnormal erythroid maturation, macrocytic anaemia and megaloblastic anaemia 
which resulted in morphological abnormalities in erythroblasts followed by death at 
15-16 months of age. Mitochondrial dysfunction therefore plays a significant role in 
cell-intrinsic haematopoiesis (Chen et al, 2009). Ahlqvist et al (2012) reported that 
PolgA mut/mut mice had neural and haematopoietic progenitor cell dysfunction from 
embryogenesis that underlies progeroid phenotype manifestation and respiratory 
chain dysfunction in non-dividing tissues in older age in these mice. 
Another study showed accelerated ageing phenotypes of PolgA mut/mut mice 
associated with increased mitochondrial hydrogen peroxide levels supporting the 
oxidative damage theory of ageing (Logan et al, 2014). They have suggested that 
prolonged persistent of mtDNA mutations may have activated the ROS production in 
redox signalling or have modified the response of the immune system to generate an 
array of pro-inflammatory cytokines contributing to progeroid phenotypes. 
Shabalina et al (2017) have documented that treating PolgA mut/mut mice for ~100 
days with mitochondrial targeted antioxidant 10-(6′-plastoquinonyl) decyltri-
phenylphosphonium cation (SkQ1) delayed the appearance of age-related features 
such as kyphosis, weight loss, alopecia and cardiac pathologies in this mouse model. 
Other antioxidants such as catalase and N-acetyl-L-cysteine (Dai et al, 2010; Ahlqvist 
et al, 2012), have also shown lifespan extension in PolgA mut/mut mice indicating ROS 
damage and oxidative stress play a major role in development of ageing 
characteristics of this mouse model.  
 
1.4 The cardiovascular system 
1.4.1  The heart  
The human heart is located medially inside the thoracic cavity between the left and 
right lung in a way that the apex of the heart is pointing towards the left lung. A 




(Molina and DiMario, 2015). The heart is made of two upper (the atria) and two lower 
(ventricles) chambers to circulate blood through the pulmonary and systemic circuit 
as shown in Figure 1.7A. The atrioventricular septum (AVS) separates the right and 
left side of the heart. Deoxygenated blood is pumped from the right ventricle through 
the left and right pulmonary arteries into the lungs for gas exchange and the 
oxygenated blood then returns back to the left atrium through the pulmonary vein. 
Oxygenated blood is pumped into the left ventricle and then into the systemic 
circulation through the aorta. The deoxygenated blood then returns back to the right 
atrium through the superior and inferior vena cava. The valves are to prevent the 
backflow of blood in the opposite direction. The valves between the atria and the 
ventricles are called AV valves (tricuspid valves between the right atria and ventricle, 
mitral valve between the left atria and ventricle). The valves leading to the aorta and 
pulmonary trunk are known as semilunar valves (left: aortic value and right: 
pulmonary valve). The valves work in conjunction with the pumping action of the 
myocardium and are attached to the papillary muscles by chordae tendineae to 
prevent the backflow of blood, however semilunar valves lack chordae tendineae and 
papillary muscles. They instead have folds of endocardium made up of connective 
tissue to seal the valves when the ventricles are filled with blood and the pressure is 
high (BHF, 2019). Cardiac muscle is encased with pericardial membrane as well as a 
pericardium bilayer which consists of three layers, epicardium which is the inner wall 
of the pericardium, myocardium which is the middle layer of pericardium and 
endocardium which is the inner lining layer in contact with the blood (Figure 1.7B). 
The human and mouse heart have exceptional anatomical similarities during 
development and postnatally. The mouse AVS is however more muscular due to 
delayed delamination of the tricuspid valve (Webb, Brown and Anderson, 1996) and 
myocardialisation of the mesenchymal tissue between atria and ventricles (Kruithof et 
al, 2003). In the mouse heart, the tendinous chords (chordae tendineae) are less 
prominent than in humans. Trabeculae carneae are protrusions in the inner lining of 
the ventricles. These protrusions vary between the right and left ventricle of human 
heart, but not in the mouse heart. In the left ventricle, these trabeculae are thin 
whereas in the right they’re being described as coarse (Wessels and Sedmera, 
2003). Morphological differences which exist between the human and mouse heart 
include the size and shape of the muscular AVS and the location of the aortic outlet 




mainly in the venous pool. Mice also demonstrate a significantly higher heart rate 
than humans. Despite these differences, mice serve a valuable model for the study of 
the heart due to the similar anatomy. 
 
 
Figure 1.7. The human heart structure. A) Anterior view of the heart. 
Deoxygenated blood enters the right atrium through superior and inferior vena cava 
and becomes oxygenated by passing through the lungs through pulmonary artery. 
Image adapted from OpenStax (2019). B) The epicardial membrane and heart wall 





1.4.2  The vasculature  
Arteries carry oxygenated blood away from the heart through systemic circulation 
except the pulmonary and umbilical arteries which carry deoxygenated blood for 
oxygenation. Coronary arteries supply blood to the cardiac muscle and branch off 
from the base of the aorta to the right coronary artery and left main coronary artery 
as well as descending artery and circumflex artery. Blockage in any of these arteries 
may cause heart diseases, known as coronary artery disease. Arteries have elastic 
properties and are able to expand and withstand changes in blood pressure 
(American Heart Association, 2019). The arterial wall consists of the tunica intima 
which is the outermost squamous epithelium layer surrounded by a connective tissue 
layer known as the basement membrane (Taki et al, 2017). The basement 
membrane is made of elastic fibres to provide malleability with blood pressure 
changes. Tunica media is the next upper layer mainly made of thicker smooth muscle 
to support diameter changes within the blood vessel and regulates blood flow. The 
final connective tissue layer is the tunica externa which contains varying proportions 
of elastic and collagenous tissue at different ends of the vessel. 
Capillaries are the smallest blood vessels present in abundance that carry out the 
exchange of O2, CO2, nutrients and waste materials between the blood and the 
tissue (Natural crest cells, 2014). On the other hand, veins carry deoxygenated blood 
from the rest of the body to the heart apart from the pulmonary and umbilical veins. 
They are smaller in diameter and do not contain any elastic fibres in the tunica intima 
layer. The smooth muscle component of veins facilitate contraction and dilation of 
veins to accommodate blood volume changes (Pinnell, Turner and Howell, 2007). 
 
1.4.3  Cardiac muscle structure 
Cardiac muscle is a myogenic, involuntary and striated muscle that usually contains 
one central nuclei in each cardiomyocyte. Individual cardiomyocytes are shorter in 
length and smaller in diameter than skeletal muscle fibres, however they are 
organised into sarcomeres and share the same banding organisation as skeletal 
muscle. On average, human adult cardiomyocytes are about 0.1mm in length and 




are myocardial contractile cells which reside predominantly in the atria and ventricles 
and are responsible for myocardial contraction. The second type are myocardial 
conducting cells which constitute a very small proportion of cells responsible for 
conduction and propagation of the action potential (Saxton and Bordoni, 2018). Each 
cardiomyocyte is surrounded with sarcolemma and is packed with mitochondria for 
continuous supply of ATP during cardiac contractions. Myofilaments are encased by 
sarcoplasmic reticulum and t-tubules at the level of Z-line cross the cell to allow rapid 
transmission of action potentials into the cell (Pinnell, Turner and Howell, 2007). 
Cardiomyocytes are extensively branched and are connected by double-membraned 
intercalated discs where individual cells are bound by desmosomes and connected 
through gap junctions to allow easy conduction of impulses between cells (figure 
1.8). Intercalated discs connect two adjacent cardiomyocytes together where two 
sarcolemma join to support the synchronised contraction of the cardiac muscle (Hong 
and Shaw, 2016). Desmosomes anchor cardiomyocyte ends together to maintain the 
integrity of muscle.  
 
 
Figure 1.8. Cardiac muscle structure. Structural arrangement of striated cardiac 
muscle which are connected by intercalated discs to allow for a wave-like pattern of 
contraction during the pumping action of the heart. 
 
1.4.4  Cardiac muscle function 
The primary function of heart muscle is to contract and pump oxygenated blood into 




form of ATP which is provided by oxidative phosphorylation in mitochondria. The 
functional adaptations of cardiomyocytes include their branched structure for faster 
signal transduction. However due to the low capacity of cardiac muscle to store 
energy, a constant energy influx in the form of ATP is required (Attansio and Netti, 
2017). Cardiac muscle also has longer contraction and refractory periods to maintain 
a viable heartbeat. External hormonal and nervous system stimulation of the heart 
muscle enables cardiac muscle to adapt to situations of different energy demand. 
Also the inherent contractile activity of cardiac muscle is controlled by the autonomic 
nervous system. Any disruption to the synchronous contraction of cardiac muscle 
may lead to uncontrolled pumping action of the heart muscle and conditions such as 
ventricular fibrillation. 
Cardiac function responds to meet the metabolic demand of the body by regulating 
either the stroke volume or respiratory rate. Increasing the respiratory rate increases 
the rate of oxygen perfusion to the working tissue. Similarly increasing the stroke 
volume will increase the volume of blood ejected from the ventricle during systole to 
the working tissue leading to regulated cardiac function. Cardiac function and 
vascular resistance can be measured by cardiac catheterisation directly or indirectly 
through thermodilution, cardiac MRI and exercise testing (Carreiro, 2009). 
It is widely reported that ageing and heart failure significantly reduce cardiac 
performance and left ventricular (LV) cardiac output when compared to younger and 
healthy individuals (Strait and Lakatta, 2012). Reduction in myocardial energetics 
such as cytoplasmic adenine nucleotide, phosphates and creatine pool with age and 
in heart failure partly influence the reduction in cardiac output ( Wu, Zhang and 
Beard, 2009; Gao, Jakovljevic and Beard, 2019). 
 
1.4.5  The cardiac muscle action potential 
Cardiac impulses that facilitate the heartbeat originate from the sinoatrial (SA) node 
also known as the pacemaker cells of the heart. The SA node is located on the right 
atrial muscle causing the atria to contract following depolarisation of the atria and 
release blood into the right ventricle through the tricuspid valve. The heart rate is 




signals from the central nervous system (CNS) and various hormones that modulate 
heart rate and regulate blood pressure (Hedegard, 2019).  
Ventricular contraction (systole) is controlled by the atrioventricular (AV) node which 
is located on the IVS septum between the two ventricles. The cardiac action potential 
originates from the spontaneous depolarisation of the SA node which generates the 
intrinsic electrical activity of the heart. The action potential in the cardiac muscle is 
more prolonged (about 300ms) than in nerve cells. During this time no further action 
potential can take place which is known as an absolute refractory period. The 
sarcoplasmic reticulum (SR) releases Ca2+ from internal stores to activate cardiac 
muscle contraction. During cardiac depolarisation, membrane permeability to K+ 
decreases and Na+ channels open resulting in membrane voltage changes from -90 
mV to +10 mV. Once the action potential reaches a plateau, membrane permeability 
to Ca2+ increases to prolong the action potential. The Na+/Ca2+ ATPase pump allows 
for the influx of Na+ and produces a net inward of positive current during the plateau 
phase. Repolarisation takes place soon after Ca2+ channels inactivate by an outward 
flux of K+ ions and the membrane potential falls back to -90mV (resting membrane 
potential). The mechanical pumping action of the heart is followed by the electrical 
activity of pacemaker cells located on the SA node. Once pressure within the heart 
drops, the contraction of the atria enters a diastole phase which is longer in duration 
than systole. The cardiac cycle is the process of one heartbeat comprising of a 
complete relaxation and contraction which lasts about 0.8 seconds in human adults 
(Malanga, 2007).  
 
1.4.6  Excitation-contraction coupling  
The auto-rhythmic ability of the heart muscle enables rapid movement of action 
potentials across gap junctions. The pacemaker activity of the cardiac muscle directly 
controls the heart rate. This action potential triggers the release of calcium from the 
sarcoplasmic reticulum and other internal calcium stores causing myofilaments to 
contract in a process called excitation-contraction coupling (Bers, 2002) (Figure 1.9). 
The two main categories of Ca2+ currents (ICa) in cardiac myocytes are L-type and T-
type Ca2+ currents. The L-type channel activates and deactivates (more slowly) at 




voltage dependent Ca2+ channels (L-VDCC) open. Unlike skeletal muscle, cardiac 
muscle relies on a constant heart beat for Ca2+ release from SR via Ca2+ release 
channels i.e. ryanodine receptors. This Ca2+ -induced Ca2+ -release process (CICR) 
causes a rapid increase in intracellular Ca2+ concentrations for optimal binding of 
Ca2+ to troponin C and contraction induction. Troponin C then releases the Ca2+ for 
reuptake by SR by activating SR Ca2+ ATPase 2a (SERCA2a) pump and through the 
Na+/ Ca2+ exchanger (NCX). At resting conditions, a cardiomyocyte takes ~600ms to 
contract, relax and recover. Ca2+ is essential for cellular integrity, cardiac gene 
expression (Finkbeiner and Greenberg, 1998) and the development of the embyonic 
heart (Rottbauer et al, 2001). T-type Ca2+ channels on the other hand are low-voltage 
activated channels and are relatively insensitive to dihydropyridines (DHPs). T-type 
Ca2+ channels are abundant in sinoatrial node (SAN) and purkinje fibres and are 
essential for establishing the frequency of AP firing (Ono and Lijima, 2010). 
 
 
Figure 1.9. Excitation-contraction coupling (ECC). ECC is accompanied by Ca2+ 
transport in the ventricular myocyte. β-adrenergic stimulation and activation by 
epinephrine or noradrenaline leads to activation pf GTP-binding protein (Gs) which 
activates adenylyl cyclase (AC) to produce cyclic AMP (cAMP) which in turn activates 
protein kinase A (PKA). PKA has both positive inotropic (contraction) and lusitropic 
(relaxation) effects on the muscle. If Phospholamban (PLB) and troponin I are 
phosphorylated, SR uptake of Ca2+ increases and Ca2+ dissociates from the 





1.4.7  Mitochondria within the heart muscle 
Cardiomyocytes possess multiple mitochondria and myoglobin since ATP is 
generated through aerobic metabolism in the heart. In fact, an adult human heart 
synthesises approximately 30kg of ATP everyday (Ferrari, Cargoni and Ceconi, 
2006).  
Fatty acids are the preferred energy supply for mitochondria (Murphy et al, 2017), 
however, they are able to convert different substrates into ATP in order to respond to 
changes in environment such as during exercise or at different altitudes. The fatty 
acid β-oxidation pathway and tricarboxylic acid cycle (TCA) are described in more 
detail in section 1.1.2.1. Once fatty acids are broken down into Acetyl-CoA, they 
enter the TCA cycle, also known as Kreb’s cycle. Electron carriers (NADH and 
FADH2) produced during TCA cycle, are fed into the electron transport chain (ETC) to 
create an electrochemical gradient across the intermembrane space to activate ATP 
synthase to produce ATP in the presence of O2 (Brown et al, 2017). 
Two types of mitochondria were observed in the ultrastructure of cardiac muscle 
including subsarcolemmal mitochondria (SSM) and interfibrillar mitochondria (IFM) 
(Palmer, Tandler and Hoppel, 1985). Interfibrillar mitochondria are located between 
myofibrils and subsarcolemmal mitochondria are located beneath the plasma 
membrane. The two mitochondrial types differ in structure, location and their 
biochemical properties. Interfibrillar mitochondria utilise substrates 1.5 times faster 
than subsarcolemmal mitochondria and have higher activities of SDH and citrate 
synthase. These differences make the two populations of mitochondria energetically 
different but very difficult in isolation (Lenaz et al, 2006). For instance, dysfunction of 
cardiac SSM was reported in a murine model of type 2 diabetes mellitus (Dabkowski 
et al, 2010). Also human studies revealed a significant reduction in complex I and 
fatty acid-mediated respiration rate in SSM population of type 2 diabetes patients 
with no changes in IFM population (Croston et al, 2014). 
It's documented that the failing human heart undergoes significant depletion of 
energy reserves as evident by low phosphocreatine to ATP ratio (PCr: ATP) through 




muscle is reported to be correlated with clinical symptoms and is thought to be a 
better predictor of mortality than EF alone (Neubauer et al, 1997). 
To understand mitochondrial function in the human heart better, measurements of 
mitochondrial enzyme activities from cardiac muscle homogenates provided valuable 
information about the capacity of different steps involved in mitochondrial 
metabolism. It’s difficult to measure the capacity of ATP production by the whole 
system since functional impairment occurs when OXPHOS enzymatic activities are 
reduced below a threshold level (Rossignol et al, 2003), however complexes III and 
IV are present in amounts larger than needed to aid maximal electron transport in 
human cells (Villani and Attardi, 1997), therefore a reduction in the activity of one 
complex in the ETC may not impact the whole process. 
Gellerich et al, 1994 have shown that the rate of respiration in the human left atrial 
appendage is lower than in the left ventricle. In contrast to skeletal muscle, the 
number of mitochondria and ETC activity is higher in cardiac muscle, but the 
OXPHOS capacity is limited in cardiac muscle. In fact, respiration coupled to ATP 
generation is about 40% of the maximal capacity of the heart muscle (Lemieux and 
Hoppel, 2009), in comparison to 80% in skeletal muscle (Boushel et al, 2007).  
In rodent models however the OXPHOS capacity of cardiac muscle is much higher 
than skeletal muscle and the OXPHOS system does not apply any limitation on the 
maximal OXPHOS capacity of the cardiac and skeletal muscle (Aragones et al, 
2008). Calcium accumulation capacity in human cardiac muscle is also much lower 
than in the hearts of a variety of animals (Lindenmayer et al, 1971). The 
particularities of human heart mitochondria reinforces the importance of 
understanding mitochondrial metabolism specifically in human heart. 
 
1.4.8  Cardiac muscle oxidative stress 
Reactive oxygen species (ROS) are generated through aerobic metabolism as a by-
product of OXPHOS in mitochondria and are normally regulated by antioxidants 
(Chen et al, 2003). Excessive production of ROS or antioxidant deficiency can cause 
ROS damage to the proteins and lipids within mitochondria. Oxidation of proteins 




role in cellular homeostasis (Droge, 2002) and are a major source of superoxide 
radicals (Turrens, 2003). Low concentrations of ROS inside a cell maintains its role 
as a signal transducer, however its excessive production and redox imbalance leads 
to oxidative stress and increases the risk of cardiovascular disease. ROS include 
hydroxyl radicals, superoxide anions, H2O2 and peroxynitrite. Those that contain free 
radicals such as superoxide anions have oxidising effects.  
 
1.4.9  ROS in cardiac disease 
Excessive ROS have a direct effect on the arterial wall by activating second 
messenger systems in vascular signalling (Taverne et al, 2013). Tunica intima is 
affected mainly by ROS scavenging system. The imbalance in cell proliferation and 
growth inhibition is also controlled by cellular ROS state which will cause extreme 
biogenesis or depletion of endothelial cells respectively (Papaharalambus and 
Griendling, 2007). Hattouri et al (2001) have documented that the ROS produced 
during ischaemia reperfusion injury activates apoptosis, and during pre-conditioning 
inhibits apoptosis by regulating expression of Bcl-2 family of proteins.  
 
1.4.10 Cardiovascular disease 
Cardiovascular disease (CVD) is the leading cause of mortality and hospitalisation 
worldwide. The prognosis in CVD is still very poor causing 17.9 million deaths 
annually which accounts for 35% of all deaths globally (WHO, 2019). The risk factors 
identified in epidemiological studies include hypertension, smoking, inactivity and 
high cholesterol (Thanassoulis and Vasan, 2010). There are multiple genetic and 
environmental factors that contribute towards developing cardiovascular disease. 
Development of CVD is initiated by molecular and cellular changes followed by 
cardiac pathophysiological remodelling. It is documented that changes in energy 
metabolism of cells activate profibrotic signalling cascades as well as a hypertrophic 
response resulting in cellular death and cardiomyocyte loss (Frangogiannis, 2012).  
The development of cardiac hypertrophy is a multi-step process beginning with an 
extracellular hypertrophic stimulus, activation of early response genes and increased 




the hypertrophic signal by activating the mitogen-activated protein (MAP) kinase 
cascade and finally there is recruitment of nuclear transcription factors, triggering 
events for cellular hypertrophy (Glennon, Sugden and Poole-Wilson, 1995). 
Alterations in Ca2+ homeostasis and proteins involved in Ca2+ transport also leads to 
impairment of contractility and relaxation by diminishing systolic function of the heart 
(Lehnart et al, 2003). 
 
1.4.11 Exercise-induced cellular adaptation 
Exercise as a physiological stress requires a synchronised response from both the 
cardiovascular, pulmonary and nervous system. The increase in blood flow to the 
working muscle during exercise is a multi-system process and an impairment to any 
of these systems may lead to decreased exercise capacity. The heart’s ability to 
augment cardiac output (CO) during the enhanced metabolic demand of exercise 
depends on the heart rate (HR) and stroke volume (SV). Exercise induced adrenergic 
stimulation enhances both the HR and SV proportional to the exercise intensity up to 
about 40-50% of maximal capacity. Once the maximal capacity is reached, the SV 
plateaus despite a further increase in HR and cardiac output (CO) (Tegtbur, Busse 
and Kubis, 2009).  
Many researches have documented the beneficial effects of exercise in humans and 
rodent models. In cardiac muscle, exercise promotes mitochondrial biogenesis by 
increasing the expression of PGC-1α (Tadaishi et al, 2011). Cardio-protection was 
also achieved with exercise by enhancing the activity of β-adrenergic signalling as 
well as SERCA2a expression and activity and increased Ca2+ handling which is 
linked to optimal contractility of cardiac muscle (Calvert and Lefer, 2012). 
Physiological cardiac hypertrophy is largely observed with exercise training 
(Fernandes, Soci and Oliveira, 2011). The increase in the size of the LV muscle and 
decrease in the LV chamber size, enhances the ejection fraction and cardiac output 





1.4.12 Exercise in mice 
Treadmill running in mice has been a subject of investigations since the 1970s and 
most of the work was carried out discerning its role and effects on cardiac and 
skeletal muscle (Avila, Kim and Massett, 2017), (Kemi et al., 2002). Researchers 
have looked into the effect of different modes of exercise in mice i.e. forced 
(treadmill) and voluntary (flywheel).  
Forced treadmill running has been associated with exacerbation of systemic 
inflammation in a mouse model of colitis (Cook et al,. 2014), induction of stress in a 
mouse model of cerebral ischaemia (Svensson et al, 2016) and promoter of 
osteoarthritis in a mouse model of decorin-deficiency (Gronau et al, 2017). These 
findings clearly demonstrate that mice with a predisposed disease burden may suffer 
following the added pressure of forced exercise. On the other hand, Luccetti et al 
(2017) have documented that moderate forced treadmill running provides better 
cardiac function and resistance against the parasitic infection causing Chagas 
disease. The findings of all the previous research highlights the fact that type of 
exercise, intensity, frequency and duration play an essential role in the outcome of 
results.  
A study by Narath, Skalicky and Viidik (2001) reported that voluntary running in rats 
increases their survival rate and reduces body fat to muscle ratio. As highlighted by 
the authors, there has been a large variation with respect to how much animals 
would voluntarily run, therefore inevitably skewing the distribution of data.  
Mitochondria play an important role in providing the enhanced ATP source to the 
working muscle during exercise, hence cardiomyocytes are packed full of 
mitochondria. It is clear that only healthy mitochondria can contribute to this 
increased energy demand. The cellular adaptations induced by exercise include 
physiological cardiac hypertrophy to accommodate the increased reliance on the 
cardiac muscle for oxygen supply to organs with high energy demand and to meet 
the increased basal metabolic rate (De Biase et al, 2014). 
Mitochondrial DNA PolgA deficient mouse (PolgA mut/mut mice) display marked 
systolic and diastolic dysfunction, cardiac hypertrophy and dilation from the age of 14 
months as well as a significant age-related decline in cytochrome-c oxidase activity 




in terms of ATP to the cardiac muscle under stress. In fact, Yan et al (2017) 
demonstrated that endurance exercise in obese mice lead to unfavourable cardiac 
remodelling through initiation of autophagy. Davies et al (1982) also reported that 
strenuous acute exercise increased oxidative stress and led to tissue damage as a 
result of enhanced tissue oxygen consumption by 3.6 fold in the heart. In 
comparison, Venditti et al (2013) have reported that 10 weeks of swimming training 
significantly reduce basal H2O2 levels in rat skeletal muscle. 
 
1.4.13 Cardiac mitochondrial adaptations to exercise 
During exercise, cardiac mitochondrial oxygen consumption increases by at least 10 
fold in order to accommodate the greater energy demand of working muscles (Olver, 
Ferguson and Laughlin, 2015). The remarkable metabolic flexibility of cardiac muscle 
during exercise is the process known as remodelling. Since cardiac muscle is a post 
mitotic tissue, the growth in the size of cardiomyocytes is more likely to occur than 
cellular proliferation (Poole et al, 2012). This physiological growth is accompanied by 
increases in mitochondrial number and energy production capacity.  
During physiological cardiac remodelling the rate of mitochondrial biogenesis and 
fatty acid oxidation increases. PGC-1α expression in cardiac muscle is increased 
significantly by exercise (Pilegaard, Saltin and Neufer, 2003). Enhanced PGC1-α 
binds to PPARα (peroxisome proliferator activated receptor α) to increase fatty acid 
oxidation and storage in the heart (Gilde and Van Bilsen, 2003). Aubert, Vega and 
Kelly (2013) have reported that augmented PGC1-α and PPARα expression in the 
cardiac muscle during exercise inhibits pathological cardiac growth and heart failure. 
In 2012, Scarpulla, Vega and Kelly added to the function of increased PGC-1α 
expression in the cardiac muscle by observing that PGC-1α promotes mitochondrial 
biogenic response by interacting with oestrogen-related receptor (ERR) and nuclear 
receptor factor 1 (NRF-1). Notably ERR is required for maximal ATP production and 





1.4.14 Age related cardiovascular disease 
Age is the major risk factor for the development of a cardiovascular disease (CVD) 
(Rosenzweig, 2016). CVDs are leading cause of morbidity and mortality worldwide 
costing the National Health Service £9 billion each year (WHO, 2019). The most 
common type of CVD is Coronary Heart Disease (CHD) killing 22,000 individuals 
under the age of 75 in the UK every year (BHF, 2019). Currently 2.3 million people 
live with CHD in the UK meaning the prevention and management of the disease with 
medication is inevitably difficult. Lifestyle changes such as exercise, healthy diet, 
weight management, limiting alcohol intake and smoking are important contributors 
of CVD both in prevention and treatment. The underlying cause of CHD is the 
formation and accumulation of cholesterol plaques (atheroma) on the arterial walls. 
Over time, the main artery supplying the cardiac muscle becomes restricted, limiting 
the amount of oxygen and nutrients supplied to the heart especially under high 
demand situations such as during exercise (Roh et al, 2016). 
Evidence suggests that events leading to the onset of atherosclerosis begin decades 
before the clinical symptoms of the disease become apparent (Singh et al, 2002). 
The underlying etiology of this this complex and slow progressing inflammatory 
disease is still largely unknown. Berliner et al (1995) investigated the atherogenic 
properties of oxidised low density lipoproteins (LDL) cholesterol and other oxidised 
lipoproteins in cellular oxidative stress. They have confirmed the interaction between 
mitochondrial redox state within the vascular wall as targets of oxidative induced-
damage and initiation of CVD. This is due to the properties of plasma which contains 
high concentrations of antioxidants and metal ions to provide the best environment 
for arterial wall to accelerate LDL oxidation by reactive oxygen and nitro-species from 
various sources such as mitochondria, NADPH or Xanthine oxidase (Berliner et al, 
1995).  
The regulatory links between ETC complexes and the normal functioning of cardiac 
muscle has been debated for many years. Researchers have argued that ADP and 
inorganic phosphate (Pi) availability for ATP generation during increased cardiac 
workload are associated with changes in cardiac function (Balaban, 2012). Others 
have suggested that regulation of cytosolic Ca2+ released from the SR and used by 
mitochondria in response to increased cardiac workload are tightly modulating the 




It’s clear that mitochondrial dynamics controlled by fission and fusion processes play 
a critical role in the normal functioning of cardiac tissue since more than 35% of 
cardiomyocyte volume is packed with mitochondria necessary for the normal 
excitation-contraction coupling process. 
Another significant risk factor for CVD and mitochondrial dysfunction is age which is 
accompanied with a general decrease in cellular energy capacity and reduced 
OXPHOS efficiency (Dhingra and Vasan, 2012). Since mitochondria play a critical 
role in cardiomyocytes cell signalling, cell death and growth, any alteration in 
mitochondrial performance due to CVD risk factors will disturb its normal functioning 
and lead to bioenergetic dysfunction and redox imbalance in cardiac tissue (Dai, 
Rabinovitch and Ungvari, 2012).  
 
1.4.15 The effect of age on cardiac responses to exercise 
Cardiovascular conditioning with exercise (i.e. improving cardiovascular function / 
cardiorespiratory fitness) has been documented previously (Mihl, Dassen and 
Kuipers, 2008). One way to improve the cardiorespiratory fitness is by regular 
exercise training (Lin et al, 2015). 
PolgAmut/mut mice suffer from respiratory chain dysfunction meaning that some 
essential organs such as skeletal and cardiac muscle are compromised as early as 6 
months of age (Trifunovic et al, 2004). It’s still largely unknown whether endurance 
exercise would mitigate the phenotypic changes and recover the decline in 
mitochondrial dysfunction observed in PolgAmut/mut mice before the manifestation of 
premature ageing phenotypes and cellular dysfunction. 
Fatigue and exercise intolerance are the most common characteristics of patients 
with mitochondrial dysfunction (Filler et al, 2014). Exercise intolerance is directly 
correlated with the severity of impaired OXPHOS in cardiac muscle, meaning that 
with age, exercise intolerance will increase as the rate of mtDNA point mutations 
increase causing lower OXPHOS rate (Taivassalo, 2003). 
One way to measure exercise intolerance is by performing a graded exercise 
treadmill test where peak exercise oxygen consumption is assessed. Taivassalo 




mitochondrial respiratory chain defects and found that the capacity of muscle to 
increase oxygen utilisation is blunted in relation to increased circulatory and 
ventilatory responses with exercise. A recent study by Safdar et al (2011) has shown 
that 5 months of treadmill running in PolgAmut/mut mice have mitigated stress 
intolerance as evidenced by a reduction in the degree of exhaustion during the stress 
test. They also observed an increased lifespan, activation of mtDNA mutation repair 
mechanisms by p53 enzyme, increased mitochondrial biogenesis, preserved 
mitochondrial morphology as well as reduced systemic multi-organ failure. 
The development of cardiac hypertrophy is a multi-step process beginning with an 
extracellular hypertrophic stimulus, activation of early response genes and increased 
production of contractile proteins into sarcoplasmic units. The next step is the 
transduction of hypertrophic signal through activatin of the mitogen-activated protein 
(MAP) kinase cascade and finally recruitment of nuclear transcription factors, 
triggering events for cellular hypertrophy (Glennon, sugden and Poole-Wilson, 1995). 
Cardiac remodelling and physiological hypertrophy are accompanied by ventricular 
wall thickening with or without changes in ventricular chamber volume (Mihl, Dassen 
and Kuipers, 2008). Cardiac adaptations to exercise include a 12-15% increase in 
overall heart weight in both eccentric and concentric growth patterns (Blomqvist and 
Saltin, 1983; Scheuer and Tipton, 1977). 
The reduction in the maximal HR with age also known as chronotropic incompetence 
is a key factor determining cardiac response to exercise. The age associated 
reduction in HR with exercise is thought to be due to an impaired autonomic 
regulation of the heart and changes in the conducting system (Brubaker and 
Kitzman, 2011). These changes are strong predictors of increased mortality and 
increased cardiovascular events (Higginbotham et al, 1986).  
The heart’s responsiveness to exercise and autonomic stimuli decreases significantly 
with age. The diminished autonomic stimuli mainly rises from dysregulation of the 
sympathetic nervous system through β-adrenergic receptor (β-AR) desensitisation on 
the cardiac muscle. This in turn reduces cardiac reserve and exercise capacity with 
age. The diminished β-AR activity with age is complex and is partly due to 10-15% 
increase per decade in total circulatory norepinephrine levels with age (Roh et al, 
2016). This will result in greater occupancy of β-AR and diminished reuptake of the 




contraction and relaxation of cardiac muscle and reduced Ca2+ transients due to 
further β-AR stimulation. Multiple proposals by which cardiac responses to exercise 
diminishes with age exist (Figure 1.10). 
 
 
Figure 1.10. Cellular changes in cardiac responses to exercise in young and 
old. 1) With age, IGF-I-PI3K-AKT activity as well as β-AR-cAMP-PKA activity is 
reduced leading to diminished SERCA2a expression and activity and so inefficient 
handling of Ca2+. 2) Impact of exercise in youth. 3) Exercise is thought to reverse the 




1.5 Aims and objectives 
What is the role of endurance exercise on ageing cardiac muscle and 
mitochondrial function investigated using mouse models of accelerated and 
physiological ageing? 
In order to observe exercise-associated changes in cardiac and mitochondrial 
function, two established mouse models of ageing known as the C57BL6/J mice and 
PolgAmut/mut mice were used to answer the following questions: 
 
• Does endurance exercise alleviate premature, accelerated ageing phenotypes 
as well as cardiac mitochondrial dysfunction in PolgAmut/mut mice? 
 
• Does late-life endurance exercise alleviate the decline in aerobic capacity, 












General consumables Supplier 
0.2ml, 0.5ml PCR tubes Star Lab  
96 well reaction plates Fisher Scientific  
Avidin/Biotin blocking kit Vector Laboratories 
Coverslips (22x22mm, 22x40mm, 22x50mm) MSD 
Falcon tubes (15ml, 50ml) BD Biosciences  
Gilson pipettes (P2, P10, P20, P100, P200, 
P1000) 
Star Lab  
Gloves Star Lab  
Hydrophobic pen Abcam  
Microfuge tubes (0.6ml, 1.5ml, 2.0ml) Star Lab  
Microvette Sarstedt  
Mouse cytokine array kit MSD 
Mouse dissection kit VWR  
Multi-channel pipettes Star Lab  
Pipette tips (10μl, 20μl, 200μl, 1000μl) Star Lab  
QIAmp DNA mini kit (50) Qiagen  
Reagent reservoirs Fisher Scientific  
Scalpels Swann Morton  
Slide mailers Cell path 
Solution reservoir  Green Bioresearch 
Superfrost glass slides MSD  




Weight boats VWR 
Whatman filter paper  Fisher Scientific  
Stainless steel beads (5mm) Qiagen 
DNeasy blood and tissue kit  Qiagen 
 
2.2 Antibodies  
List of antibodies Supplier 
Active cleaved caspase-3 Abcam 
Donkey anti-rabbit IgG-Alexa Fluor ®750 Abcam 
Goat anti-mouse IgG1-Alexa Fluor ®647 Thermo Fisher 
Goat anti-mouse IgG2a-Alexa Fluor ®546  Life technologies  
Goat anti-mouse IgG2b-Alexa Fluor®488  Life technologies 
Goat anti-rabbit IgG-Alexa Fluor ®405 Thermo Fisher 
Goat-anti-rabbit IgG-Alexa Fluor ®488 Life technologies 
Mouse anti-MTCO1 IgG2a  Abcam 
Mouse anti-NDUFB8 IgG1 Abcam 
Mouse anti-VDAC1 IgG2b Abcam  




Acetic acid VWR 
4% Paraformaldehyde (PFA) in PBS  Santa Cruz Biotechnology  




Bovine Serum Albumin (BSA) Sigma-Aldrich 
Catalase Sigma-Aldrich 
Cytochrome c Sigma-Aldrich 
3,3'-diaminobenzidine (DAB) Sigma-Aldrich 
DEPC treated water  Ambion 
DPX TM Merck 
Eosin Cell Path 
Ethanol (AnalR) MSD  
Haematoxylin TCS Biosciences Ltd 
Histoclear TM National Diagnostics 
Hydrochloric acid (HCl)  VWR International Ltd,  
Isopentane Merck 
Liquid nitrogen BOC 
Methanol (AnalR)   MSD  
MSD cytokine immunoassay kit MSD  
Nito Blue Tetrazolium (NBT) Sigma-Aldrich  
Normal Goat Serum (NGS) Sigma-Aldrich 
Nuclease-Free water   Fisher Scientific  
OCT mounting media Pyramid innovation 
PBS tablets OXOID  
Phosphate buffer Saline (PBS) tablets Sigma-Aldrich 
Phosphotungstic acid Sigma-Aldrich  
Prolong gold mounting media   Fisher Scientific  
Proteinase K Invitrogen 




Scot’s tap water Leica Biosystems 
Sodium Azide Sigma-Aldrich 
Sodium Chloride (NaCl) Sigma-Aldrich 
Sodium succinate Sigma-Aldrich  
SYBR Green Fisher Scientific 
Trizma base  Sigma-Aldrich 




TBST (pH 7.4) 100mM NaCl 
5 mM Trizma base  
0.1% (v/v) Tween 20%  
EDTA antigen retrieval buffer (pH 8) 1mM EDTA 
PBS (pH 7.4) 1 tablet in 100ml dH2O 
RIPA buffer 1M Tris-HCl pH 7.6 
SDS 10% 
5M NaCl 
Sodium deoxycholate 10% 
1% IPEGAL 
Protein inhibitor cocktail (1 
tablet) 
Sodium citrate antigen retrieval buffer (pH 6.0) 10mM Tri-sodium citrate 
0.1M Phosphate buffer solution (pH 7) 0.4M sodium dihydrogen 
orthophosphate 
0.06M disodium hydrogen 
orthophosphate 






In 0.1M phosphate buffer 
Tris Lysis buffer  150 mM NaCl 






2.5 Equipment and computer software 
Equipment Supplier 
TissueLyser II Qiagen 
ABI Verti 96 well plate Thermal Cycler Applied Biosystems 
Antigen retrieval unit 2100 Retriever 
Aperio Scanner Leica Biosystems 
Autoclave Prior Clave 
Zeiss Axioimager fluorescence microscope with 
apotome (widefield upright) 
Zeiss 
Benchtop Micro Centrifuge Fisher Scientific  
Eppendorf thermo-shaker Eppendorf 
Microtome Leica 
MSD SECTOR MSD 
Nanodrop ND-1000 spectrophotometer Labtech International 
Nano-Pure water purification system  Barnstead 
OFT 5000 Cryostat Bright  
UV hood (PCR clean room) Astec 




Magnetic stirrer  IKA 
Nikon A1R scanning confocal microscope Nikon 
Zeiss AxioObserver/SD1 (inverted)/AirScan Zeiss 




Oxymax metabolic treadmill Columbus instruments 
NIBP Columbus instruments 
Rotarod Ugo Basile 
 
 
Computer software  Supplier 
Segment v2.0 R5165 Medvision 
Aperio Image Scope analyser  Leica Biosystems 
NIBP software Columbus 
instruments 
Vnmrj Cardiac MR software Agilent 
technologies 
Image J, Fiji NIH 
Matlab R2015a Math Works 
Oxymax treadmill software Columbus 
instruments 
Treadmill software PanLab 
Minitab 17 Minitab 
ND-1000 software Labtech 
International 
NIS Elements Nikon 
Prism v7.0 and v8.0 Graph Pad 




Step-One Plus Real time PCR  Applied 
Biosystems 
ZEN blue version Zeiss 
Mousetrap GitHub 
 
2.6 Mouse models  
2.6.1  C57BL/6J mouse 
C57BL/6J male mice aged to 59 weeks were purchased from Charles River 
Laboratory (Kent). Each mouse was identified by a unique ear notch. Mice were 
housed in cages of 2, 3 and 4 and those from the same litter were kept in the same 
cage.  
 
2.6.2  PolgAmut/mut mouse 
PolgAmut/mut male and female mice were kindly donated by Tomas Prolla (University 
of Wisconsin, Washington, USA) and a breeding colony was subsequently 
established at the Wellcome Centre for Mitochondrial Research (Newcastle 
University). Each mouse was accurately genotyped and an RFID microchip (Destron 
Fearing, USA) implanted under the skin which was used for both identification and 
temperature monitoring purposes. PolgAmut/mut male mice were housed with their 
heterozygous and wild type littermates in cages of 3-5. 
 
2.7 Mouse husbandry and monitoring 
Mice were kept at a temperature controlled room (25°C) and cages (25°C) with 12hrs 
light/dark cycle. They had ad libitum access to expanded RM3 chow diet (Special 
Diet Services, LSB Biotech) as detailed in appendix 3 and dH2O. Enrichment 
materials such as pieces of wood and cardboard tunnels were placed in the cages. 
Mouse monitoring criteria (table 2.1) and a recording table were used to assess the 





2.8 Ethical considerations 
All animal work was approved by the animal welfare and ethical review board- 
Newcastle University (reference BH136648) in compliance with the UK Home Office 
under project licence numbers P3F79C606 and P76987201. 
 
2.9 Statistical analysis 
Statistical analysis used to compare two groups at one time-point was an unpaired t-
test. When the effect of age at two time-points were taken into account in one group 
a paired t-test was used. A one-way ANOVA (repeated measures) was implemented 
when one group was compared at three time-points and a two way ANOVA 
(repeated measures) was implemented when two groups were tested at more than 
two time-points. Graphpad Prism (v.8) was used to carry out statistical analysis and 
graphs were generated through this statistical package. The biological significance 
was determined as the p-value of below 0.05. 
 
2.10  Mouse clinical scoring and monitoring  
Clinical scoring was performed in order to assess the severity of disease, predict 
disease progression and implement endpoints in mice. The clinical scoring was 
designed by Dr Claire Richardson (Named veterinary surgeon, Newcastle University) 
and Dr Laura Greaves (Newcastle University) in order to evaluate the welfare of mice 
quantitatively (Table 2.1). The clinical scoring criteria is based on eight characteristics 
which are further categorised into scores of 0= normal, 1= mild, 2= moderate and 3= 
substantial. In PolgAmut/mut mice, clinical scoring was carried out at 14 weeks of age 
(pre-intervention), 29 weeks of age (mid-intervention) and 43 weeks of age (post-
intervention) in order to observe any changes in each group of mice with age and/or 
as a result of the exercise intervention. In C57BL/6J mice clinical scoring was carried 
out at 14 months of age (pre-intervention), 18 months of age (mid-intervention) and 




on the same day and time in order to eliminate effects of circadian cycle changes as 




Table 2.1. Mouse monitoring criteria. Clinical phenotypes of PolgAmut/mut and C57BL/6J mice were assessed based on a scoring 
system (Richardson and Greaves, 2015).
Characteristic Score 0- 
Normal 
1- Mild 2- Moderate 3- Substantial  




5-15% weight loss 15-20% weight loss Over 20% weight loss 
2 Coat- 
general 
Normal Slight lack of 
grooming 
Starey  
3 Skin Tone Normal Tents, returns to 
normal in 1-2 seconds 
Tents, persists  
4 Behaviour Normal Subdued but 
responsive. 
Animal shows normal 
behaviour patterns. 
Interacts with peers 
Subdued- animal 
shows subdued 
behaviour. Little peer 
interaction. May show 
aggression. 
Animal unresponsive to 
extraneous activity and 




Normal Transient hunched 
posture, especially 









None None Abdominal distension 
up to the size expected 
in late pregnancy  
Severe abdominal distension 
beyond that of late pregnancy 




Normal Whitening of feet due 
to mild anaemia 
Whitening of feet due to 
moderate anaemia 
Feet are completely white due to 
severe anaemia 




(>72h). No dehydration. 
Continuous diarrhoea (>72h) with 





2.11  Mouse Cardiac Magnetic Resonance Imaging (cMRI) 
2.11.1 Mouse preparation pre- and post- cMRI 
Cardiac Magnetic Resonance Imaging (cMRI) was carried out on anaesthetised mice 
(5% isoflurane, 1.5% O2, 0.3ml/min flow rate) in order to assess cardiac function. 
Mice were prepared by having their hair removed from the ECG contact regions and 
eyes lubricated with an ointment prior to the scan. The amount of isoflurane and 
oxygen flow rate was monitored to ensure that the mice were fully anaesthetised, and 
their breathing rate was within the normal range (~25-40 breaths/min). Mice were 
secured inside the MRI machine using a pneumatic pillow and skin tapes (figure 2.1, 
left image). A rectal thermometer was used to monitor the temperature of mice 
throughout the scan as this may affect their heart rate. Mice were warmed inside the 
MRI machine with a heater fan tube to avoid hypothermia. Post-scan, mice were 
transferred to a heating pad for recovery and were housed individually for an hour 
before being transferred to their original cages. 
 
2.12  Cardiac MRI 
CMRI was carried out using a 7-Tesla horizontal bore microimaging system (Varian 
Inc, Palo Alto, CA, USA) equipped with a 12cm microimaging gradient insert (40 
gauss/cm) (figure 2.1, right image). Mice were scanned in supine position where 
parameters including heart rate and breathing rate were kept stable to ensure limited 
respiratory artefacts during the scan. Scout scans were obtained using Vnmrj 
software to ensure left ventricular (LV) short and long axes were obtained in the 
correct orientation. Respiratory and ECG-gated cine-MRI images were obtained 
following a general shimming process to homogenise the MR magnet. A total of 20 
phases per cardiac cycle from each mouse was obtained to measure global cardiac 
function. Sufficient contiguous short axes slides of 1mm thick in plane resolution of 
~1mm/pixel and temporal resolution of 40-50ms was obtained to cover the whole LV 





Figure 2.1. MRI system compatible for mice. The mouse was placed on a 
pneumatic pillow to allow rapid physiological interfacing (left image). Oxygen and 
isoflurane was delivered through a nosecone throughout the scan. 
 
2.12.1 MR image analysis 
The obtained cardiac MRI scans were used to track cardiac measures and short-axis 
images were analysed in Segment v2.0 (http://segment.heiberg.se) by semi-
automatically tracing epicardial and endocardial borders as shown in figure 2.2. LV 
segmentation ensured volume measurements at the end of systole and diastole were 
accurate. Cardiac function measurements including LV mass (LVM), and the LV 
functional parameters including the end diastolic volume (LVEDV), end systolic 
volume (LVESV) as well as stroke volume (SV), ejection fraction (EF) and cardiac 
output (CO) were analysed by two investigators independently blinded to the 
experiment design at both time points (pre- and post-intervention). Due to 
fluctuations in body weights, left ventricular mass, volume measurements and cardiac 






Figure 2.2. ECG-gated cine cMRI images in segment software. A) LV 
segmentation at the end of systole (ES) where LV is in its smallest form. B) LV 
segmentation at the end of diastole (ED) where LV is at its largest stage. The volume 
difference between ED and ES determines the stroke volume (SV). 
 
2.13  Oxymax metabolic treadmill 
Oxymax (Columbus instrument, Ohio, USA) is a system designed to monitor oxygen 
consumption (VO2) and carbon dioxide production (VCO2) while the mice are running 
on the one-lane enclosed metabolic treadmill chamber (figure 2.3). The open system 
pumped air through the test chamber and gas sensors and then expelled into the 
atmosphere. The O2 and CO2 content of the atmospheric air were tested periodically, 
and the changes were recorded to compute VO2 and VCO2 as well as respiratory 
exchange ratio (RER) and heat generated at three time points (pre-, mid- and post-
exercise intervention). During calibration, the reference air measurements were taken 
as well as the animal weight to equilibrate the system for each mouse. Sample air 
flow rate was set to 4-5L/min. Depending on the size of the mouse, gas flow rate 
changed i.e. for a mouse of up to 40g the flow rate was set to 0.5L/min based on 
handbook recommendations. The pressure of the gas was set to 800mmHg with tank 
output pressure of 10psi. Coarse and fine gain knobs were used to adjust room O2 
and CO2 readings making sure O2 was within 20.88-20.95% reading and CO2 was 
within 0.04-0.06% range. Both sedentary and exercised mice were initially 
acclimatised to the treadmill lane and running protocol one week prior to the actual 
measurements by being placed on the motionless treadmill for 5 minutes, followed by 





subjected to a 20 minute run in an enclosed chamber at 20cm/s which included 5 
minute warm-up and 5 minute cool-down. Mice were homed individually for 30 
minutes post-testing before returning back to their original cages. 
 
 
Figure 2.3. Single-lane Oxymax metabolic treadmill system. O2 and CO2 gases 
were calibrated and normalised to room gas content pre-testing.  
 
2.14 Treadmill running protocol 
Exercised mice were first acclimatised to the 5-laned treadmill (Panlab, Harvard 
apparatus, USA) and environment 5 days prior to the start of the intervention for two 
minutes with the treadmill switched off on day one, at 17cm/s for one minute on day 
two, at 17cm/s for two minutes on day three, at 17cm/s for seven minutes on day four 
and 17cm/s for 10 minutes on day five (figure 2.4). In this treadmill protocol, only the 
exercised mice are subjected to endurance exercise whereas the Oxymax metabolic 
treadmill is carried out at two time points only (pre- and post-intervention) in 
exercised and sedentary animals. 
Exercise intervention in PolgAmut/mut mice commenced at four months of age and 
terminated at 11 months of age. The speed of treadmill running remained at 20cm/s 




times/week. A five minute warm up and cool down periods were included in each run 
at 12cm/s. Sedentary mice were allowed to carry on their normal cage activity while 
exercised mice were running on the treadmill.  
Exercise intervention in C57BL/6J mice commenced at 16 months of age and ended 
at 22 months of age due to the fact that no long term physiological benefits of 
exercise was seen in PolgAmut/mut mice. Mice were acclimatised to the treadmill in the 
same way as the PolgAmut/mut mice. The speed at which mice were running remained 
at 20cm/s for 30 minutes for the duration of the study three times/week plus five 
minutes of warm up and cool down at 12cm/s. 
 
 
Figure 2.4. Multi-lane air-puff equipped treadmill. Mice were allowed to run 
alongside each other on the 5-laned treadmill. 
 
2.15  Non-invasive blood pressure monitor 
Non-invasive blood pressure (NIBP) system (Columbus instrument, Ohio, USA) was 
used to measure tail arterial blood pressure (figure 2.5). Mice were weighed and 
placed inside a suitably sized restrainer with a nose cone and had blinded vision to 
ensure a comfortable fit and limited stress during the test. Mice were acclimatised to 




measurements, the mouse’s tail was warmed in lukewarm water to ensure good 
circulation. Room temperature was controlled, and the mouse was warmed with a 
heater fan to avoid hypothermia during the test. The occlusion cuff was placed near 
the tip of the tail and was set to a maximum of 200mmHg whereas the smaller sensor 
cuff was placed near the base of the tail proximal to the occlusion cuff. The pressure 
of the sensor cuff was set to up to 45mmHg depending on the size of the mouse. 
Both cuffs were tested to ensure no leakage was detected in the system by 
generating a generic BP curve as demonstrated further in 8-Channel Non-Invasive 
Blood Pressure Monitor NIBP-8 User’s Manual 0219-008M. Blood pressure was 
taken at two time points pre- and post-intervention to ensure the stress exerted to 
mice is minimal. Each time three measurements were taken from each mouse 
leaving a one minute gap between each test to allow full arterial occlusion and 
expansion. Heart rate (HR) was also measured at the same time in order to calculate 
blood pressure from mice. 
 
 
Figure 2.5. Blood pressure monitor system. Mice were restrained secure during 





2.16  Mouse behavioural tests 
2.16.1 Open field testing (OFT) 
Open field testing (OFT) was carried out using an enclosed arena with a tablet 
underneath (figure 2.6) to assess behavioural and locomotor activity of mice using 
the mousetrap software (Ryanware v4.0). Since the OFT is time, handling and sex 
dependent, the mice were acclimatised to the testing procedure and environment for 
two minutes each day for a week prior to the test. The acclimatisation period limits 
any fear-related behaviour such as stretch attend in which mice elongate their 
abdomen for any movement, as well as activity in the corners of the open field 
device. Mice were tested during a five minute period where they were placed inside 
an enclosed arena on a black background. The quality and quantity of activity and 
behavioural state was recorded using a series of measures such as rearing 
frequency, distance travelled, velocity of movements, and number of touches. Step 
length was calculated as the total distance moved divided by the total number of 
touches. The apparatus was cleaned after each use to limit inquisitiveness in mice 
due to unfamiliar smells or situations. The temperature, humidity and lighting 
remained constant for every single test. 
 
 
Figure 2.6. Open field testing device to record locomotive and behavioural 
changes within 5 minutes. Mice were allowed to carry out normal cage activity 





2.16.2 Rotarod  
The rotarod (Ugo Basile, Italy) is a multi-lane device that measures coordination, 
endurance, the grip strength and motor activity of mice (figure 2.7). The test was 
carried out by placing a mouse on a set speed rotating rod and the time it took for the 
animal to fall was recorded as the latency to fall. Since this is a learnt test, the mice 
were only acclimatised to the device once prior to the first test. The mice were tested 
for their balance, grip strength and motor coordination over three trials and the 
latency (time to fall) to fall was recorded. The ramp speed was set to 5rpm and 
steadily increased up to 40rpm by 300s. 
 
 
Figure 2.7. Rotarod device to measure latency to fall. The multi-lane device 
allowed for grip strength and coordination testing independently over three trials. 
 
2.17 Tissue harvest 
Mice were culled by cervical dislocation and organs were harvested, weighed and 
processed under a sterilised fume hood according to the tissue harvesting protocol in 
table 1 of appendix 2. Blood was aspirated from the heart by cardiac puncture. The 






2.18 Blood and serum collection 
Tail vein blood was collected from approx. 1/3 along the length of the tail tip using a 
sterilised lance to make an incision and blood was collected using a microvette 
containing lithium heparin. Mice were placed inside a warming cabinet (39°C) for up 
to 10 minutes to dilate blood vessels prior to sampling. Mice were placed in a suitably 
sized restrainer with their tail secured with an end cap. A maximum of 10% of total 
blood volume was taken at any time point according to the license allowance. Serum 
was obtained by centrifugation of whole blood at 8000rpm for 10 minutes and stored 
at -80°C for long term. 
 
2.19  Mouse tissue preparation for histochemical analysis  
2.19.1 Fixed cardiac muscle preparation 
Hearts were sectioned longitudinally through the interventricular septum. The right 
side of the heart was fixed in 4% paraformaldehyde (4% PFA) intra-septal side down 
inside a tissue cassette for no more than 48 hours. The hearts were then transferred 
to 70% ethanol solution at room temperature and were processed further first by 
dehydrating specimen in increasing ethanol gradient to remove water and formalin, 
next by clearing in histoclear to allow infiltration with paraffin wax and finally embed in 
paraffin wax at Newcastle University Biobank services. For sectioning, the cooled 
blocks of fixed right heart were sectioned (4μm) using a microtome (Leica 
Biosystems, UK) on glass superfrost slides (MSD) and were stored in 37°C oven at 
least for 48 hours before any histochemical procedure. The slides were then air-dried 
for one hours at room temperature before long-term storage at 4°C. 
 
2.19.2 Frozen cardiac muscle preparation 
The left side of the heart was slowly snap frozen in isopentane cooled to -150°C in 
liquid nitrogen for 15 seconds to maintain the integrity of organelles. The skeletal and 
cardiac muscle were processed this way to avoid ice crystal formation due to high 




during full tissue harvest and were placed in -80°C freezer for long-term storage. For 
sectioning, the left side of the heart was mounted intra-septal side down on Whatman 
filter paper with a small amount of OCT cryo-embedding medium. Once the OCT 
turned white at -20°C (inside Cryostat), the tissue was submerged in liquid nitrogen 
until fully frozen using previously cooled forceps and scalpels. Sections were cut at 
8μm using an OFT 5000 Cryostat (Bright) on to a polysine slides (Thermofisher, UK) 
and air-dried at room temperature for an hour before being stored at -80°C freezer in 
sealed slide mailers. A small chunk from the LV (~25mg) was cut by a cooled 
sterilised scalpel for tissue homogenisation and subsequent DNA extraction. Similarly 
a small chunk of quadriceps (~100-200mg) from the right leg was cut for protein 
extraction from each mouse and stored in a microcentrifuge tubes for future cytokine 
analysis. 
 
2.20 Histochemistry  
2.20.1 H&E 
Haematoxylin and Eosin (H&E) staining was carried out to assess the morphology 
and structural integrity of tissues. 4μm paraffin embedded cardiac sections were 
deparaffinised in Histoclear (2x10 minutes) and rehydrated in an ethanol gradient 
(100%, 95% and 70%) each for 5 minutes. Slides were then washed in dH2O for 5-10 
minutes and stained in Harris haematoxylin for 8 minutes to stain nuclei blue/black. 
The slides were washed in running tap water subsequently until ran clear and ‘blued’ 
in Scott’s tap water for 1 minute to blue the nuclei stain. Slides were washed in 
running tap water for 5 minutes and counterstained in eosin for 1 minute to stain 
other basic proteins such as cytoplasm, muscle fibres and the extracellular matrix 
pink or red. After a brief wash under running tap water, the sections were dehydrated 
in a graded ethanol series (70%, 95%, and 100%) and cleared in two changes of 






2.20.2 Cardiomyocyte width analysis 
Cardiomyocyte width analysis was performed in Zen 2.5 software (Zeiss) by 
measuring the shortest cross-sectional width of individual cardiomyocytes from 5 
random fields of x20 magnification. 50 cardiomyocytes per field were selected and 
the average width of cardiomyocytes were calculated. Since cardiomyocytes come in 
various shapes and sizes, analysis was performed only on transverse 
cardiomyocytes. The analysis technique was based on the publication by Huynh et 
al, (2010) (figure 2.8). 
 
Figure 2.8. Cardiomyocyte width analysis. Representative example of H&E image 
for cardiomyocyte width analysis. The shortest width of cardiomyocytes were 
measured as shown by yellow arrows. Cardiomyocytes are shown in dark pink/red; 
nuclei are shown in blue. Magnification x20. Scale bar=100μm. 
 
2.21 Sequential COX/SDH histochemistry 
Cytochrome c oxidase/ succinate dehydrogenate (COX/SDH) histochemistry was 
carried out on 8μm cryo-sectioned mouse hearts. Sections were air-dried for an hour 
at room temperature and incubated in COX histochemical media (~100μl/section) 
(100 μM cytochrome c, 4mM DAB and 20μg/ml catalase from bovine liver in 0.2M 
phosphate buffer, pH 7.0) at room temperature for 20 minutes. Sections were then 
washed in PBS (3x5 minutes) and incubated in SDH histochemical medium (1.5 mM 




phosphate buffer pH 7.0) at room temperature for 10 minutes. Sections were then 
washed in PBS (3x5mins) and dehydrated through an ethanol gradient (70%, 95%, 
100%) for 2 minutes each and cleared in histoclear (National diagnostics, Atlanta, 
Georgia, USA). Sections were mounted on DPX (BDH laboratory, UK) and stored at 
room temperature for 24 hours until imaging. To minimise time delay, a maximum of 
10 slides were processed at a time, with further staining took place straight after. Two 
serial sections from each mouse heart were processed to reduce variability between 
experiments. COX and SDH histochemistry were also performed individually using 
the same protocol as above but with incubation in COX or SDH histochemical media 
only.  
2.21.1 Quantification of COX/SDH histochemical analysis 
Sections were imaged using Nikon TiE wide field invert microscope. Five regions at 
x10 magnification from the left ventricle were randomly picked and imaged. For direct 
comparison, areas with transverse cardiomyocytes were chosen from each section. 
An auto-white balance was used across all slides and the same settings i.e. same 
LED power and gain were used across all sections. Images were analysed using NIS 
elements software to distinguish between the brown (COX functional) and blue (COX 
deficient) fibres. The software uses the RGB thresholding method to separate and 
mask blue COX-deficient fibres from the whole tissue area (figure 2.9). The 
percentage of COX deficiency is then calculated from the total tissue area versus 
total blue area. The LED intensity and RGB channel threshold remain constant 






Figure 2.9. COX/SDH analysis. COX deficiency was quantified using NIS elements 
software RGB general analysis for COX/SDH histochemistry (top left image) by 
thresholding for COX deficient blue colour (top right image), pink tissue area (bottom 
left image), and combined merged channels (bottom right image). Magnification x10. 
Scale bars=100μm. 
 
2.22  Masson Trichrome staining 
Masson trichrome stain is a laboratory technique used to distinguish collagen from 
muscle tissue by utilising dyes that stain cell cytoplasm, collagen and nuclei. 
Transverse mouse fixed heart sections (4μm) were deparaffinised in 2 changes of 
Histoclear (2x10 minutes) and rehydrated in ethanol gradient (100%, 95%, 70% and 
dH2O), each for five minutes. Sections were then incubated in Bouin’s solution 
overnight at room temperature. This fixes the sections slowly allowing for better and 
crisper nuclear staining. Slides were then cooled in dH2O and incubated in working 
Wiegert’s iron haematoxylin for 5-10 mins to stain the nuclei blue/black followed by a 
10 minute wash in deionised H2O. Slides were then stained in Biebrich Scarlet-Acid 
Fucshin for 5 mins to stain the cytoplasm red and were subsequently rinsed in 
deionised H2O. Staining was followed by a 5 minute incubation in working 
Phosphotungstic/Phosphomolybdic acid solution for uptake and incubation of aniline 
blue solution to stain collagen blue. After a brief washes under running tap water, 
slides were washed with 1% glacial acetic acid for 2 minutes to remove any excess 




100% ethanol each for 3 minutes. The slides were cleared in Histoclear for 5 minutes 
and mounted on DPX. After drying at room temperature, the image acquisition took 
place using the Nikon Tie widefield microscope and images were analysed in NIS 
elements software.  
 
2.22.1 Cardiac fibrosis analysis 
Cardiac fibrosis was carried out using masson trichrome staining and quantified in 
NIS elements software using the RGB general analysis algorithm. The analysis was 
carried out by setting a threshold for each channel manually which were 
differentiated by the different colours (figure 2.10). Manual thresholding remained 
consistent across all the samples and the percentage of blue collagen accumulation 
shown in yellow was quantified as the percentage of whole tissue section in green.  
 
     
Figure 2.10. Cardiac fibrosis analysis. Fibrosis analysis by NIS elements 
quantifying the percentage of light blue collagen in the whole tissue section. Top right 
image represents all cardiomyocytes in green and bottom right image represents the 
distribution of collagen in yellow. Bottom left image show the background in blue 





2.23  Immunohistochemistry 
2.23.1 Cleaved caspase-3 immunohistochemistry 
Cleaved caspase-3 staining is used to detect apoptotic cells. 4μm mouse cardiac 
sections were deparaffinised in Histoclear (2x10 minutes) and dehydrated in an 
ethanol gradient (100%, 95%, 70% and dH2O) for 5 minutes each. Sections were 
placed in citrate buffer (10mM, pH 6.0) in an antigen retrieval unit to reveal epitopes 
under a heat and pressure cycle of 20 minutes. Slides were allowed to cool in the 
unit for 20 minutes and were then washed under running tap H2O and then incubated 
in 10% normal goat serum (NGS) in TBST for 30 minutes. TBST washes were 
carried out subsequently (3x5minutes) and primary antibody solution (Rabbit anti-
active caspase 3- cleaved (Merck Millipore, Hertfordshire, UK) was diluted in TBS 
(1:35) and applied to sections overnight at 4°C. TBST washes were carried out (3x5 
minutes) and sections were incubated in HRP-labelled polymer (Dako envision kit) for 
30 mins. Slides were washed in TBST 3x5 mins followed by incibation on a DAB+ 
chromogen mixture (100μl DAB in 1ml of substrate buffer) for 10 minutes. Slides 
were then washed in dH2O briefly and dipped in Haematoxylin (Sigma, Misouri, USA) 
solution to counterstain nuclei for 10 minutes. Slides were washed in dH2O for 10 
minutes and rehydrated by passing through an ethanol gradient (70%, 95% and 
100%) for 10 seconds each with two changes of Histoclear. Sections were mounted 
on DPX and visualised using Image Scope software (Aperio Scanner) in NICR 
(Newcastle University). 
 
2.23.2 Cardiac active cleaved-caspase 3 analysis 
Cardiac active cleaved caspase-3 staining (CC3) was quantified by nuclear staining 
algorithm in Imagescope software (http://aperioscanner.ncl.ac.uk/Login.php) in which 
active caspase-3 labelled cells were stained brown by HRP-conjugated CC3 antibody 
and nuclei were stained blue by haematoxylin (figure 2.11). Number of dark brown 
regions were counted, and the frequency of apoptotic cells was quantified as a 






Figure 2.11. Cardiac active cleaved caspase- 3 analysis. Percentage of dark 
brown apoptotic nuclei (represented with red arrow) was quantified against normal 
blue nuclei. Magnification x10. Scale car=200μm. 
 
2.24  Immunofluorescence  
2.24.1 NBTx, laminin immunofluorescence assay 
NBTx assay was performed to support the findings of COX/SDH histochemistry and 
furthermore categorise cardiomyocytes into COX positive, COX intermediate and 
COX negative activity using a numbering system based on the COX activity of wild-
type tissue. This assay reveals the dual affinity of oxidised PMS (electron donor) for 
molecular oxygen in fully functional OXPHOS system and for NBT in a dysfunctional 
OXPHOS system. Cardiac cryosections (8μM) were incubated in cytochrome c 
solution (500μM in 0.1M PBS pH 7.0) for 10 minutes at room temperature. Sections 
were subsequently washed in PBS and incubated with NBTx solution containing 130 
mM sodium succinate, 2mM NBT, 0.2 mM PMS in 0.1M phosphate buffer (pH 7.0) for 
20 minutes and washed briefly in PBS. Sections were fixed in 4% paraformaldehyde 
for 10 minutes at room temperature and washed subsequently in TBST for 5 minutes. 
Sections were then permeabilised in a graded methanol series (70% and 90%) for 10 
minutes and 100% for 20 minutes. They were then taken down the methanol gradient 
(90% and 70%) for 10 minutes each. The slides were washed in TBST for 5 minutes 





Primary antibody (anti-laminin polyclonal antibody produced in rabbit) diluted in TBS 
(1:75) was added to the sections and incubated overnight at 4°C. To best detect the 
cardiomyocyte boundary post NBTx assay, the concentration of laminin primary 
antibody was first optimised using various dilutions of anti-Laminin antibody (Sigma-
Aldrich) in TBS (1:200, 1:100, 1:75 and 1:50). The sections were then washed in 
TBST (3x5 minutes) and incubated with secondary antibody solution (goat anti-rabbit 
IgG 488) (1:200) for 2 hours and washed with TBST (3x5 minutes). Sections were 
rehydrated in ethanol gradient (70%, 95% and 100%) 2 minutes each, cleared in two 
changes of Histoclear (10 minutes) and mounted on prolong gold. The sections were 
then left to dry overnight at room temperature and imaged using Zeiss 
Axioobserver/SDI/LSM800 inverted microscope to take five random snapshots of x10 
magnification from LV transverse cardiomyocytes. The sections were analysed using 
the immunoanalyzer software similar to quadruple OXPHOS immunofluorescence 
analysis which is explained further in section 2.1.1.2. A numbering system was used 
to categorise cardiomyocytes into positive (<-3 SD from the mean optical density 
(OD)), intermediate (-3SD<x>-6SD from the mean OD), negative (<-6SD from the 
mean OD) based on the activity of NDUFB8 and MTCOI in the wild-type PolgA mut/mut 
mice tissue.  
 
2.24.2 Quadruple OXPHOS immunofluorescence 
2.1.1.1 Optimisation 
An array of antibody concentrations were tested for the specific detection of two 
OXPHOS complexes, Complex I (NDUFB8 subunit) and Complex IV (MTCOI 
subunit). The optimisation included a series of primary antibody dilutions as 
described in table 2.2. Each cardiac section was only incubated with one dilution of 



















1:200 Mouse Abcam (14705) 
1:150 
1:100 







Table 2.2. Optimisation of primary antibody concentration for paraffin-
embedded cardiac tissue. Secondary antibodies are the same dilution as described 
in table 2.3.  
 
2.24.2.1 Final OXPHOS immunofluorescence assay 
Fixed heart sections (4μm) were deparaffinised in Histoclear (2x10 minutes) and 
rehydrated through an ethanol gradient (100%, 95%, and 70%) each for 5 minutes 
and washed under tap water for 5 minutes. Antigen retrieval was carried out using 
EDTA pH 8 in a pressure cooker for 20 minutes and washed subsequently in TBST 
(3x5 minute). Sections were incubated in 10% NGS solution for 30 minutes and 
washed in TBST (3 x 5 minutes). The primary antibody cocktail was made (table 2.3) 




control (NPC) slides were only incubated with anti-laminin antibody solution (1:50) in 
TBST. The sections were washed in TBST (3x 5 minutes). Both the test and NPC 
slides were incubated with the secondary antibody cocktail (table 2.3) for two hours 
and washed subsequently in TBST in the dark (3x5 minutes). The sections were then 
mounted in prolong gold to extend their fluorescence life and were left to dry at room 
temperature overnight. For better retention of fluorescent signal, slides were stored at 
4ºC. Sections were then analysed using an inverted microscope (LSM800/SDI) 
(Zeiss Axio-Observer) against an NPC slide. The monochrome camera used filter 
cubes for detection of light at 405nm, 488nm, 546nm and 647nm. The smart path 
was used to select two filters in one track (AF488 and AF647) and (AF405 and 
AF546) in another track. The pinhole remained consistent across all samples at 
34μM, 1AU). Master gain and digital offset also remained consistent for all slides. 


















Antibody Host Dilution Producer (product 
b ) 
Primary antibodies 
Laminin Rabbit 1:50 Sigma-Aldrich (L9393) 
VDAC-I (IgG2b) Mouse 1:300 Abcam (Ab14734) 
MTCOI (IgG2a) Mouse 1:150 Abcam (14705) 
NDUFB8 (IgG1) Mouse 1:50 Abcam (Ab110242) 
Secondary antibodies 
Anti-rabbit IgG 
Alexa Fluor 405nm 
Goat 1:100 Thermofisher Scientific (A-
31556) 
Anti-mouse IgG2b 
Alexa Fluor 488nm 
Goat 1:200 Thermofisher Scientific (A-
31556) 
Anti-mouse IgG2a 
Alexa Fluor 546nm 
Goat 1:200 Thermofisher Scientific (A-
31556) 
Anti-mouse IgG1 
Alexa Fluor 647nm 
Goat 1:200 Thermofisher Scientific (A-
31556) 
Table 2.3. Primary and secondary antibodies for immunofluorescent detection 
of OXPHOS complexes, mitochondrial mass (VDAC-1) and cardiomyocyte 
boundary marker (Laminin). 
 
2.1.1.2 Densitometry analysis using immunoanalyzer software  
Quadruple OXPHOS immunofluorescent images were acquired and .czi files were 
uploaded on the immunoanalyzer software. Laminin was used to detect 
cardiomyocytes where possible based on the threshold and size of the fibres (figure 




sometimes required if the signal was weaker in some areas. The software used a 
MATLAB based technique (R2015a) to convert .czi images to low resolution Tiff files 
for each channel. The mean optical density (OD) of each channel was measured on 
each section i.e. OD-COXI, OD-NDUFB8 and OD-VDACI. The NPC slides were also 
analysed to determine the background signal intensity of each channel. Laminin was 
used in the NPC slides to determine the background channel signal intensity on a 
fibre by fibre basis. Data were merged and uploaded to R studio Inc. (Version 
0.97.551) at (http://research.ncl.ac.uk/mitoresearch/). 
 
 
Figure 2.12. Laminin outlining cardiomyocytes. Laminin was detected (left image) 
and cardiomyocytes were semi-automatically selected through immunoanalyzer 
software (right image). 
 
2.1.1.3 Quadruple immunofluorescence analysis 
Analysis of optical density data that were corrected for background signal was used 
to normalise the data i.e. OD VDACI, OD NDUFB8, OD MTCOI. A plot of NDUFB8 vs 
MTCOI was generated by the software for each sample. Linear regression analysis 
of the data enabled an estimated level of MTCOI and NDUFB8 for each fibre based 
on porin (VDAC-I) levels. Z-scores are used to describe the deviation of levels in 
NDUFB8 and MTCOI from the predicted levels described in table 2.4. The 
classification of fibres this way has been validated, published and used extensively in 




Classification  Z-score boundaries (standard deviation) 
Porin (VDAC-I) 




Very high  z>3 
MTCOI and NDUFB8 
Negative  Z<-6 
Intermediate negative -6<z<-4.5 
Intermediate positive  -4.5<z<-3 
positive z>-3 
Table 2.4.Cardiomyocytes classification based on defined and optimised z-
score values.  
 
2.25  DNA extraction form mouse tissues 
2.25.1 DNA homogenisation using pestle and mortar 
Frozen LV cardiac muscle (25mg) was homogenised using a sterilised and 
autoclaved pestle and mortar. Tissue was broken down carefully by addition of liquid 
nitrogen and the samples were scraped off with cooled scalpel to a sterile collecting 
tube for DNA extraction. This method was proven to not be free of contamination 




more consistent method of homogenisation was tried with a TissueLyser II (Qiagen) 
as listed below. 
 
2.25.2 DNA homogenisation using TissueLyser II  
Frozen LV cardiac muscle (25mg) was homogenised using TissueLyser II (Qiagen) 
with 80μl cooled PBS and a sterilised titanium bead (Qiagen) in a sterilised and 
autoclaved 2mL tube. The tissues were shaken vigorously at a frequency of 20Hz for 
a total of 4 minutes until all broken down. The beads were taken out carefully and 
tissues were briefly centrifuged ready for DNA extraction. This method provided a 
more consistent DNA yield within an efficient time. 
 
2.25.3 DNA extraction  
Isolation and purification of DNA from homogenised cardiac muscle was carried out 
using a QIAamp DNA mini kit (Qiagen) according to the manufacturer’s instructions in 
QIAamp DNA mini and blood handbook (fifth edition). DNA extracts were aliquoted in 
smaller volumes of 20μl and stored in -20°C for future use. 
 
2.25.4 DNA purification 
DNA concentration was assessed using the NanoDrop 2000 spectrophotometer. The 
Nanodrop was cleaned initially with 1μl of nuclease free dH2O. 1μl of ATL buffer was 
loaded on the Nanodrop to calibrate the system. For measurements, 1μl of each 
sample DNA was loaded and the absorbance was determined at 260/280nm and 
260/230nm range. The initial range determined the purity of DNA. A ratio of ~1.8 is 
acceptable for pure DNA. The latter 260/230nm range was used as a secondary 
measure of nucleic acid purity. A ratio of less than ~2.0 indicated a source of 





2.26  Real-time PCR 
2.26.1 Preparation of reagents 
Primers (table 2.6) were prepared by reconstitution using nuclease-free water under 
the microflow OMNI PCR workstation (ASTEC). Primers (ND1 and B-actin) were 
diluted from 100μM to 10μM using nuclease-free water and stored at -20°C. Prior to 
PCR, all the pipettes including p5,p10,p20,p100, p200 and p1000 as well as 
annotated 96-well plate, adhesive film, annotated microcentrifuge tubes, pipette tips 
and autoclaved dH2O were placed in PCR UV hood (Bio air instruments) for 30 
minutes to eliminate contamination rate. Other reagents such as SYBR green, 
primers and DNA samples were left on ice to thaw. Two x15μl/well PCR-amplification 
reaction mixtures (master-mixes) were prepared, one for mitochondrial targeted gene 
(ND1) and one for a housekeeping nuclear-encoded gene (B-actin). Each master-mix 
consisted of ND1 primers (forward and reverse) (0.6μl/well) or B-actin primers 
(forward and reverse) (0.6μl/well) as well as SYBR green (10μl/well) and DEPC 
treated dH2O (3.8μl/well) (Sigma). The reaction mixture for 20 wells is listed in table 





Master mix Volume  Supplier  
Forward primer (0.6μl/well) 12μl Eurofins Genomics 
Reverse primer (0.6μl/well) 12μl Eurofins Genomics 
DPEC dH2O (3.8μl/well) 76μl Sigma Aldrich 
Platinum SYBR Green 
(10μl/well) 
200μl Thermofisher  
Table 2.5. Reagents used for PCR reaction mixtures for 20 wells. 5μl of sample 
gDNA is added to each well following master mix addition. 
 
Primers Sequence  
Mouse ND1-F 5’-ACA CTT ATT ACA ACC CAA GAA CAC AT-3’ 
Mouse ND1-R 5’-TCA TAT TAT GGC TAT GGG TCA GG-3’ 
Mouse B-actin-F 5’-CCA TCT TGT CTT GCT TTC TTC A-3’ 
Mouse B-actin-R 5’-CCA CCG ATC CAC ACA GAG TA-3’ 
Table 2.6. ND1 and B-actin forward and reverse primer sequence. Primer 
sequences were used to amplify nuclear (β-actin) and mitochondrial DNA (ND1) 
genes. 
 
The two reaction mixtures were vortexed briefly and 20μl/well of reaction mixture 
including master mix solution (15μl/well) plus gDNA (5μl/well) was added to each well 
in triplicate including the standard curve solutions. Three wells for ND1 and three 
wells for β-actin was left without gDNA sample to act as No Template Controls 




mixture without bubbles within wells. DNA was amplified over 30 cycles according to 
the listed cycling conditions (table 2.7). The data obtained as CT values were 
averaged from triplicate results.  
 
Cycling stage Temperature  
Initial denaturation 95°C for 3 minutes 
35 cycles of denaturation 95°C for 30 seconds 
Annealing 58°C for 35 seconds 
Extension 72°C for 30 seconds 
Elongation 72°C for 15 minutes 
Table 2.7. Thermal cycling conditions for quantitative real time-PCR.  
 
2.26.2 Standard curve preparation  
Standard curve solutions were prepared using a high concentration DNA samples 
from mouse. A 10-fold serial dilution of sample DNA was loaded in triplicate on each 
well. Average CT values for each standard curve value was plotted against the 
dilution on a base-10 semi logarithmic graph with a line of best-fit. The equation of 
the line, slope and reaction efficiency of the plot was used to calculate the absolute 
quantification of gene of interest. The standard curve was acceptable only if R2 was 
greater than 0.99. 
 
2.27 Total cytokine Array muscle preparation 
Cytokine array utilises a U-PLEX plate to detect the expression of cytokines present 
in the sample. A multiplex assay kit (MSD) was used to measure 10 analytes 




from protein extracts of mouse quadriceps. Frozen quadriceps from the left leg were 
homogenised manually using TissueLyser II as explained in section 2.24.2. Cell lysis 
and protein extraction was carried out by Tris Lysis buffer where tissue homogenates 
were incubated with Tris lysis buffer in 1:10 ratio. The resultant mixture was 
centrifuged at 12,000 rpm for 20 minutes at 4ºC. The supernatant was removed and 
placed on ice-cold clean microcentrifuge tube for protein concentration determination 
by Bradford assay. Protein extracts was stored for long term in -80ºC freezer. 
 
2.27.1 Protein quantification  
The amount of protein in each sample was quantified using Bradford assay. A 
standard curve solution is made using serial dilution of 1μg/ml Bovine Serum Albumin 
(BSA) to cover the range of protein values obtained from the sample, i.e. standards 





BSA (μl) dH2O (μl) Bradford reagent (μl) 
0 800 200 
2 798 200 
5 795 200 
10 790 200 
15 785 200 
20 780 200 
Table 2.8.Bradford reagents for standard curve set up. 
 
1μg/mL of each sample was added to 200μl Bradford reagent and 799μl of dH2O. 
The higher the amount of protein present in the sample, the bluer the solution, the 
less protein available the browner the solution will turn. 250μl of each sample was 
loaded on a 96 well Bradford plates in duplicate and measured on a plate reader 
(Elx800) at 595nm. The concentration of standard curve samples were recorded and 
the concentration of proteins in samples were extrapolated from the linear graph 
generated. 
 
2.27.2 Cytokine analysis of mouse skeletal muscle 
A 10 spot/well multi-array 96-well plate uses antibodies to detect cytokines that are 
labelled with an electro-chemiluminescent compound (MSD SULFO-TAG). When a 
voltage is applied to the plate electrodes inside the MSD Sector instrument, the 
SULFO-TAG label binds to the electrode surface to emit light and determine the 
concentration of cytokines inside samples. Calibrators, buffers and control solutions 




handbook. The concentration of cytokines were normalised to protein concentration 
measured using Bradford assay. Initially the U-plex plate is prepared by addition of 
200μL of each biotinylated antibody to 300μl of assigned linker, centrifuged briefly 
and incubated at room temperature for 30 minutes. The multiplex coating solution is 
then prepared by addition of 600μl of prepared U-plex coupled antibody into a 15ml 
tube and vortexed briefly. 50μl of each multiplex coating solution is then added to 
each well using a multi-channel pipette. The plates were then sealed and incubated 
at room temperature on the plate shaker for one hour. The plate was then washed 
with MSD wash buffer or PBST for at least three times.  
An 8-point standard curve solutions were prepared from 1μg/mL of calibrator stock 
solution (50μl) in diluent 41 by adding 200μl of diluent 41 to 50μl calibrator stock. 
75μL of the diluted stock calibrator was then added to 225μl diluent 41 to generate 
the rest of the calibrator standard solution. The recommended 8th standard is diluent 


















 225 300 
2 From tube 1 75 225 300 
3 From tube 2 75 225 300 
4 From tube 3 75 225 300 
5 From tube 4 75 225 300 
6 From tube 5 75 225 300 
7 From tube 6 75 225 300 
8 (zero 
calibrator) 
- 0 300 300 
Table 2.9. Dilution of calibrator for standard curve (tubes 1-7) and control 
solution (8th tube).  
 
25μl of diluent 4 was dispensed into each well and the sealed plate was incubated for 
30 minutes over a plate shaker (1000rpm) at room temperature. 25μl of calibrator 
solution for standard curve wells and 25μl of sample was added to test wells of the 
MSD plate, sealed and incubated at room temperature on a shaker (1000rpm) for two 
hours. Plate was washed with PBST three times. 25μl of detection antibody solution 
was added to each well, plate was sealed and incubated at room temperature for two 
hours on a shaker (1000rpm). Plates were washed three times with PBST. 150μl of 
2x read buffer T was added to each well and plates were analysed on SECTOR 
imager (MSD) immediately. Standard curve graphs were generated by plotting the 









Chapter 3. The role of mtDNA mutation in ageing mouse cardiac 
muscle 
3.1 Introduction 
3.1.1  Mitochondria and ageing 
Ageing is defined as a progressive and time-related deterioration in physiological 
functions with an ever increasing risk of death. Mitochondria are thought to be 
involved in the ageing process as an accumulation of cells with mitochondrial 
dysfunction due to mutations of mitochondrial DNA (mtDNA) have been documented 
in a number of ageing tissues such as the heart (Müller-Höcker et al, 1986) brain 
(Cottrell et al, 2001), skeletal muscle (Fayet et al, 2002), colon (Greaves et al, 2014) 
and liver (Yen et al, 1989). The mitochondrial free radical theory of ageing was 
proposed in the 1950s (Harman, 1956) and refined in the early 1980s (Miquel et al, 
1980). The theory predicts that reactive oxygen species (ROS) generated through 
premature electron leakage in the respiratory chain, mainly at Complexes I and III, 
(Lenaz, 2001) can directly target and damage mtDNA. This damage can result in 
mtDNA mutations which cause dysfunction of the oxidative phosphorylation 
(OXPHOS) system which can impair ATP production. It was further proposed that 
dysfunctional OXPHOS could then induce further ROS production and further 
mutation resulting in a vicious cycle (Bandy and Davison, 1990). More recent studies 
have refuted both the vicious cycle and free radical theory of ageing. MtDNA has 
been shown to be densely and efficiently packaged (Jiang et al, 2017) and is well 
protected with the vast majority of repair mechanisms present in the nucleus also 
present in the mitochondrial (Gredilla, Garm and Stevnsner, 2012). In addition, 
mitochondria have multiple antioxidant defence mechanisms to maintain the 
physiologically required ROS levels (Poljsak, Suput and Milisav, 2013), and the 
mtDNA mutational spectrum present in ageing cells does not show the predicted 
ROS-damage signature (Kauppila and Stewart, 2015). Two mouse models which 
accumulate high levels of mtDNA mutations due to a loss of the proof-reading 
capability of the mtDNA polymerase gamma (PolgA) do not show evidence of 
increased ROS related cellular damage at young ages (Dai et al, 2014), and only 
mild increases in H2O2 production at older ages (Logan et al, 2014). Since 
mitochondria exist in thousands of copies per cell, the mutant mtDNA load must 




2003). The level of heteroplasmy indicates the proportion of mutant and wild type 
mtDNA in a cell and the biochemical threshold is determined by the percentage of 
mtDNA heteroplasmy. Shoffner et al (1993) first reported that the phenotypic 
threshold is around 60% for mtDNA deletions and around 90% for other mtDNA 
mutations depending on the type of mutation and the tissue affected. As the 
biochemical defect doesn’t become apparent until the clonal expansion has occurred, 
if ROS are playing a role in ageing, it may only be at this point that their levels begin 
to change due to OXPHOS dysfunction. Greaves et al (2014) used aged human 
colorectal epithelium as an example of a well-defined stem cell population to assess 
the age-related decline in mitochondrial function. They found that clonally expanded 
mtDNA point mutations within individual cells were responsible for the decline in 
mitochondrial function during ageing, rather than an ever increasing rate of mtDNA 
mutation occurrence. 
 
3.1.2  PolgAmut/mut mouse model 
A direct causal role for mtDNA mutations in the ageing process was established by 
studies in mice expressing a proof-reading deficient mtDNA polymerase gamma 
(PolgA) (Trifunovic et al, 2004, Kujoth et al, 2005). The mice have a knock-in 
mutation causing an aspartate to alanine amino acid change (D257A) in the second 
exonuclease domain of the catalytic (PolgA) subunit of the mtDNA polymerase 
(Polγ). The mice harbouring the homozygous PolgA mutation (PolgAmut/mut mouse, 
also known as the mitochondrial mutator mouse) have a 3-5 fold increase in the 
number of point mutations and large scale deletions compared with WT control mice. 
The PolgAmut/mut mice show a premature ageing phenotype with phenotypic 
characteristics including: loss of muscle mass, cardiac enlargement, alopecia, 
kyphosis, reduced subcutaneous fat, weight loss, osteoporosis, reduced fertility and 
anaemia from as early as 25 weeks of age. The median lifespan of the PolgAmut/mut 
mice was reduced to 48 weeks of age and the premature signs of ageing accelerated 
from 7-9 months of age resembling human ageing. Safdar et al (2011) have 
documented that 5 months of endurance exercise rescues the progeroid phenotypes 






3.1.3  PolgAmut/mut mouse cardiovascular phenotypes 
Due to the inherent dependency of normal cardiac physiology on mitochondria, 
Trifunovic et al (2004) investigated the cardiovascular phenotypes of PolgAmut/mut 
mice. They reported significant cardiac remodelling including cardiac hypertrophy as 
evident by enlarged cardiomyocyte width, heart size and a marked increase in left 
ventricular mass index compared to wild type littermates. Cardiomyocyte 
mitochondrial complex IV deficiency and enlarged mitochondria were also 
characteristic of PolgAmut/mut mouse hearts. A second study by Dai et al (2010) 
reported age-related changes in PolgAmut/mut mouse hearts including increased levels 
of mtDNA deletions and protein oxidative damage as well as increased expression of 
apoptotic and senescence markers, and a decline in mitochondrial biogenesis 
signalling. Other phenotypic features of PolgAmut/mut mouse hearts were depressed 
cardiac fractional shortening which determines myocardial performance, as well as 
systolic dysfunction, diastolic dysfunction, ventricular interstitial and perivascular 
cardiomyocyte fibrosis (Dai et al, 2010). 
 
3.2 Aims of study 
The focus of this chapter was to characterise the PolgAmut/mut mice phenotypes 
compared with wild-type PolgA+/+ mice at the physiological and cellular level to 
establish baseline characteristics prior to the exercise intervention. Specifically, I 
aimed to characterise the following: 
1. Clinical phenotype of the PolgAmut/mut vs PolgA+/+ mice from 3 to 11 months of 
age 
2. Behavioural characteristics of PolgAmut/mut vs PolgA+/+ mice from 3 to 11 
months of age 
3. Cardiac structure, histology and mitochondrial function in PolgAmut/mut vs 





3.3.1  Survival curve, Clinical scoring and Body weight of PolgA+/+ mice and 
PolgAmut/mut mice 
Clinical scoring is a measure of health span and is a determinant of the severity of 
disease and the clinical end point for this study. The phenotypic features rate the 
health condition of mice and include weight, coat condition, skin tone, behaviour, 
posture and mobility, abdominal distension, foot colour and hydration of mice (table 
2.1). The clinical scoring criteria and an example of monitoring sheet are detailed in 
the appendix 1 tables 8.1 and 8.2. Clinical scoring was performed on n=5 PolgA+/+ 
mice and n=10 PolgAmut/mut mice on a weekly basis from 14 weeks of age (baseline) 
up to 43 weeks of age. Animals were scored from 0 to 3 for each characteristic, 0 
being normal and 3 being substantial worsening of the animal’s condition for each 
characteristic. All 8 characteristics were assessed during each monitoring session 
and the final total score was recorded. The higher the total clinical score value, the 
worse body condition was deemed to be. If a mouse received one score of 3, three 
scores of 2, over 20% weight loss or temperatures below 30ºC, the animal was 
humanely killed by cervical dislocation.  
The survival curve in Figure 3.1A shows that 100% of PolgA+/+ mice lived until the 
end of the study (46 weeks) whereas only 53.85% of PolgAmut/mut mice survived to the 
end of the study. Mice that died prematurely from prolapse or fight wounds were 
excluded from the survival curve. Since only 53.85% of PolgAmut/mut mice lived until 
the 46 week endpoint, all the in vivo measurements including the body weight, 
temperature, open field testing and clinical scoring were taken from 43 weeks of age 
in both groups for reliable statistical analysis. 
Figure 3.1B shows the body weights of PolgA+/+ mice from 14-43 weeks of age (up to 
40.52g± 2.26g at 43 weeks of age). This is within the normal range when compared a 
database of the expected body weight of C57Bl6/J mice body at the same age 
(39g±4.5g) (The Jackson Laboratory, 2019). At 43 weeks of age, the body weight of 
PolgA+/+ mice was significantly higher than 14 weeks (p<0.001). In comparison, 
PolgAmut/mut mice also showed a steady but significant (p<0.01) weight gain (up to 
32.5g±1g at 43 weeks of age) which was significantly lower than PolgA+/+ mice at the 




Figure 3.1C shows that at 14 weeks of age there were no significant differences in 
the total clinical scores between PolgAmut/mut and PolgA+/+ mice. However, by 46 
weeks of age PolgAmut/mut had a significantly higher clinical score as a result of a 
decline in their body condition compared to their total score at 14 weeks (p=0.0003) 
and a significantly higher total clinical score compared with PolgA+/+ mice at 43 weeks 
(p=0.0013) (two-way repeated measure ANOVA). At 43 weeks of age 85% of 
PolgAmut/mut mice showed significant piloerection, 14.3% demonstrated hunched 
posture and reduced mobility, 57.1% had paling of the feet due to anaemia, 14.3% 
showed behavioural changes such as lack of social interaction and 14.3% 
experienced up to 20% weight loss (all with a total score of ≥2). In addition, 100% of 
age-matched PolgA+/+ mice showed normal body weight, 100% with no signs of 
piloerection, 100% with normal posture and mobility and 100% with behavioural 





Figure 3.1. Comparison of PolgA+/+ mice and PolgAmut/mut mice survival curve, 
clinical scoring and body weight. A) 100% of PolgA+/+ mouse survived to the end 
of the study in comparison to 53.85% PolgAmut/mut mice. B) PolgA+/+ mice showed a 
significant increase in body weight with increasing age (p<0.001). Body weight from 
14 weeks to 43 weeks in PolgAmut/mut mice (p<0.01). PolgA+/+ and PolgAmut/mut mice at 
14 weeks (p>0.05), PolgA+/+ and PolgAmut/mut mice at 43 weeks (****p<0.0001). C) 
Clinical scoring at 14 weeks was not significant different between the two cohorts 
(p=0.422). PolgAmut/mut mice had significant decline in body condition at 43 weeks in 
comparison to PolgA+/+ mice (****p=0.0003) and with increasing age (****p=0.0013, 





3.3.2 Body temperature in PolgA+/+ mice and PolgAmut/mut mice  
The body temperature of individual mice was recorded from a subcutaneous RFID 
chip implanted under the skin on the top of the mouse’s neck using a chip reader four 
times per week from 14 weeks onwards for the duration of the study. PolgAmut/mut 
mice were group-housed with PolgA+/+ mice and PolgAmut/+ mice in cages of 2, 3 or 4. 
Figure 3.2 demonstrates the mean body temperature of PolgA+/+ mice (n=5) and 
PolgAmut/mut mice (n=10) at the age of 14 weeks, 29 weeks and 43 weeks. There was 
no significant difference between the body temperatures of PolgA+/+ mice and 
PolgAmut/mut mice at 14 weeks and 29 weeks of age (p>0.05). At 43 weeks of age the 
mean body temperature of PolgAmut/mut mice (35.1°C ±0.2) was significantly lower 
than PolgA+/+ mice (36.47°C ±0.58) (p<0.001, two way repeated measures ANOVA). 
The body temperature of PolgA+/+ mice increased significantly from 14 weeks 
(35.3ºC±0.9) to 43 weeks (36.5ºC±0.6) of age (p<0.01, two way repeated measures 
ANOVA). The body temperature of PolgAmut/mut mice did not change significantly with 
advancing age from 14 weeks to 43 weeks (p>0.05). Although the cages were 
temperature regulated, the ability to control core body temperature is down to the 
basal metabolic activity of each mouse. Temperature regulation also depends on 







Figure 3.2. Body temperature of PolgA+/+ mice and PolgAmut/mut mice at 14, 29 
and 43 weeks of age. PolgA+/+ vs PolgA mut/mut mice at 14 weeks and 29 weeks of 
age (p>0.05), PolgA+/+ vs PolgAmut/mut mice at 43 weeks (***p<0.001), PolgA+/+ mice 
14 weeks vs 43 weeks (**p<0.01). PolgA mut/mut mice 14 weeks vs 43 weeks (p>0.05), 
(Two-way repeated measures ANOVA). Error bars represent mean ±SD. 
 
3.3.3 Open Field Testing (OFT) of PolgA+/+ mice and PolgAmut/mut mice 
In order to understand and characterise the locomotive and behavioural 
characteristics of the two groups of mice, open field testing (OFT) was carried out 
over a 5 minute period at 15 weeks, 29 weeks and 43 weeks of age in PolgA+/+ mice 
(n=5) and PolgAmut/mut mice (n=10). The method by which OFT was carried out 
detailed in chapter 2 section 2.16.1. The graphs shown in figure 3.3 indicate a range 
of quantitative measures from the emotional and behavioural state of mice to 
ambulatory ability using the mousetrap software (Ryanware v4.0). The total distance 
moved indicates the locomotive state of mice. The velocity at which mice travel may 
indicate responsiveness and assesses reaction time to an unknown stimuli or 
situation. Rearing behaviour is described as a position where the mouse is standing 
on both hind limbs in an upright position and its frequency is a measure of 
inquisitiveness and exploratory behaviour in mice. Total number of touches is the 
number of times the animal’s forelimbs touched the arena which sometimes gives an 
indication of fear-related behaviours such as when the sum of touches were high and 




and coordination of animals as a higher number of touches; lower travelling distance 
and shorter step length indicate a state of impaired coordination. Step length was 







Figure 3.3.Open Field Testing at 15, 29 and 43 weeks of age in PolgA+/+ vs 
PolgAmut/mut mice. A) Total distance moved significantly reduced with advancing age 
in PolgAmut/mut mice (**p<0.01) and was significantly lower in PolgAmut/mut at 15 weeks 
(*p<0.05), 29 weeks, (**p<0.01) and 43 weeks (***p<0.001) of age in comparison to 
PolgA+/+ mice. B) No significant changes in the velocity of movements and C) rearing 
frequency of both cohorts were seen. D) Number of touches were significantly higher 
in PolgA+/+ mice at 29 weeks (**p<0.01) and 43 weeks (***p<0.001) in comparison to 
PolgAmut/mut mice and decreased significantly in PolgAmut/mut mice with age (*p<0.05). 
E) Step length significantly reduced in PolgAmut/mut mice with age (**p<0.01) and is 
significantly lower in PolgAmut/mut mice at 43 weeks (*p<0.05) in comparison to 






The total distance moved in PolgAmut/mut mice was significantly lower in comparison to 
PolgA+/+ mice at 15 weeks (p<0.05), 29 weeks (p<0.001) and 43 weeks (p<0.001) of 
age. There was however no age-associated changes in the total distance travelled of 
PolgA+/+ mice but a significant decline in Polgmut/mut mice with age (p<0.01). There 
was no significant difference in velocity of movement and the rearing frequency 
between the two groups and within groups at any time points as shown in figures 
3.3B and 3.3C. In general, the less contact the mouse has with the arena, the lower 
the locomotive activity of the mouse is considered to be. At 15 weeks of age, no 
significant differences in the number of touches were seen between the cohorts. A 
significantly lower number of touches were observed in PolgAmut/mut mice in 
comparison to PolgA+/+ mice at 29 weeks (p<0.01) and 43 weeks (p<0.001) of age 
(figure 3.3D). The number of touches did not significantly change with age in PolgA+/+ 
mice but was significantly reduced in PolgAmut/mut mice from 15 weeks to 43 weeks of 
age (p<0.05). PolgAmut/mut mice showed a significant decline in their step length by 43 
weeks of age in comparison to PolgA +/+ mice (p<0.05). Step length in PolgA+/+ mice 
did not change significantly with age (figure 3.3E). PolgAmut/mut mice showed a state 
of imbalance with age progression indicated by significant decline in step length at 43 
weeks of age (p<0.01) (Two-way repeated measures ANOVA). 
Incorporating all the OFT parameters measured to assess the state of locomotion 
and physical capacity of mice, it is evident that PolgAmut/mut mice have significantly 
less movement and therefore less contact with the arena as shown by the lower 
frequency of touches and significantly lower step length that indicate an overall 
musculoskeletal weakness and coordination imbalance in comparison to PolgA +/+ 




3.3.4 Organs weights in PolgA+/+ mice and PolgAmut/mut mice 
Organs were harvested according to the mouse organ harvesting sheet in appendix 
2. Organ weight was recorded immediately following cervical dislocation at the end of 
the study or when the clinical endpoint was reached. Organ weight data are 
presented as both the actual organ weights (Figure 3.4A) and organ to body weight 
ratios (Figure 3.4B) in PolgA +/+ mice (n=5) and PolgAmut/mut mice (n=10). Figure 3.4A 
demonstrates that the weight of; liver (p<0.001), spleen (p<0.01) and heart (p<0.05) 
was significantly higher in PolgAmut/mut mice and the weight of pancreas (p<0.001) 
was significantly higher in PolgA +/+ mice (unpaired t-test). The liver (p<0.01), spleen 
(p<0.01), right kidney (p<0.05), left kidney (p<0.01), heart (p<0.01), lungs (p<0.05) 
and brain (p<0.05) weight when normalised to body weight was significantly higher in 
PolgAmut/mut mice in comparison to PolgA +/+ mice using an unpaired t-test. The weight 
of pancreas was non-significantly different between the two cohorts when the body 
weight was taken into consideration. As body weight was significantly reduced in 
PolgAmut/mut mice compared with PolgA+/+ mice at endpoint, it is difficult to determine 






Figure 3.4.Organ weights. A) Liver, spleen and heart weight was significantly higher 
in PolgAmut/mut mice in comparison to PolgA+/+ mice. B) Normalised organ weight in 
PolgA+/+ mice and PolgAmut/mut mice. Liver, spleen, left kidney and heart (**p<0.01), 
lungs, right kidney and brain (*p<0.05) were significantly bigger in PolgAmut/mut mice in 




3.3.5 Cellular and molecular analysis of the heart in PolgAmut/mut and PolgA+/+ 
mice at 46 weeks of age 
Since the heart was the organ of interest in this study, I harvested and longitudinally 
dissected the hearts and froze the left side in isopentane, and fixed and embedded 
the right side in paraffin for further analysis. 
Histological and molecular techniques such as COX/SDH histochemistry, NBTx 
analysis and mitochondrial DNA copy number analysis were carried out on the frozen 
left ventricular tissue. Haematoxylin and Eosin stain, Masson trichrome cardiac 
fibrosis analysis, cleaved-caspase 3 immunohistochemistry (apoptotic marker) and 
mitochondrial complexes I and IV immunofluorescence was carried out on the right 
fixed ventricular tissue.  
 
3.3.6 Histological analysis of PolgA+/+ mice and PolgAmut/mut right ventricle at 
endpoint 
Haematoxylin and Eosin (H&E) staining was carried out to visualise cardiomyocyte 
morphology and assess cardiomyocyte width (Figure 3.5A). The nuclei were stained 
blue and cardiomyocytes were stained various shades of pink. 4μm paraffin 
embedded cardiac tissue from (n=10) PolgAmut/mut mice and (n=5) PolgA+/+ mice were 
subjected to H&E staining and visualised using the Zeiss light microscope. Five 
random snapshots from the RV were taken at x20 magnification and the width of 50 
cardiomyocytes per image were measured using Zen image analysis software. 
Figure 3.5B shows that the width of cardiomyocytes in PolgAmut/mut mice was 
significantly larger in comparison to PolgA+/+ mice (p=0.0001, unpaired t-test)  
Cardiac fibrosis was assessed in n=10 PolgAmut/mut mice and n=5 PolgA+/+ mice 
hearts by Masson’s trichrome staining. This technique uses three dyes to detect 
cardiac myopathies such as scarring and accumulation of excess collagen during 
pathological cardiac hypertrophy and fibrosis. The histochemical technique stains cell 
nuclei purple by Haematoxylin, cytoplasm and cardiomyocytes red by Biebrich scarlet 
solution and collagenous connective tissue blue by Aniline blue solution. 4μm paraffin 
embedded cardiac sections were subjected to Masson’s trichrome staining and 




sections were analysed in NIS elements software using RGB general analysis 
algorithm by creating RGB channels and setting the threshold for the intensity of 
each colour ensuring no under/over saturated regions remained. The LED intensity 
and analysis settings remained constant throughout. Areas of interstitial and 
perivascular fibrosis were identified and analysed per mouse cardiac section, and the 
percentage of tissue fibrosis was quantified. The percentage of collagenous 
connective tissue (tissue fibrosis) was significantly higher in the cardiac tissue of 
PolgAmut/mut mice in comparison with PolgA+/+ mice (p=0.01) (figure 3.5C). Collagen 
accumulation is evident as the area of blue collagen aggregation and the 






Figure 3.5.Cardiac fibrosis and cardiomyocyte width in PolgAmut/mut and 
PolgA+/+ mice. A) Representative x20 H&E and trichrome images of PolgAmut/mut and 
PolgA+/+ mice cardiac tissue. H&E images were used to measure cardiomyocyte 
width (scale bars=100μm). Masson trichrome images (x10) represent collagenous 
connective tissue in blue and cardiomyocytes in red (scale bars=200μm). B) There is 
a significant increase in PolgAmut/mut mice cardiomyocyte width (****p<0.0001) in 
comparison to PolgA+/+ mice. C) Percentage of fibrosis in PolgAmut/mut mice cardiac 
tissue is significantly higher than PolgA+/+ hearts (**p=0.01) (unpaired t-test). Error 





3.3.7  Apoptosis  
Caspases are a family of peptides that cleave their target substrates proteolytically in 
the process of apoptotic cell death. Cleaved caspase-3 (CC-3) is an executioner 
caspase and becomes activated by an apoptotic signalling event responsible for 
chromatic condensation and DNA fragmentation (Bressenot et al, 2008). Activated-
cleaved caspase 3 (CC3) immunohistochemistry was carried out in order to visualise 
and quantify apoptotic nuclei in cells by targeting CC3 as a critical executioner of 
apoptosis in PolgA+/+ mice (n=5) and PolgAmut/mut mice hearts (n=10). Five random 
fields were taken and the frequency of CC3 positive nuclei shown as dark brown 
staining was quantified (Figure 3.6). Images were obtained using Aperio-scanner and 
analysed using Image-scope software nuclear staining algorithm (Leica Biosystems). 
The total number of nuclei and the total number of apoptotic nuclei were counted, 
and the percentage of apoptotic nuclei was calculated. The percentage of CC3 nuclei 
was significantly higher in the cardiac muscle in PolgAmut/mut mice compared with 





Figure 3.6. Percentage of apoptosis. A) Apoptosis measured by CC3 
histochemistry in PolgAmut/mut mouse heart. CC3-positive cells are shown with red 
arrows. B) The percentage of cell death was quantified as the frequency of cleaved 
caspase-3 positive cells ratio to normal nuclei count which is significantly higher in 
cardiac muscle of PolgAmut/mut mice in comparison to PolgA+/+ mice (**p=0.001). Error 




3.3.8 Mitochondrial Complex I and Complex IV expression levels in PolgA+/+ 
mice and PolgAmut/mut mice hearts 
Mitochondrial OXPHOS complex I and complex IV expression levels were quantified 
in transverse fixed RV cardiac muscle by immunofluorescence assay using 
antibodies against MTCOI subunit of complex IV and NDUFB8 subunit of complex I. 
The optical density (OD) values of each enzyme is quantified from each 
cardiomyocyte through the fluorescence signal arising from the secondary antibody 
binding to the antigen of interest marked by the primary antibody. Mitochondrial mass 
was detected using an antibody against VDAC1 (Porin). Cardiomyocytes were 
differentiated from one another by an anti-laminin antibody that outlines each 
cardiomyocyte for easier differentiation and quantification. Five random snapshots of 
x10 magnification from 4μm paraffin embedded cardiac muscle were randomly 
selected and images were acquired using Zeiss AxioObserver LS800/SD/Airscan 
inverted microscope. The final .czi images were uploaded on to in-house analysis 
software known as the Quadruple Immuno-analyser created by Dr John Grady 
(Wellcome Centre for Mitochondrial Research, Newcastle University). The semi-
automated software allows for the detection of individual cardiomyocytes visualised 
by laminin labelling. No primary control sections were used to remove background 
signal and set the exposure times accurate to visualise genuine signal with the right 
brightness. Merged files were uploaded on (http://research.ncl.ac.uk/mitoresearch/) 
for further analysis using PolgA+/+ mice as reference value for normality. The 
mitochondrial complex I and complex IV OD values were normalised to Porin levels 
by the software, z-scores were generated and used to classify fibres into negative, 
intermediate negative, intermediate positive and positive complex I and complex IV 
expression levels (Rocha et al, 2015). Mitochondrial respiratory chain (MRC) plots 
were created for each subject to showcase the distribution of cardiomyocytes with 
different complex I and complex IV expression levels.  
Mitochondrial Complex I subunit (NDUFB8) and Complex IV subunit (MTCOI) 
expression levels were quantified in the RV cardiac muscle of PolgA+/+ mice (n=5) 
and PolgAmut/mut mice (n=10). Figure 3.7A shows micrographs from the RV cardiac 
muscle. Expression of both complexes were obtained from individual transverse 
cardiomyocytes using quadruple immune-analyser software which is based on 
MATLAB. The OD values obtained were averaged for each cardiomyocytes, omitting 





Figure 3.7.Mitochondrial Complex I (CI) and Complex IV (CIV) subunits 
expression levels in PolgA+/+ mouse and PolgAmut/mut mouse hearts. CI was 
detected using an antibody against NDUFB8 and CIV was detected using an 
antibody against MTCOI. Mitochondrial mass was visualised using an antibody 
against Porin. Cardiomyocytes boundary was marked using an antibody against 







Cardiac muscle from all PolgA+/+ mice showed 100% positive NDUFB8 (Complex I) 
and MTCOI (Complex IV) expression levels since the software used OD values 
obtained from PolgA+/+ mice as a control to compare the PolgAmut/mut mice data 
against it. Therefore figure 3.8 represents the percentage of cardiomyocytes with 
categories of NDUFB8 and MTCOI in PolgAmut/mut mice relative to PolgA+/+ 
cardiomyocytes as well as the MRC graphs. An example from each cohort is shown 
(figures 3.8A and 3.8B). Each dot on the graphs represents a cardiomyocyte which is 
colour coded by the levels of mitochondrial mass (porin) (blue=very low, light blue= 
low, beige=normal, orange=high, red=very high). In addition, dashed lines represent 
the standard deviation limits for the classification deficiency of complexes I and IV in 
individual cardiomyocytes.  
Figure 3.8 (C-D) shows the variation in optical density of NDUFB8 and MTCO1 in 
cardiomyocytes; ranging from negative to positive covering intermediate positive and 
intermediate negative levels in the middle. In PolgAmut/mut mice hearts, relative to age-
matched PolgA+/+ hearts, 23.79% of cardiomyocytes were NDUFB8 positive, 42.8% 
were intermediate positive, 25.1% were intermediate negative and 8.1% negative. 
30.13% of cardiomyocytes were MTCOI positive, 65.1% were intermediate positive, 
4.6% intermediate negative, and 0.12% negative in PolgAmut/mut mice relative to age-
matched PolgA+/+ mice. The significant reduction in the percentage of complex I and 
complex IV positive cardiomyocytes and significant increase in the percentage of 
negative complex I and intermediate negative complex IV levels in PolgAmut/mut mice 
hearts is the result of increased mtDNA mutagenesis. This could limit the capacity of 
cardiac tissue for efficient ATP generation since the NDUFB8 subunit of complex I 
and MTCOI subunit of complex IV are crucial for correct functioning of the electron 
transport chain. Figure 3.8E demonstrates porin expression levels as z-score values 
(detailed chapter 2 talbe 2.4) where values between -2 and 2 represent normal porin 






Figure 3.8. Mitochondrial NDUFB8 (Complex I) and MTCOI (Complex IV) 
immunoreactivity levels in PolgA+/+ mice and PolgAmut/mut right ventricular 
cardiac muscle. A) Mitochondrial Respiratory Chain (MRC) plot obtained from a 
PolgA+/+ mouse heart showing the categorisation of each cardiomyocyte for CI and 
CIV. B) MRC plot from a PolgAmut/mut mouse heart. C) Percentage of cardiomyocytes 
with positive, intermediate positive, intermediate negative and negative NDUFB8 
expression in PolgAmut/mut mice hearts. D) Percentage of cardiomyocytes with 
positive, intermediate positive, intermediate negative and negative MTCOI 
expression in PolgAmut/mut mice hearts. E) Mitochondrial mass marker (porin) levels 




3.3.9  Complex IV activity in PolgA+/+ mice and PolgAmut/mut mice 
Mitochondrial complex IV (cytochrome c oxidase or COX) activity was investigated by 
sequential cytochrome c oxidase/succinate dehydrogenase (COX/SDH) 
histochemistry. Complex IV is the only complex of the OXPHOS system in which 
enzyme activity (rather than protein levels) can be demonstrated histochemically. 
SDH is entirely encoded by nuclear DNA and is unaffected by mtDNA mutations. The 
sequential COX/SDH histochemical assay allows for the visualisation of COX positive 
cardiomyocytes by localisation of the brown indamine polymer DAB (electron donor) 
in mitochondrial cristae in the presence of functional COX. Cardiomyocytes with 
dysfunctional COX do not saturate with DAB. Following incubation in media to 
demonstrate SDH activity, in those cells with no DAB precipitate there is the 
formation of a blue formazan end product due to the reduction of NBT by SDH in 
COX negative fibres (figure 3.9). 8μm cryosections of LV cardiac tissue from 
PolgAmut/mut mice (n=10) and PolgA+/+ mice (n=5) underwent COX/SDH 
histochemistry and were imaged using a Nikon widefield Tie microscope. Five 
random snapshots were taken at x10 magnification from each LV mouse heart and 
COX deficiency was quantified in cardiomyocytes using NIS elements software. The 
software categorised the cardiomyocytes according to their colour using RGB 
general analysis algorithm. Since a mosaic pattern of COX deficiency is documented 
in PolgAmut/mut mouse heart, this three colour analysis software was used to extract 
most of the pigments with combination of red, green and blue for each fibre. The 
manual thresholding was kept constant for all the samples. The percentage of COX 
deficiency is quantified based on differentiating and subtracting the percentage of 
deficient SDH blue staining from the whole tissue area. There was a significant 
increase in COX deficiency in the LV tissue of PolgAmut/mut mice at 46 week of age 
compared with age-matched PolgA+/+ mice following a two-tailed unpaired t-test 






Figure 3.9.COX/SDH imaging and analysis. Representative serial sections of COX, 
SDH histochemistry and sequential COX/SDH from PolgA+/+ mice and PolgAmut/mut 
mice hearts. COX/SDH analysis was carried out using NIS elements by creating 
surfaces to mask and distinguish cardiomyocytes with respiratory chain deficiency 
(COX negative area) from the blue region to COX normal brown area. Magnification 





Figure 3.10. COX deficiency in the LV cardiac muscle of PolgA+/+ and 
PolgAmut/mut mice. The percentage of total COX deficient blue regions were 
significantly higher in PolgAmut/mut mice hearts in comparison to PolgA+/+ mice hearts 




3.3.10 NBTx and laminin immunofluorescence in PolgA+/+ mice and PolgAmut/mut 
mice hearts 
A disadvantage of the COX/SDH histochemical assay is that this dual colour test may 
hinder the detection of low or intermediate deficiency levels since the prominent 
brown colour may obstruct the light blue colour. Therefore, a more sophisticated 
histochemical assay known as the NBTx assay (Simard et al, 2018) was carried out 
to determine the intermediate COX level fibres. The NBTx assay exploits the 
competing redox reactions between electron carrier PMS, complex IV and NBT as 
explained in detail in chapter 2 section 2.24.1. Figure 3.11 shows a simplified 





Figure 3.11. NBTx assay. Oxidised PMS has a dual affinity for COX and NBT. 
PMSH passes on electrons to molecular oxygen via electron acceptors in COX in a 
fully functional system (left image) resulting in no colour change. When COX is 
dysfunctional, PMS preferentially passes electrons to NBT for reduction to a blue 





An advantage of NBTx assay over COX/SDH histochemistry is that the pathogenic 
loss of COX is distinguishable from lower levels of COX activity in cells with 
heterogeneous mitochondrial activity. Since the amount of NBT deposition in cells is 
directly proportional to the degree of COX deficiency, the darker the blue, the more 
COX negative the cardiomyocytes were. 
NBTx histochemistry was performed in combination with laminin immunofluorescence 
(to demarcate the outline of individual cardiomyocytes) on 8μm LV cryosections of 
PolgAmut/mut mice (n=10) and PolgA+/+ mice (n=5) hearts. Five random snapshots 
were taken at x10 magnification and a minimum of 500 LV transverse 
cardiomyocytes were investigated per mouse. Figure 3.12 shows laminin outlining 
the cardiomyocytes and NBTx image outlining the COX deficient fibres in blue. 
Images were acquired using Zeiss LSM800/SDI inverted microscope and analysed 





Figure 3.12. NBTx and laminin immunofluorescence. Laminin is used to outline 
cardiomyocytes. The images obtained from NBTx brightfield colour camera highlights 
the various degree of COX deficiency in blue in PolgA+/+ mice and PolgAmut/mut mice 
LV tissue. Images from NBTx monochrome camera are uploaded on the quadruple 





The analysis software measures the optical density (OD) of each individual 
cardiomyocytes. OD is a measure of how slowly light can travel through an object, 
therefore the higher the OD value, the slower the light travels and the darker the 
object is. The higher the optical density values, the darker the pixels and the more 
COX deficient the fibres are. The lower the optical density value, the lighter the pixels 
and the higher the COX activity is. An arbitrary numbering system was used to 
categorise COX levels into: positive (anything below -3SD from the mean OD of the 
cardiomyocytes in PolgA+/+ mice hearts), intermediate (between -3SD and -6SD from 
the mean OD cardiomyocytes in PolgA+/+ mice hearts) and negative (anything below 
-6SD from the mean of the cardiomyocytes of PolgA+/+ mice hearts). The mean OD of 
the no primary control sections (NPC) were measured to determine the levels of non-
specific fluorescent signal which was subtracted from each value. Figure 3.13 shows 
the percentage of cardiomyocytes with positive, intermediate and negative COX 
activity in PolgAmut/mut mice hearts relative to PolgA+/+ mice hearts. Eat dot represent 





Figure 3.13. Category of COX activity levels. The percentage of COX positive, 
intermediate and negative cardiomyocytes in PolgAmut/mut mice hearts relative to 




3.3.11 Mitochondrial DNA copy number in PolgA+/+ mice and PolgAmut/mut mice 
To assess whether the observed OXPHOS defects were only due to mtDNA 
mutations or whether there was any change in mtDNA copy number, real-time 
quantitative PCR was carried out to quantify mtDNA copy number in left ventricular 
(LV) cardiac muscle of PolgAmut/mut mice (n=10) and PolgA+/+ mice (n=5). LV tissue 
was homogenised at the end of the study and the total genomic DNA was obtained. 
ND1 and β-actin primers were used to detect mtDNA and nuclear DNA respectively 
using relative standard curve method for three replicates per mouse. The ratio of 
ND1 to B-actin determined the relative mtDNA copy number frequency. There is no 
significant difference in mtDNA copy number in the cardiac muscle of PolgAmut/mut and 
PolgA+/+ mice as shown in figure 3.14. 
 
 
Figure 3.14. Mitochondrial DNA copy number as the ratio of ND1 to B-actin in 
PolgA+/+ mice and PolgAmut/mut mice LV homogenates. There is no significant 
difference between the mtDNA copy number in the LV cardiac muscle of both cohorts 
(p=0.8) (unpaired t-test). Error bars represent mean ±SD. 
 
3.4 Discussion 
The aim of this study was to characterise the PolgAmut/mut mice phenotypes and 
cardiac features in comparison to PolgA+/+ mice from the age of 14 weeks to 43 




reaching the end of the study while 100% of PolgA+/+ mice survived to the endpoint. 
These data are in agreement with previous studies using the PolgAmut/mut mice. Kujoth 
et al (2005) demonstrated a significant reduction in lifespan of at least 230 
PolgAmut/mut mice (p<0.0001) in comparison to wild-type littermates. A significant 
deterioration in health span of PolgAmut/mut mice was also evident with advancing age 
in comparison to PolgA+/+ mice shown by the clinical scoring data. Similarly, Kujoth et 
al (2005) also identified an age-related decline in PolgAmut/mut mice including weight 
loss, loss of bone density, loss of intestinal crypts and testicular atrophy. They 
investigated the role of oxidative stress caused by mitochondrial ROS generation in 
isolated PolgA mut/mut mice hearts and livers to identify sources of increased mtDNA 
mutation load and found that the levels of mitochondrial H2O2, F2-isoprostanes and 
protein carbonyls (marker of ROS-induced damage) were not significantly different 
between the young and old PolgAmut/mut and PolgA+/+ mice. Parallel with our findings 
of cellular apoptosis, Kujoth et al (2005) showed that PolgAmut/mut mice display early 
onset of caspase-3 mediated apoptotic pathway in their liver, testes, thymus and 
duodenum. They concluded that post-mitotic tissues such as skeletal muscle and 
brain are more resistant to the induction of apoptosis mediated mtDNA mutations in 
PolgAmut/mut mice. They suggested that phenotypic features of these mice were due 
to a depletion of oxidative capacity of tissues which is not as severe in normal ageing 
mice. 
Trifunovic et al (2004) first identified the defects in the oxidative phosphorylation 
capacity of PolgAmut/mut mice in various tissues and correlated the phenotypic 
premature ageing phenotypes to the accumulation of somatic mtDNA mutation and 
clonal expansion of point mutations and deletions when PolgAmut/mut mice reach about 
48 weeks of age. The phenotypic data presented in this chapter were supported by 
biochemical defects in oxidative phosphorylation capacity of cardiac muscle shown 
as the patchy pattern of respiratory chain deficiency in PolgAmut/mut mice confirming 
the findings of previous studies. Trifunovic et al (2004) reported significant levels of 
COX deficiency in the hearts of PolgAmut/mut mice as well as cardiac hypertrophy and 
development of cardiomyopathy at 40 weeks of age in comparison to their WT 
counterparts, similar to findings in ageing human studies (Muller-Hocker, 1990) and 
findings of this study. They confirmed the presence of abnormal vacuolated 
mitochondria in the cardiac muscle of PolgAmut/mut mice by electron microscopy. The 




(2004). They found that the number of full length mtDNA copy number in PolgAmut/mut 
mice was only 70% of the level in WT mice, however this observation did not alter the 
mtDNA expression levels. Consistent with the findings of this study, changes in the 
mtDNA copy number of PolgAmut/mut mice hearts was not associated with respiratory 
chain function, since significant COX deficiency with no change in mtDNA copy 
number was evident. 
Safdar et al (2011) also highlighted the decline in clinical phenotypes of PolgAmut/mut 
mice from as early as 6 months of age, confirming the baseline characteristics of 
these mice. They have shown that PolgAmut/mut mice had significant loss of body fat, 
muscle mass and brain atrophy, anaemia as well as cardiac hypertrophy and 
cardiomyopathy compared with WT mice. They concluded that COX deficiency, 
reduction in electron transport chain protein subunits and nuclear DNA fragmentation 
as a measure of apoptosis were also significantly diminished in the hearts of 
PolgAmut/mut mice. The link between sustained mitochondrial dysfunction and 
activation of caspase 3 in DNA fragmentation of aged tissues and neurometabolic 
disorders were investigated by many other researchers (Hiona et al, 2010, 
Wohlgemuth et al, 2010, Wasilewski and Scorrano, 2009). One group showed that 
suppression of apoptosis prevented cardiomyopathy in the cardiac mitochondria of 
PolgAmut/mut mice (Mott et al, 2004). A study by the same group of scientists proposed 
that somatic mtDNA mutation-driven generation of misfolded mitochondrial proteins 
bind to pro-apoptotic enzymes to activate systemic apoptosis (Mott et al, 2004). Here 
we have shown that PolgAmut/mut mice hearts developed significant complex I and 
complex IV deficiency along with observations in increased cardiac muscle 
apoptosis. 
Body energy stores such as fat are regulated by many factors in mice and have a 
direct effect on body temperature regulation. The changes in the mental behaviour 
and vegetative state of mice as well as disease state control energy expenditure and 
potentially body temperature. Since PolgAmut/mut mice do not show significant weight 
gain after 24 weeks of age, it’s not surprising to see lower core body temperatures in 
PolgAmut/mut mice. The thermogenic capacity of PolgAmut/mut mice is partly diminished 
according to Shabalina et al (2017). We have not observed any body temperatures 
below 34°C in PolgAmut/mut mice. It’s assumed that living in groups may hinder any 




The link between the level of activity and emotional state of mice was first observed 
by Costall et al (1989). Seibenhener and Wooten (2015) also documented that 
significant reduction in ambulatory ability of mice may be as a result of disturbed 
emotional state. My study showed that PolgAmut/mut mice had a significant reduction in 
their total distance moved from the age of 15 weeks onwards which is a determinant 
of their overall level of activity. A reduction in the total number of touches and shorter 
step lengths were also characteristic of PolgAmut/mut mice with advancing age in 
comparison to PolgA +/+ mice at 43 weeks of age. Step length is a measure of gait 
and balance according to Lakes and Allen (2016) in a way that smaller step length 
indicates disturbed balance and coordination. Viveros et al (2007) documented that 
the intensity of behavioural responses to stressful conditions are inversely related to 
their lifespan. They assessed BALB/c mice in a T-maze test and concluded that 
those that slowly explore the maze are biologically similar to observations seen in 
prematurely aged mice. They have impaired neuromuscular ability and coordination 
as well as decreased locomotor activity, increased levels of anxiety and reduced 
lifespan. Dai et al (2013) have also shown that PolgAmut/mut mice showed a significant 
decline in the locomotor activity at the age of 52 weeks in comparison to PolgA+/+ 
mice counterparts. 
Pathological organ hypertrophy in PolgAmut/mut mice is documented by many studies 
(Trifunovic et al, 2004, Dai et al, 2010) and is correlated with increased mtDNA point 
mutations and deletions and OXPHOS protein dysfunction. In this study cardiac 
hypertrophy was detected in the form of increased heart weight and increased 
cardiomyocyte width in PolgAmut/mut mice. Organ weights are excellent screening tool 
to compare intervention-related effects which will be looked into more detail in 
chapters 4 and 5. Kujoth et al (2005) and Trifunovic et al (2004) have previously 
shown that there is a significant decline in subcutaneous fat and muscle mass as well 
as development of osteoporosis at around the age of 7-9 months in PolgAmut/mut mice. 
The increase in organ size and decrease in body weight could mean a reduction in 
muscle mass, adipose tissue and/or bone density as these were the only tissues not 
weighed in this study. Others have previously shown that there is a significant 
reduction in adiposity, muscle mass and osteoporosis in the PolgAmut/mut mice 
(Trifunovic et al, 2004). It was noted during the dissections that there was very little 
subcutaneous and visceral fat in the PolgAmut/mut mice compared with the PolgA+/+ 




(BMD) on PolgAmut/mut mice from this colony was generated in our lab showing 
significant loss of BMD by micro CT at 11 months of age compared with PolgA+/+ 
mice (Philip Dobson, PhD Thesis). 
Cardiac tissue is a highly metabolic organ and is rich in mitochondria (Boengler et al, 
2017). As PolgAmut/mut mice accumulate mtDNA mutations at a faster rate than 
PolgA+/+ mice, highly active organs such as the heart work under pressure to supply 
other bodily organs with oxygenated blood. Due to the fact that adult cardiomyocytes 
are terminally differentiated and are highly specialised cells, the hypertrophic 
response is predominantly observed as increased cardiomyocyte size, rather than 
number as confirmed by the significant increase in cardiomyocyte width in this study. 
Myocardial hypertrophy is divided into physiological and pathological categories. 
Vanempel and Windt (2005) have demonstrated that when cardiac muscle 
experiences increased biochemical stress, individual cardiomyocytes grow in size to 
normalise wall tension by activating G-protein coupled receptors (Gαq) and the 
downstream signalling cascade leading to normal cardiac function in mice. The 
hypertrophic signalling cascade is linked to cellular apoptosis in such a way that 
over-expression of Gαq by 25 fold, leads to a significant chamber dilation and a 
higher percentage of myocyte apoptosis eventually leading to heart failure. The 
molecular mechanism underlying this phenomenon is explained in the ability of Gαq 
to cause mitochondrial membrane potential loss and cytoplasmic release of 
cytochrome c when overexpressed in the cardiac muscle. Cytochrome c activation in 
turn initiates a cascade of events leading to activation of pro-apoptotic Bcl-2 family 
members and initiates proteolytic activity of caspase-3. The outcomes of this study 
are in agreement with the current research confirming the correlation between 
cardiac hypertrophic response and activation of cardiac apoptosis (Mayorga et al, 
2004). 
It’s well documented that mitochondrial dynamics, biogenesis and turnover is 
dysregulated with age resulting in accumulation of damaged and compromised 
mitochondria (Leeuwenburgh et al, 2016). What happens to mtDNA copy number 
with age in post-mitotic cardiac muscle is however not fully understood. Recent 
research has shown that altered mtDNA copy number is associated with numerous 
disorders such as cancer (Xing, 2008), liver disease (Morten et al, 2007) 
developmental delays (Macmillan and Shoubridge, 1996), cardiomyopathies (Bai and 




number was seen in all cases. Perier et al (2013) have reported a significant increase 
in the mtDNA copy number of PolgAmut/mut mice ventral midbrain sections and have 
suggested that the increase in mtDNA copy number may be a compensatory 
protective mechanism at older age. They have also confirmed that this compensatory 
mechanism of increasing the mtDNA copy number were only applicable to neurons 
with mtDNA deletions of below 60% of total mtDNA when mitochondrial biochemical 
defects were not detected in the tissue.  
 
3.5 Strengths and limitations of the study 
One of the strengths of this study was the establishment of a colony of PolgAmut/mut 
mice over a few years and a large sample size dedicated for this study. Power 
calculations were carried out to evaluate the sample size according to the aims and 
objectives of this research and current literature. This gives precision, reliability and 
direction to the data obtained from a variety of investigations. On the other hand, the 
PolgA+/+ mice with smaller sample size may leave a larger margin for error as the 
level of confidence was lower. However due to extensive research on the PolgA+/+ 
mice, as expected we obtained data with a narrow distribution. 
 
3.6 Conclusion 
An in-depth investigation of PolgAmut/mut mice phenotypes in comparison to PolgA+/+ 
mice was carried out in this study. The cardiac mitochondrial function was assessed, 
and the cardiac muscle pathology was quantified in PolgAmut/mut mice. The phenotypic 
data accompanied the molecular findings of age-dependent decline in PolgAmut/mut 
mice such as diminished locomotive activity, deterioration of body conditioning, 
weight loss, organ hypertrophy, increased cardiac fibrosis and cardiomyocyte width 
as well as increased cardiac apoptosis and mitochondrial COX dysfunction. The 
results of this chapter set the foundation for further investigation of effects of 











Chapter 4.  The effects of moderate to high intensity treadmill 
running on cardiac mitochondrial function and progeroid ageing 
phenotypes in PolgAmut/mut mice 
 
4.1 Introduction  
4.1.1 The impact of endurance exercise on mouse and human studies 
The baseline characteristics of PolgAmut/mut mice were established in chapter 3 of this 
thesis and confirmed the phenotype described in previous studies (Trifunovic et al, 
2004 and Kujoth et al, 2005) which included a premature ageing phenotypes, 
reduced lifespan, systemic mitochondrial dysfunction and multisystem pathology with 
advancing age. Safdar et al (2011) demonstrated that 5 months of endurance 
exercise training in PolgAmut/mut mice prevented the premature mortality rate, reduced 
pathological levels of apoptosis, mtDNA depletion and mutation rate, induced 
mitochondrial biogenesis, increased oxidative capacity and restored mitochondrial 
morphology. Safdar et al in 2016 published a follow up study demonstrating a 
reduction in mitochondrial oxidative stress with endurance exercise. They concluded 
that alleviation of premature ageing phenotypes in PolgAmut/mut mice muscle by 
exercise is not associated with reduction of mtDNA mutation load, but rather with 
reduction in oxidative stress. Endurance exercise-mediated PGC-1α expression 
promotes mitochondrial biogenesis and increases the expression of mitochondrial 
antioxidants hence depressing oxidative stress (St-Pierre et al, 2006). Wenz et al in 
2009 demonstrated that increasing the expression of PGC-1α attenuates age-
associated metabolic disorders and sarcopenia. Peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (PGC-1α) is a key regulator of energy 
metabolism in mitochondria acting as a transcriptional coactivator that is central to 
induction of mitochondrial biogenesis (Austin and St-Pierre, 2012). P53 is a tumour 
suppressor protein which translocates to the mitochondria during endurance exercise 
and in response to intra- and extra-cellular insults such as ROS accumulation, to 
facilitate mtDNA mutation repair mechanisms and mitochondrial biogenesis by 
interacting with mtDNA, POLG1 and PGC-1α (Safdar et al, 2016). In the absence of 
nuclear p53, PGC1-α should be acting to ameliorate the mutator phenotypes in 




PGC1-α. However biochemical analysis of p53 revealed its inherent 3’-5’ 
exonuclease activity which helps promote mitochondrial genomic stability in PolgA 
mut/mut mice. Also an exercise intervention in muscle-specific p53 knockout 
PolgAmut/mut mice failed to alleviate oxidative stress and premature signs of ageing. 
Saleem and Hood (2013) suggested that p53 is working in a PGC-1α independent 
manner to supress reactive oxygen species (ROS) generation. A study by Meek et al 
(2009) reported that transgenic mice with high endurance capacity run ~3 times more 
than control mice. They determined that the mechanistic basis of high endurance in 
these mice appear to be partly due to elevated VO2max levels (Rezende et al, 2006), 
enhanced insulin-triggered glucose in skeletal muscle (Dumke et al, 2001) and 
enhanced ability of lipid oxidation to fuel sustained exercise (Gomes et al, 2009). 
Endurance exercise is documented to be the most potent inducer of mitochondrial 
biogenesis in many organs especially those with higher ATP demand (Irrcher et al, 
2003). Safdar et al (2011) reported that endurance exercise rescued mitochondrial 
depletion, increased mitochondrial abundance, maintained mitochondrial morphology 
and ETC subunit content and regulated COX activity in the cardiac tissue of 
exercised PolgAmut/mut mice. They also reported that endurance exercise has 
systemically abrogated apoptosis and prevented cardiac fibrosis. Although 
PolgAmut/mut mice do not show increased levels of ROS in cardiac tissue (Kujoth et al, 
2005 and Trifunovic et al, 2005), the expression of mitochondrial-targeted catalase 
(mCAT), which protects cells from oxidative damage, reverses the accumulation of 
mtDNA mutations in cardiac tissue of PolgA mut/mut mice (Dai et al, 2010). 
The cardiovascular benefits of exercise have also been widely investigated on 
humans and on mice studies. Munukka et al (2018) published their work indicating 
that 6 weeks of bicycle endurance training three sessions/week significantly modified 
the composition and function of gut microbiota without any dietary changes. They 
observed a reduction in the levels of proteobacteria post exercise by 16s rRNA 
sequencing. Proteobacteria are involved in gut inflammation while the levels of 
beneficial bacteria were increased indicating better metabolism with exercise. 
Pekkala et al (2017) investigated the cardiometabolic benefits of endurance exercise 
and established that endurance training decreased plasma phospholipids and VLDL 
(very-low density lipoprotein) levels significantly. VLDLs transport lipids from the liver 
to other organs, converting into bad cholesterol in the circulation, thus has 




adhesion protein-1 (VAP-1) was lowered with endurance training. VAP-1 is involved 
in lipolysaccharide-induced inflammation and is proven to mediate microenvironment 
to pro-inflammatory direction hence have detrimental effects on the vasculature (Yu 
et al, 2006). 
Human ageing is associated with loss of muscle mass (sarcopenia) and reduced 
muscle function that results in frailty (Fried et al, 2001). At least some of this muscle 
mass loss has been proven to be linked to reduced physical activity and muscle 
disuse with age. However, Faulkner et al in 2008 reported that life-long exercise 
cannot fully rescue age-related decline in muscle mass, indicating the multi-factorial 
process that lead to sarcopenia with age. Lutz and Quinn (2012) have suggested that 
elevated levels of inflammatory biomarkers may play a role in the pathogenesis of 
sarcopenia. Mikkelsen et al, (2013) have reported that life-long endurance exercise in 
non-obese individuals was linked to a reduction in the age-associated increase in 
insulin sensitivity, as well as significant reduction in inflammatory biomarkers such as 
C-reactive protein (CRP) and Interleukin-6 (IL-6).  
The degree of exercise intolerance in patients with mtDNA mutations varies from low 
to debilitating (Taivassalo, 2003). These exercise-related symptoms inevitably cause 
a high proportion of patients with mtDNA mutations to lead a sedentary lifestyle 
(Taivassalo and Haller, 2004). It’s also confirmed that inactivity results in 
deconditioning which is associated with a decrease in functional mitochondrial 
number and limited capacity of skeletal muscle for oxidative phosphorylation (Gehrig 
et al, 2016) as well as diminished cardiovascular capacity (Martin et al, 1986). 
Patients with mtDNA mutations thus further exacerbate their functional limitations by 
being inactive. Taivassalo et al (2006) have shown that 14 weeks of endurance 
exercise training improved peak oxygen capacity with no changes in the level of 
deleted mtDNA. 
The gene-shifting theory was established by Crameri et al (2004) stating that satellite 
cells in skeletal muscle become activated and replace the mature post-mitotic 
myofibrils in response to muscle overload such as during injury or acute muscle 
resistance overload. Clark et al (1997) used a myotoxic agent to induce muscle 
necrosis and revealed that regenerated muscle fibres had wild-type mtDNA genotype 
upon induction of satellite cells. Satellite cells have proliferative and regenerative 




are needed to ascertain the type of muscle contraction required to maximally induce 
satellite cell activation. Eccentric muscle contraction is proven to provide a more 
potent stimulus however this is less practical for patients with mtDNA mutation 
(Franchi, Reeves and Narici, 2017). Therefore, the magnitude of physiological 
benefits of exercise depend on duration, intensity and frequency of training. 
Endurance exercise-related increase in mitochondrial biogenesis may cause an 
increase the proportion of absolute wild-type mtDNA and mutant mtDNA in skeletal 
muscle below threshold for phenotypic disease expression but enough to confer 
physiological and biochemical benefits in patients with mtDNA defects (Taivassalo 
and Haller, 2004). 
 
4.2 Aims of study 
The aim of this study was to investigate the effect of 6 months of endurance exercise 
on the premature age-associated phenotypes in PolgAmut/mut mice compared to the 
sedentary PolgAmut/mut mice characterised in chapter 3 focusing particularly on the 
cardiac muscle. The data were used in keeping with the 3Rs of animal use 
(reduction, refinement and replacement). This study used an established treadmill 
running protocol, previously shown to be well-tolerated and advantageous in 
PolgAmut/mut mice (Safdar et al, 2011). The central questions, I aimed to answer were 
to ascertain the following: 
 
1. What is the effect of endurance exercise on the clinical phenotype of 
sedentary and exercised PolgAmut/mut mice from 3 to 11 months of age? 
2. What is the effect of endurance exercise on the behavioural characteristics of 
sedentary and exercised PolgAmut/mut mice from 3 to 11 months of age? 
3. What is the effect of endurance exercise on cardiac structure, histology and 
mitochondrial function in sedentary and exercised PolgAmut/mut mice from 3 to 





4.3.1  Survival curve, Clinical scoring and Body weight of sedentary and 
exercised PolgAmut/mut mice  
PolgAmut/mut mice were housed with their heterozygous (PolgAmut/+) and wild type 
littermates (PolgA+/+) in cages of 2, 3 or 4. They were randomly divided into groups of 
(n=10) exercised and (n=10) sedentary mice from the age of 4 months. An 
endurance exercise intervention programme was performed on exercised PolgAmut/mut 
mice according to the protocol documented in chapter 2 section 2.14. The lifespan of 
mice was recorded and is shown in the survival curve in figure 4.1A. 53.85% of 
sedentary mice lived to the end of the study and 58.4% of exercised mice made it to 
the 46 week endpoint. Those that did not survive to the endpoint for reasons such as 
fight wounds and anal prolapse were not included in the survival curve. 
Figure 4.1B shows the body weight of sedentary and exercised PolgAmut/mut mice 
from weeks 14 to 43. There was no significant difference between the body weight of 
sedentary PolgAmut/mut mice and exercised PolgAmut/mut mice at 14 weeks (30.07±2.78 
and 29.87±3.01 respectively) and at 43 weeks of age (32.5±0.0002 and 30.02±2.15 
respectively). There was also no significant age-related weight changes within each 
group (p>0.05, two-way ANOVA repeated measures). 
The clinical scoring of mice was carried out from the age of 14 weeks up to 43 weeks 
to assess the health span of mice including weight, coat condition, skin tone, 
behaviour, posture and mobility, abdominal distension, foot colour and the level of 
hydration of mice. Sedentary (n=10) and exercised (n=10) mice were scored for each 
characteristic from 0 to 3 which indicate the normal and worsening of specific 
characteristic respectively. 8 characteristics were rated, and the total score was 
recorded and plotted in figure 4.1C. Each dot on the graph represent an individual 
mouse. At 43 weeks 100% of exercised mice showed no evidence of weight loss, 
28.6% had piloerection, 14.3% showed behavioural changes such as isolation and 
avoidance, 14.3% had hunched posture and compromise mobility and 28.6% had 
pale foot colour (indicative of anaemia). In comparison to sedentary mice in which 
14.3% showed weight loss, 85% had piloerection, 14.3% demonstrated behavioural 
isolation and avoidance, 14.3% had hunched posture and compromised mobility and 




PolgAmut/mut mice declined significantly with advancing age shown as the increase in 
clinical scores (p<0.001 in both cases, Two-way ANOVA repeated measures). There 
was no significant difference between the body condition of sedentary and exercised 








Figure 4.1. Kaplan-Meier survival curve, body weight and clinical scoring in 
sedentary and exercised PolgAmut/mut mice. A) 53.85% of sedentary mice and 
58.4% of exercised mice survived to the end of the study. B) The body weight of 
sedentary and exercised PolgAmut/mut mice was not significantly different between the 
two cohorts at any time point. C) Clinical scoring at 14 week, 29 weeks and 43 weeks 
of age. Both cohorts have shown a significant decline in body condition (****p<0.001) 





4.3.2 Body temperature in sedentary and exercised PolgAmut/mut mice  
The body temperature of sedentary and exercised PolgAmut/mut mice was recorded 
4x/week from 14 weeks of age to 43 weeks of age. Figure 4.2 shows the body 
temperature of both cohorts of mice which was recorded before treadmill running in 
exercised PolgAmut/mut mice (n=10) and at the same time from the sedentary 
PolgAmut/mut mice (n=10). The room and cage temperatures remained constant at all 
times. Figure 4.2 shows that the body temperature of sedentary and exercised 
PolgAmut/mut mice at 14 weeks (pre-intervention), 29 weeks (mid-intervention) and 43 
weeks (post-intervention) did not differ significantly at different time points. At 14 
weeks of age, the body temperature of sedentary PolgAmut/mut mice was 
35.36°C±0.74 in comparison to 35.33°C±0.4 in exercised mice (p>0.05). At 29 weeks 
of age the body temperature of exercised PolgAmut/mut mice started to go down to 
34.79°C±0.7 however this was not significantly different to the sedentary mice at 29 
weeks (35.05°C±0.2). Similarly, at 43 weeks, the body temperature of sedentary 
mice was 35.1°C±0.2 in comparison to exercised mice 34.63°C±0.83 (p>0.05). The 
exercised mice however seemed to have significantly lower body temperature with 
advancing age, falling from 35.3°C±0.4 to 34.6°C±0.83 from 14 weeks to 43 weeks of 
age (p<0.05) as shown in figure 4.2 (Two-way ANOVA repeated measures). 
 
 
Figure 4.2. Body temperature in sedentary and exercised PolgAmut/mut mice at 
14, 29 and 43 weeks of age. Exercised mice had a significant decrease in body 
temperature with advancing age, 14 weeks vs 43 weeks (*p<0.05, Two-way ANOVA, 





4.3.3 Open field testing (OFT) in sedentary and exercised PolgAmut/mut mice 
In order to evaluate motor performance and quantitatively assess gait analysis, open 
field testing was performed in sedentary (n=10) and exercised (n=10) PolgAmut/mut 
mice pre- (15 weeks), mid- (29 weeks) and post- (43 weeks) intervention. The room 
temperature, humidity and the lighting were kept consistent at all times during the 
OFT. The parameters measured within a 5 minute period of testing time included the 
total distance moved, average velocity, rearing frequency, total number of touches 
and average step length (figure 4.3). A two-way ANOVA repeated measures was 
carried out in order to see the interaction between and within groups. 
Total distance moved by both groups of mice (figure 4.3A) increased significantly 
with age up to the age of 29 weeks, however exercised mice showed a further 
increase in distance travelled by 43 weeks of age (p<0.01). Sedentary mice showed 
a significant reduction in their velocity of movement with age up to 43 weeks (p<0.01) 
and exercised mice moved faster at 43 weeks of age in comparison to sedentary 
mice (p<0.01) (figure 4.3B). 
Figure 4.3C shows that the number of touches reduced significantly with age in 
sedentary mice (p<0.05) and was significantly lower at 43 weeks in sedentary mice 
comparison to exercised mice (p<0.05). A reduction in the number of touches with 
age are indicative of less movements or longer step lengths. In general step length 
was reduced significantly in sedentary cohort at 43 weeks (p<0.01) however both 
groups had significant decline in step length with age. Interestingly exercised mice 
seem to have a slight but significant decrease in their step length at 29 weeks of age 
(p>0.05) however that increased significantly at 43 weeks of age in comparison to 
sedentary cohort (p<0.01). The final parameter obtained from the OFT device was 
the rearing frequency in which mice stand on their hind legs and explore their 
environment as a measure of exploratory and inquisitiveness behaviour. Figure 4.3E 
shows that rearing frequency has significantly decreased in sedentary mice with 
advancing age from 29 weeks to 43 weeks of age (p<0.05) however there was no 
significant difference between the rearing frequency of sedentary and exercised mice 
at different time points. A two-way ANOVA statistical analysis test repeated 





Figure 4.3.Open field testing in sedentary and exercised PolgAmut/mut mice at 15, 
29 and 43 weeks of age. A) Total distance moved significantly increased in 
exercised and sedentary mice with advancing age up to 29 weeks (*p<0.05). B) 
Average velocity of sedentary mice reduced significantly with advancing age 
(**p<0.01) and exercised mice had significantly higher velocity at 43 weeks 
(**p<0.01) in comparison to sedentary mice. C) Total number of touches significantly 
reduced in sedentary mice with advancing age (*p<0.05) and was significantly higher 
in exercised mice at 43 weeks of age (*p<0.05). D) Step length has significantly 
reduced in both groups with advancing age but was significantly higher in exercised 
mice at 43 weeks of age (**p<0.01). E) Rearing frequency has significantly reduced 
in sedentary mice with age (*p<0.05) (Two-way ANOVA repeated measures). Error 






4.3.4 Organ weights in sedentary and exercised PolgAmut/mut mice 
Organs weights (figure 4.4A) were recorded immediately after harvest in both groups 
according to the mouse organ harvesting sheet in appendix 2. Normalised organ 
weights were also calculated by the ratio of organ weight to body weight to observe 
changes in organ weight in proportion to body weight (figure 4.4B). Since body 
weights were not significantly different between the groups at any time point 
throughout the intervention, it’s unlikely that organ weights would significantly alter 
due to body weight fluctuation. There were no significant differences in the weight or 







Figure 4.4.Organ weight and normalised organ weights in sedentary and 
exercised PolgAmut/mut mice. A) Organ weights in sedentary and exercised mice 
were not significantly different. B) None of the organ to body weights ratios of 





4.3.5 . Cellular and molecular analysis of the heart in sedentary and exercised 
PolgAmut/mut mice 
Mouse hearts were harvested and dissected through the interventricular septum 
longitudinally to divide into left and right sides with one atria and one ventricle on 
each side.  
Histological techniques including COX/SDH histochemistry, NBTx assay and 
mitochondrial DNA copy number analysis was carried out on the frozen left 
ventricular tissue as explained in chapter 2 sections 2.21, 2.24.1 and 2.26 
respectively. H&E staining, Masson trichrome, cleaved caspase 3 
immunohistochemistry as well as mitochondrial OXPHOS complex I and complex IV 
immunofluorescence was carried out on the fixed RV tissue as detailed in chapter 2 
sections 2.20,2.22, 2.23.1 and 2.24.2 respectively. 
 
4.3.6 . Histological analysis of sedentary and exercised PolgAmut/mut mice right 
ventricle at 46 weeks of age 
In order to asses cardiomyocytes size and morphology, Haematoxylin and Eosin 
(H&E) staining was carried out on 4μm paraffin embedded right ventricular section 
from sedentary (n=10) and exercised (n=10) PolgAmut/mut mice hearts according to 
protocol detailed in chapter 2 section 2.20. Five random snapshots of x20 
magnification images were selected and 50 random transverse cardiomyocytes were 
analysed per image. Images were acquired using Zeiss Axiomager microscope and 
analysed in Zen (v2.5) software to record the width of cardiomyocytes. Figure 4.5A 
top row shows representative H&E images from both cohorts of mice. There was no 
significant difference between the mean cardiomyocyte width of both groups 
(p=0.245, unpaired t-test), although the individual mouse data showed more variation 
in the exercised cohort. 
Right ventricular fibrosis was also carried out by Masson trichrome staining in 10 
sedentary and 10 exercised PolgAmut/mut mice (figure 4.5A bottom row images). 4μm 
paraffin embedded cardiac sections were stained for the presence of nuclei in purple, 
collagenous connective tissue in blue and cardiomyocytes in red. Images were 




total tissue was calculated in NIS elements software by the thresholding method 
using the RGB general analysis algorithm. The three channel analysis method masks 
off and measures the percentage of total blue collagen area from total tissue section. 
The thresholding for each channel and LED light intensity remained constant for all 
the mice. There was no significant difference in the percentage of fibrosis between 
the two cohorts (p=0.61, unpaired t-test). The left hand side images presented in 






Figure 4.5. Cardiomyocyte width and fibrosis in sedentary and exercised 
PolgAmut/mut hearts. A) Top row: H&E staining showing cardiomyocytes in pink and 
nuclei in blue, scale bars= 100μm (x20 magnification). Bottom row: Masson trichrome 
staining (x10 magnification) showing the presence of fibrous tissue in light blue and 
cardiomyocytes in red. Scale bars=200μm. B) Cardiomyocyte width in sedentary and 
exercise PolgAmut/mut hearts (p=0.245). C) Percentage of collagen in cardiac muscle 
of sedentary and exercised PolgAmut/mut hearts (p=0.61) (unpaired t-test). Error bars 





4.3.7 Cardiac apoptosis in sedentary and exercised PolgAmut/mut hearts 
Active-cleaved caspase 3 (CC3) immunohistochemistry was carried out to identify 
cardiomyocytes with apoptotic nuclei in sedentary (n=10) and exercised (n=10) 
PolgAmut/mut mice according to the protocol stated in chapter 2 section 2.23. Paraffin 
embedded right ventricular cardiac muscle (4μm) were subjected to CC3 
immunohistochemistry to identify apoptotic nuclei. Five random snapshots of x10 
magnification images were selected and the frequency of apoptotic nuclei as dark 
brown circular regions were quantified in comparison to the total number of non-
apoptotic nuclei. Images were obtained using Aperio-scanner and analysed using 
Imagescope nuclear staining algorithm. An unpaired t-test was carried out to 
statistically compare the percentage of CC3 positive nuclei in the two groups. There 
was no significant difference in the percentage of CC-3 positive cells in sedentary 




Figure 4.6. Cardiac apoptosis in sedentary and exercised PolgAmut/mut mice. 
Percentage of cardiac apoptosis is not significant different between the two cohorts 





4.3.8 Mitochondrial complex I and complex IV expression levels in sedentary 
and exercised PolgAmut/mut hearts 
Mitochondrial OXPHOS complex I (NDUFB8) and complex IV (MTCOI) subunit 
immunofluorescence was carried out according to the method in chapter 2 section 
2.24.2. 4μm fixed right ventricular sections were immunolabelled for detection of 
complex I (NDUFB8), complex IV (MTCOI), mitochondrial mass marker (Porin) and 
cardiomyocyte boundary marker (laminin). N=10 mice were analysed per group 
(exercise or sedentary). Figure 4.7 shows representative images obtained from 
LSM800 Axio-observer microscope from a sedentary and an exercised PolgAmut/mut 
mouse heart. The expression levels of NDUFB8 and MTCOI were quantified relative 
to mitochondrial mass marker (Porin) levels through immunoanalyzer software. 
Cardiomyocytes were marked with laminin for easier detection and analysis through 
immunoanalyzer software which is explained in more detail in chapter 2 section 
2.24.2. Cardiomyocytes were categorised into groups of positive (Pos), intermediate 
positive (Int +), intermediate negative (Int -) and negative (Neg) in both NDUFB8 and 
MTCOI levels (figure 4.8) according to their z-scores adapted from Rocha et al 
(2015). Mitochondrial respiratory chain plots (MRC) were obtained from the 
immunoanalyzer software. Representative MRC plots from a sedentary and an 
exercised mice are shown in figure 8 A-B. These plots show the levels of MTCOI and 
NDUFB8 proteins in individual cardiomyocytes. The colour of each dot represents the 
level of Porin, and the category boundaries are marked with yellow and black lines. 
As shown in figure 4.8C, the percentage of cardiomyocytes with negative CI levels 
and negative CIV levels were significantly higher in the sedentary cohort (p<0.001 
and p<0.05 respectively). The percentage of cardiomyocytes with CIV intermediate 
negative was significantly higher in the exercised cohort (p<0.001) through unpaired 





Figure 4.7.Mitochondrial Complex I (CI) and Complex IV (CIV) expression 
levels. CI was detected using antibody against NDUFB8 subunit and COX was 
detected using antibody against MTCOI subunit. Porin was used to mark 
mitochondrial mass and laminin was used to mark myocardial boundaries. 







Figure 4.8. Mitochondrial NDUFB8 (CI) and MTCOI (CIV) immunoreactivity in 
sedentary and exercised PolgAmut/mut mice cardiac muscle. A) MRC plots of 
sedentary mouse heart. B) MRC plots of exercised mouse heart. C) Percentage of 
cardiomyocytes with negative NDUFB8 and negative MTCOI levels were significantly 
higher in the sedentary cohort (***p<0.001 and *p<0.05 respectively). D) Percentage 
of cardiomyocytes with intermediate negative MTCOI is significantly higher in the 
exercised cohort (***p<0.001) (unpaired t-test). E) Porin levels in sedentary and 
exercised mice are within the normal range between 2 and -2SD. Error bars 





4.3.9 Complex IV activity in sedentary and exercised PolgAmut/mut mice hearts 
Mitochondrial COX activity was assessed using sequential COX/SDH histochemistry 
in the cardiac tissue of sedentary (n=10) and exercised (n=10) PolgAmut/mut mice as 
detailed in chapter 2 section 2.21. Cryosections from the left ventricle (8μm) were 
stained to visualise cytochrome c oxidase and succinate dehydrogenase activity 
levels by localisation of DAB (electron donor) in COX functional cardiomyocytes and 
formation of NBT in COX deficient cardiomyocytes. Sections were visualised using 
Nikon Tie microscope (figure 4.9) and the percentage of blue COX deficient 
cardiomyocytes were quantified using General analysis RGB algorithm in Nikon 
imaging software elements programme. Five random snapshots of x10 magnification 
per mouse heart was selected and the percentage of COX deficiency was calculated 
from the ratio of total tissue area to COX negative tissue area. The analysis software 
uses RGB channel intensity to demonstrate the analysis process where total tissue 
area visualised by pink is differentiated from total COX deficient blue area. There was 
no significant difference between the cardiac muscle COX activity of both groups of 






Figure 4.9. Mitochondrial CIV activity in sedentary and exercised mice hearts. 
Representative serial sections of COX, SDH, and COX/SDH histochemistry images 
of x10 magnification to assess mtDNA encoded COX activity in comparison to 
nuclear DNA encoded SDH activity. Merged images (COX/SDH) were used to 
quantify COX activity using NIS elements software by thresholding of RGB channel 
to obtain the percentage of desired staining i.e. percentage of COX negative blue 





Figure 4.10. COX deficiency in left ventricular cardiac muscle of sedentary and 
exercised PolgAmut/mut mice. There is no significant difference between the COX 
activity of both groups (p=0.19) (unpaired t-test). Error bars show mean ±SD. 
 
4.4 NBTx and laminin immunohistochemistry in sedentary and exercised 
PolgAmut/mut mice  
NBTx assay and laminin immunofluorescence was carried out according to the 
method explained in chapter 2 section 2.24.1 in order to visualise and quantify COX 
deficiency based on NBT activity only. Different levels of COX deficiency were 
detected by quantifying the amount of NBT deposition in cells ranging from light blue 
to dark blue (detailed in chapter 3 section 3.3.10). Laminin immunofluorescence was 
carried out to determine cardiomyocyte boundaries for easier detection and analysis. 
Figure 4.11 shows images obtained from LSM800 microscope. NBTx brightfield 
images represent only the NBTx assay without laminin to confirm COX deficiency in 
blue in the absence of fluorescent signal. Merged images from five random 
snapshots of x10 magnification were uploaded on the immunoanalyzer software for 
analysis. 500 LV transverse cardiomyocytes from each mouse heart were analysed. 
The darker the cardiomyocytes, the higher the COX deficiency and the higher the 
optical density (OD) values were. Data from both groups of animals was compared 




categorise fibres into COX positive, intermediate and negative fibres as described in 
chapter 3, section 3.3.10. OD values less than 3SD of the mean was categorised as 
positive COX fibres, anything between 3SD and 6SD were named as intermediate 
COX fibres and those more than 6SD were categorised as negative COX fibres 








Figure 4.11. NBTx assay and laminin immunofluorescence. Images were 
obtained from LSM800 microscope. Merged files were used for analysis on 
immunoanalyzer software by automatically selecting transverse cardiomyocytes for 





Figure 4.12 shows the percentage of cardiomyocytes with positive, intermediate and 
negative COX activity. There were no significant differences in percentage of COX 
positive, intermediate or deficiency cardiomyocytes between the exercised and 




Figure 4.12. CIV activity levels in sedentary and exercised PolgAmut/mut mice 
hearts. The level of CIV activity was not significantly different between the two 
cohorts (p>0.05) (unpaired t-test). Error bars represent mean ±SD.  
 
4.4.1 Mitochondrial DNA copy number in sedentary and exercised PolgAmut/mut 
mice hearts 
Mitochondrial DNA copy number was quantified in homogenised left ventricular 
cardiac muscle using quantitative real-time PCR by amplifying a portion of the gene 
on the mtDNA known as ND1 and a housekeeping nuclear DNA encoded gene β-
actin. The ratio of ND1 to B-actin determines the relative mitochondrial DNA copy 
number as explained in more detail in chapter 2 section 2.26. There was no 
significant difference in the mitochondrial copy number in sedentary (n=10) and 





Figure 4.13. MtDNA copy number in sedentary and exercised mice LV. There is 
no significant difference between the copy number of mtDNA in the two groups 
(p>0.05).  
 
4.5 Discussion  
This study showed that 7 months of treadmill running exercise did not extend the 
lifespan of PolgAmut/mut mice in comparison to non-exercised PolgAmut/mut mice. In 
terms of the clinical phenotype, exercised and sedentary mice both experienced 
premature aging phenotypes such as hunched posture, weakened mobility, 
piloerection, and anaemia with advancing age. Both groups showed significantly 
higher clinical scores with advancing age indicating worsening of the body condition 
as they age. The body weight of mice did not significantly change with advancing age 
and with exercise. The body temperature however revealed that exercised mice 
experienced significantly lower body temperatures with advancing age however this 
was not significantly different in comparison to the sedentary cohort at any time point. 
The gradual drop in body temperature of exercised mice may not be biologically 




(Okazaki, 2016) and the fact that both cohorts of mice were group housed would help 
to maintain environmental temperature stable. 
From a behavioural point of view, my data revealed that exercised mice experienced 
a significant increase in their mobility level with advancing age up to 43 weeks of age 
and sedentary mice only had an increase in their locomotive activity up to 29 weeks 
of age. Exercised mice also moved a lot faster than sedentary mice at 43 weeks of 
age and sedentary mice experienced a significant decline in their velocity of 
movement with advancing age, indicating that sedentary mice may have slower 
reaction time to any stimuli as they age. Similarly, exercised mice had a significantly 
higher number of touches at 43 weeks and longer step lengths showing an 
improvement in locomotive and behavioural phenotypes. Exercised mice took more 
frequent steps and longer steps at 46 weeks in an attempt to keep their gait 
balanced. Lemieux et al (2016) reported that longer step lengths occur as a 
consequence to enable postural stability in mice. 
I have shown that the degree of cardiac fibrosis, percentage of active CC-3 labelled 
nuclei, cardiomyocyte width, heart weight and cardiac mtDNA copy number were not 
significantly different between the two cohorts. Mitochondrial CI and COX expression 
levels were not significantly different in the cardiac muscle of both cohorts and the 
level of COX activity was down regulated in both groups to the same extent. 
Interestingly, exercised mice showed a great variation in COX activity through NBTx 
assay revealing that mice have responded to exercise differently. 
Safdar et al in 2011 have reported that 5 months of endurance exercise rescued 
accelerated aging phenotypes in PolgAmut/mut mice. They showed that exercise 
increased the functional capacity of the mice, attenuated cardiac fibrosis, cardiac 
apoptosis and cardiac hypertrophy in comparison to sedentary mice. Their research 
also showed that endurance exercise enhanced systemic CIV activity in the heart 
and skeletal muscle of PolgA mut/mut mice and attenuated the decline in mtDNA copy 
number. In 2016 Safdar et al went on to demonstrate that the same endurance 
exercise protocol led to the reduction of non-mutational mtDNA damage in the 
skeletal muscle of PolgAmut/mut mice through a p53 mediated mechanism. P53 acts as 
an accessory fidelity enhancer to the DNA repair mechanism of POLG by localising 




My research has shown that exercise does not extend the lifespan PolgA mut/mut mice 
and does not provide physiological benefits to PolgA mut/mut mice, contrasting with the 
findings of Safdar et al (2011). I have also confirmed that cardiac pathology and 
cardiac mitochondrial function remain unchanged with exercise in PolgA mut/mut mice 
which is controversial to Safdar et al (2011) research despite using mice originating 
from the same colony with the same age and exercise protocol. There were some 
differences between the two studies. Safdar et al (2011, 2016) singly housed their 
mice in an attempt to keep external factors such as cage fights to minimal level. 
However, since mice are social animals, they will be affected by living in solitude. 
They also performed different assays on different numbers of mice. They started with 
n=18/group with male and female mice however only four from each group were 
selected to be included on the survival curve plot, 12 from each group were selected 
for clinical phenotyping and six from each group were selected to be analysed for 
heart weight. There were no reasoning on the selection process for different assays 
meaning that further research is needed to affirm conclusions. Safdar et al (2011) 
also used both sexes in their experiments without taking into account the effects of 
female endocrine system on parameters measured and possible higher physical 
performance in male mice. 
Some possible reasons for discrepancies between the two studies may include 
differences in husbandry of mice, diet and environmental factors such as lighting, 
temperature, handling and pathogens present in the cages. Other factors may 
include different genetic background of mice, despite the same in-bred colonies. Also 
Safdar et al (2011) generated wild-type control mice (PolgA+/+) from PolgAmut/+ mice 
colonies indicating the chances of transmitting mtDNA mutation from the mother to 
the offspring through the female germline. The smallest difference in the genetic 
background could have a significant impact on the phenotype and response of 
individuals to external stimuli such as exercise training (Skinner, 2005). More than 
600 genes and chromosomal regions were suggested to be involved in energy 
metabolism regulation (Deram and Villares, 2009). A review study by Leońska-
Duniec, Ahmetov and Zmijewski (2016) investigated the impact of human genetic 
variants of obesity related genes causing polymorphism on exercise intervention and 
concluded that some genes play a significant role in determination of individual 




Faraci et al (2018) investigated the impact of 6 months of treadmill running exercise 
on oocyte number and yield in PolgAmut/mut mice at 5,7 and 9 months of age. No 
significant differences were seen in the number of ovulated oocytes between the two 
groups, however improvements in ovarian follicle reserve and oocyte quality were 
observed in exercised mice in comparison to sedentary group. Oocyte quality was 
assessed based on meiotic spindle assembly, chromosomal segregation and 
mitochondrial distribution at the age of 7 months. They reported a significant decline 
in the number of ovulated oocytes in PolgAmut/mut mice in comparison to wild type 
littermates after 9 months of age, but there was no significant difference between the 
sedentary and exercised cohort. They documented that exercise prevented the 
decline in the reserve of oocyte containing primordial follicles in the ovaries up to 7 
months of age, however the trend was not sustained in 9 month old exercised mice. 
They suggested that exercise may prevent early loss of follicles in PolgAmut/mut mice 
but does not sustain the quantity of follicles and the number of ovulated oocytes after 
9 months of age. MtDNA mutation load and copy number in the oocytes of 
PolgAmut/mut mice were also assessed and were not significantly different between the 
two groups at 9 months of age, suggesting that unlike somatic tissues, exercise does 
not induce mitochondrial biogenesis in the oocyte. Faraci et al (2018) showed that 
there was no direct effect of exercise on mtDNA repair mechanism unlike in skeletal 
muscle, however improvements in mitotic spindle and chromosomal alignment were 
observed. 
Salesniemi et al (2011) have shown that mice lacking PGC-1α exhibit increased 
offspring mortality, but females that do survive to 12 months of age demonstrate 
improved oocyte quality, reduced spindle abnormalities and chromosomal 
misalignment and a decrease in abnormal mitochondria aggregation with age, 
showcasing a positive impact of lack of PGC-1α in oocyte quality. Similar to PGC-1α, 
the role of p53 in the oocyte function is different to those that operate in the soma 
and so is the mechanism that governs the impact of exercise on oocyte quality. 
According to previous research, (Zahn et al, 2006, Bua et al, 2006, Lynons et al, 
2006) age-related mitochondrial adaptations include reduction in mitochondrial 
components, capacity and biogenesis especially in high energy demand organs such 
as skeletal muscle. Also due to the lack of protective proteins and proximity of 
mtDNA to free radicals, mtDNA is more prone to replicative error which increases 




mitochondrial biogenesis with age is initiated through activation of AMPK and 
subsequent reduction in co-activation of PGC-1α. Since PGC1-α is a master 
regulator of mtDNA biogenesis through positive feedback, it’s over expression was 
shown to be linked to increased protein content. Therefore, aging muscle is 
associated with a decline in mtDNA copy number since mitochondrial transcripts 
reduce in number in less oxidative muscle due to decreased use of muscle with age. 
Aged muscle is also less able to respond to mitochondrial biogenesis-altering factors 
such as exercise, nutritional imbalance, ROS and Ca2+ changes. A study carried out 
by Menshikova et al (2006) reported that 12 weeks of moderate exercise training 
significantly increased the ETC protein activity, increased muscle contractile protein 
synthesis, mitochondrial content and function and mtDNA copy number in 
subsarcolemmal mitochondria of aged human skeletal muscle. Koltai et al (2012) and 
Kang et al (2013) have shown that endurance exercise training in rats reduces age-
associated decline in skeletal muscle mitochondrial biogenesis and dysfunction. 
Rowe et al (2012) have investigated the effects of 12 weeks of cycling in the skeletal 
muscle of elderly women and found that exercise-induced mitochondrial biogenesis 
is independent of PGC1α expression.  
Despite many previous exercise-related studies in PolgAmut/mut mice, it’s still unclear 
the exact impact of exercise on cardiac mitochondrial function. Since cardiac muscle 
is composed of many cell types with different functions and capacities, it’s important 
that similar experiments are carried out on the same region of the muscle to achieve 
representative results. For example the study carried out by Safdar et al (2011) 
documented that heart mitochondrial abundance and morphology was improved with 
endurance exercise. They have looked at electron micrographs of cardiac tissue, 
from six mice/group without further specifying which region of the cardiac muscle 
they were investigating. They reported improvements in mitochondrial morphology as 
reversal of enlarged and abnormally shaped mitochondria in exercised mice. Since 
mitochondrial dynamics in different cells of cardiac muscle is varied, it’s crucial to 
declare which region of cardiac tissue is selected for histological and molecular 
assays (Piquereau et al, 2013). Even though mice with similar genetic background 
were selected throughout the studies, but the environmental factors such as the 
amount of food consumed, level of stress due to cage fights, impact of solitary 




heteroplasmy in the tissues of each mouse differ. These factors inevitably increase 
data variability and remain a confounding factor in animal studies.  
Safdar et al (2011) confirmed that sedentary PolgAmut/mut mice lived up to ~240 days 
(n=4) whereas their exercised mice survived to ~500 days (n=4) similar to their 
control mice group. Their controversial findings raise questions to why only four mice 
from the exercised and control group were included in the survival curve assessment.  
Unpublished data from our lab showed that the maximum survival of our PolgAmut/mut  
sedentary mice at the animal facility of Cardiff University was up to 220 days (Ashwin 
Sachdeva, personal communication) whereas at Newcastle University these mice 
lived up to 300 days after which they were culled and so could potentially have lived 
longer. Kujoth et al (2005), Trifunovic et al (2004) and Vermulst et al (2008) 
documented that the maximum survival rate of PolgAmut/mut mice is 460 days, 427 
days and 547 days respectively. Possible reasons for discrepancies in lifespan data 
could be due to differences in mice husbandry practices, diet, environmental 
pathogens and genetic background. One difference between Safdar et al (2011) 
study and other studies were the housing condition in mice, in which Safdar et al 
(2011) have singly housed their mice and my study group housed the mice. This 
seems to have a significant effect on the lifespan of mice and the very early 
appearance of progeroid phenotypes of PolgAmut/mut mice. 
Many factors influence body temperature such as environmental temperature, 
amount of brown adipose tissue in the body, levels of basal metabolic activity and 
effects of physical activity or diet. Body temperature of wild type laboratory mice is 
tightly regulated to around 36-37C° in order to maintain metabolic processes in the 
body within a normal range (Ades, 2019). PolgAmut/mut mice seem to have an overall 
lower body temperature in comparison to wild-type mice by the age of 43 weeks as 
shown in chapter 3 section 3.3.2 due to the effect of a high mtDNA mutation burden. 
The temperature of mice may have a direct effect on the overall health and general 





4.6 Conclusion and future work 
This study has provided an in-depth insight into the role of endurance exercise in 
cardiac mitochondrial function, general wellbeing and lifespan of PolgAmut/mut mice. 
Endurance exercise did not seem to alleviate pre-mature signs of aging and did not 
improve mitochondrial dysfunction. The future work is to identify the maximal aerobic 
capacity (VO2 max) of each mouse which gives an indication of each subject’s 
aerobic capacity and the degree of conditioning in each mouse. Although it’s known 
that young muscle is able to respond to chronic exercise by undergoing plasticity to 
increase its oxidative capacity, the aged muscle is already under compromised 
physiological mechanisms and that strenuous exercise may have an adverse impact 
on the function of the muscle. Even though, PolgAmut/mut mice have the same 
genotypes, the level of mtDNA heteroplasmy may differ between animals and so the 
state of oxidative phosphorylation. For this reason, the aerobic capacity of each 
mouse will differ. In order to make sure mice benefit from an exercise regime, 
therefore it’s recommended to exercise mice between 60%-80% of individual’s VO2 
max to improve aerobic fitness levels. Future work would be to assess fat to muscle 
ratio in these mice and normalise the data for the effects of environmental factors 









Chapter 5.  The effects of single housing and endurance exercise on 
cardiac mitochondrial function and progeroid ageing phenotypes 
in PolgAmut/mut mice 
 
5.1 Introduction 
The discrepancies between this study and that of Safdar et al (2011) (discussed in 
chapter 4) led us to investigate further the possible causes of differences. One major 
difference was the single housing of experimental animals and so I performed a pilot 
study to see if this could explain the variation between the two studies. 
 
5.1.1  Housing conditions in mice 
Housing conditions affect different strains of mice in different ways, meaning that 
some mice withstand environmental stresses better. Collins and Tabak (2014) have 
shown that environmental conditions such as diet, housing conditions and exercise 
play a significant role in the expression of ageing phenotypes in mouse models. 
Previous research has shown that although younger mice are not used to handling, 
they are extremely malleable in adjusting to environments, meaning that regular 
human interactions puts an added stress on mice within tolerated levels. Olsson and 
Dahlborn (2002) have reported that restrictive housing conditions cause long-term 
stress and limit the animal’s potential for managing their social and physical 
interactions. This directly affects their reaction to external challenges such as 
exercise. A study carried out by Kalliokoski et al (2014) has provided evidence that 
male BALB/c immunodeficient mice suffer from marked hypothermia following 3 
weeks of solitary housing. They have demonstrated that male mice deprived of social 
contact respond with altered serotonergic signaling activity. Another study by the 
same author in 2013 showed that singly housed BALB/c male mice suffer from 
elevated levels of oxidative stress evident by a significant increase in their urine 
corticosteroid metabolites. Some researchers on the other hand, argue that more 
than housing conditions, lack of familiarity of mice with their cage mates triggers 
social stress. Bartolomucci, Palanza and Parmigiani (2002) suggested that group 




with siblings of the same sex from birth is the ideal social environment for mice. A 
study carried out by Nagy et al (2001) on the effect of group housing on phenotypic 
variance of C57BL/6J mice revealed that group housing increases the variation in 
measures such as bone mineral density (BMD) and content as well as tissue and fat 
mass. They have concluded that singly housing wild type mice provides a more 
representative genotype effects on body composition than group housing. Although 
singly housed mice were overall smaller in size and had less soft tissue and body fat 
when compared to group housed mice.  
Since PolgAmut/mut mice suffer from pathogenic mtDNA mutations and pre-mature 
ageing phenotypes, housing conditions and other lifestyle factors have a significant 
influence on their ageing and potentially on cellular and molecular findings. For this 
reason, in order to eliminate the influence of external variables in experiments most 
researchers singly house the mice, however this could be a limiting factor in ageing-




5.2 Aims of study 
The general aim of this study was to investigate the impact of housing condition on 
the ageing profile of PolgAmut/mut mice and in response to exercise.  
The objectives of this study were met by investigating the clinical phenotypes, 
behavioural characteristics, cardiac structure, histology and mitochondrial function of 
the following mice: 
1. Group-housed and singly-housed sedentary PolgAmut/mut mice from 3 to 11 
months of age. 
2. Singly-housed sedentary and exercised PolgAmut/mut mice from 3 to 11 months 
of age.  






PolgAmut/mut mice were randomly assigned to groups of n=5 sedentary, n=5 exercised 
in single cages and were compared with the data generated from the group-housed 
animals investigated in chapters 3 and 4 (n=10 sedentary and n=10 exercised). 
Group-housed mice are referred to as ‘GH’ and singly-housed mice are referred to as 
‘SH’, throughout this thesis. This study used the same treadmill running protocol as in 
chapter 4. Exercise regime commenced at 16 weeks of age for the duration of 6 
months while sedentary mice kept normal cage activity. Comparisons were made 
between groups at 14/15 weeks (pre-intervention), 29 weeks (during-intervention) 
and 43 weeks (post-intervention). 
 
5.3.1  Survival curve, Clinical scoring and Body weight of PolgAmut/mut mice  
A.  Sedentary GH compared with sedentarySH PolgAmut/mut mice 
The lifespan of sedentary PolgAmut/mut GH mice (n=10) and sedentary PolgAmut/mut SH 
mice (n=5) were compared. The end point for the study was 46 weeks (322 days), 
however those mice that died prior to their culling date for reasons other than fight 
wounds and prolapse were included in the survival curve. Figure 5.1A demonstrates 
that only one mouse (20%) from the SH cohort lived to the endpoint (322 days) the 
other 4 mice died as early as 272 days. 
Sedentary SH mice had significantly lower weights in comparison to GH mice at 37 
and 39 weeks (p<0.05) as well as 41 (p<0.001), 42 and 43 (p<0.0001) weeks of age. 
The body weight of sedentary GH mice increased significantly with advancing age 
(p<0.05) raising from 30.08g±2.78 to 32.5g±0.0002. SH mice showed an overall 
significant decline in body weight with advancing age from 30.78g±0.61 to 
25.97g±0.08 (figure 5.1B) (P<0.01, two-way ANOVA repeated measures). 
Clinical scoring was carried out in sedentary PolgAmut/mut GH and SH mice on a 
weekly basis from the age of 14 weeks to 43 weeks. Eight characteristics were 
assessed in mice and the severity of conditions were scored from 0 (normal) to 3 
(worsening of condition). Higher clinical score values indicate worsened body 
condition. A weight loss of over 10-15% and any characteristic above the score of 2 




study), 29 weeks (mid-point) and 43 weeks (end point) from the SH and GH mice 
were compared (two-way ANOVA repeated measures). Body condition assessment 
through clinical scoring (figure 5.1C) revealed that sedentary GH and SH mice had 
significant body condition deterioration with advancing age (p<0.001, p<0.01 
respectively). At 14 weeks the average clinical score of SH mice was 2.2±0.97 
whereas for GH mice it was 1±0.98 (p>0.05). Similarly, the body condition of GH 
mice at 29 weeks was 2.4±1.7 and of SH mice was 3.4±1.5 (p>0.05). Clinical scores 
increased at 43 weeks in GH mice to 6.16±1.86 and in SH mice to 6±0.054 (p>0.05) 
revealing a trend but with low numbers of SH mice there was no significant difference 
between the two groups at 14 weeks, 29 weeks and 43 weeks of age. 40% of SH 
mice suffered from severe weight loss, 100% with piloerection and 20% with anemia. 
In comparison to GH mice with 14.3% severe weight loss, 85% with piloerection, 
14.3% behavioral isolation where mice do not engage in social interaction with other 





Figure 5.1. Survival curve, Clinical scoring and Body weight of sedentary 
group-housed and singly-housed PolgAmut/mut mice at 14, 29 and 43 weeks of 
age (two-way ANOVA repeated measures). A) Survival curve. B) Body weight was 
significantly reduced in sedentary SH mice in comparison to sedentary GH mice from 
weeks 27 onwards. C) Clinical scoring was significantly reduced in sedentary GH and 
sedentary SH mice with advancing age (***p<0.001 and **p<0.01 respectively). Error 





B.  Sedentary compared with Exercised SH PolgAmut/mut mice  
Figure 5.2.A shows the lifespan of sedentary and exercised PolgAmut/mut SH mice. 
Only one exercised mouse lived to 316 days, the other 3 died at days 272, 278 and 
288. The median survival of the exercised and sedentary cohorts were 283 days and 
276 days respectively. Only 1 mouse from the sedentary cohort survived longest to 
322 days hence a 20% survival rate, the others died at 321, 272 and 276 days of 
age. 
Figure 5.2B shows that the body weight of sedentary PolgAmut/mut SH mice decreased 
significantly with advancing age (p<0.001), however exercised PolgAmut/mut SH mice 
showed no significant age-related change in body weight (p>0.05). At weeks 17, 21 
(p<0.05) and 20 (p<0.01) the body weight of sedentary SH mice was significantly 
higher than exercised mice. Exercised SH mice seemed to be able to maintain their 
body weight with advancing age, however the body weight of sedentary SH mice 
declined significantly from 30.74g±0.61 at 14 weeks to 25.98g±0.08 at 43 weeks of 
age (p<0.001, two-way ANOVA repeated measures).  
There was no significant difference between the body conditions of sedentary and 
exercised PolgAmut/mut SH mice at any time point (p>0.05, two-way ANOVA repeated 
measures) (figure 5.2C). The body condition of both groups however declined 
significantly with advancing age as shown as an increase in the clinical scoring 
graph. The body condition of sedentary mice declined from the score of 2.2±0.9 to 
6±0.54 (p<0.001) whereas in exercised mice it changed from 2.2±0.97 to 5±0.98 
(p<0.01). At 43 weeks of age 40% of sedentary SH mice suffered from severe weight 
loss in comparison to 20% of exercised mice. 100% of sedentary and 100% of 
exercised mice suffered from piloerection and 20% from each sedentary and 





Figure 5.2. Survival curve, Clinical scoring and Body weight of singly-housed 
sedentary and exercised PolgAmut/mut mice at 14, 29 and 43 weeks of age (two-
way ANOVA repeated measures). A) Survival curve. B) Body weight. C) Clinical 
scoring was significantly increased in sedentary and exercised SH mice with 






C.  Exercised GH compared with exercised SH PolgAmut/mut mice 
The lifespan, body weight and clinical scores of two exercised cohorts from 
PolgAmut/mut mice GH (n=10) and SH (n=5) were compared (two-way ANOVA 
repeated measures). Figure 5.3A shows that 58.4% of exercised GH mice lived to 
the endpoint whereas none of the exercised SH mice survived to the endpoint. The 
longest lived mouse in the SH cohort survived to 316 days. The shorter survival rate 
of SH mice is reflected in their poor body condition.  
Figure 5.3B shows the continuous body weight of exercised GH and SH mice which 
was not significantly different between the two cohorts at any time point throughout 
the intervention. 
The finding that exercised SH mice had a shorter lifespan was supported by 
significantly higher clinical scores than the exercised GH mice. Clinical scores at 14 
weeks of age were significantly higher in SH mice in comparison to GH mice 
(p<0.001) (figure 5.3C) as well as 29 weeks (p<0.01) and 43 weeks (p<0.01, two way 
ANOVA repeated measures). Both groups had a significant decline in their body 
condition with advancing age. At 43 weeks of age 28.6% of GH mice and 100% of 
SH mice show signs of piloerection, 14.3% of GH mice and none of SH mice with 
hunched posture and mobility, 28.6% of GH mice and 20% of SH mice with signs of 





Figure 5.3. Survival curve, Clinical scoring and Body weight of exercised 
group-housed and singly-housed PolgAmut/mut mice at 14, 29 and 43 weeks of 
age (two-way ANOVA repeated measures). A) Survival curve. B) Body weight. C) 
Clinical scoring was significantly increased in exercised GH and exercised SH mice 
with advancing age (****p<0.0001 and ***p<0.001 respectively). Body condition of 
exercised GH mice was significaly worse at 43 weeks (**p<0.01) in comparison to 




5.3.2  Body temperature in PolgAmut/mut mice 
Body temperature from sedentary PolgAmut/mut GH mice (n=10), sedentary 
PolgAmut/mut SH mice (n=5), exercised PolgAmut/mut GH mice (n=10) and exercised 
PolgAmut/mut SH mice (n=5) were recorded at 14 weeks, 29 weeks and 46 weeks of 
age using a two-way ANOVA repeated measures statistical analysis. Room and cage 
temperatures were maintained at all times. There was no significant difference 
between the body temperatures of sedentary GH and SH mice at any time point 
(figure 5.4A). 
The body temperature of exercised SH mice increased briefly from 14 weeks to 29 
weeks of age and declined subsequently at 43 weeks of age (p<0.01) (figure 5.4B). 
Exercised SH mice showed significantly higher body temperatures in comparison to 
exercised GH mice during (29 weeks of age) and post-intervention (43 weeks of age) 
(figure 5.4C). The mechanism by which exercised SH mice regulate their core body 
temperature seems to be different in those of group-housed mice. Exercise is likely to 
have an effect since the sedentary SH mice also have significantly lower body 






Figure 5.4. Body temperature of mice at 14, 29 and 43 weeks of age. A) No 
significant changes in the body temperature of sedentary group-housed (GH) and 
singly-housed (SH) mice were observed. B) Sedentary SH mice showed higher body 
temperature at 29 weeks (****p<0.0001) in comparison to exercised SH mice. C) 
Exercised SH mice showed significantly higher body temperatures at 29 weeks 
(****p<0.0001) and 43 weeks of age in comparison to exercised GH mice (**p<0.01). 





5.3.3  Open field testing (OFT) in PolgAmut/mut mice 
OFT was carried out to discern any changes in behaviour and/or locomotive activity 
within a 5 minute period between different cohorts of mice at three time points (15, 29 
and 43 weeks of age). OFT was performed using the open field arena and dark 
phase programme on Mousetrap software (detailed chapter 2 section 2.16.1). The 
parameters obtained included the total distance travelled by the mouse, average 
velocity, average rearing frequency, sum of number of touches and average step 
length within a 5 minute period of testing time. A two-way ANOVA repeated 
measures was used to make comparisons between and within groups with age. 
 
A.  Sedentary GH compared with SH PolgAmut/mut mice  
OFT was carried out on sedentary PolgAmut/mut GH mice (n=10) and sedentary 
PolgAmut/mut SH mice (n=5) (figure 5.5). The total distance moved was significantly 
reduced in sedentary GH mice with advancing age (p<0.001). There were no 
significant changes in the total distance moved with age in sedentary SH cohort 
(figure 5.5A). The average velocity in 5 minutes in sedentary GH mice increased 
significantly with advancing age up to 29 weeks (p<0.01). However, there was no 
significant difference between the velocities of groups at any time point (figure 5.5B). 
Rearing frequency shown in figure 5.5C also shows that at 15 weeks and 43 weeks 
of age, SH mice had significantly higher rearing frequency than GH mice (p<0.001, 
p<0.01 respectively). Also the rearing frequency of GH mice reduced significantly 
with advancing age (p<0.01) (figure 5.5.C). The total number of touches were also 
measured in both groups which decreased significantly in sedentary GH mice with 
advancing age (p<0.05). Also, the total number of touches were significantly higher in 
the sedentary SH mice in comparison to sedentary GH mice at 15 weeks (p<0.05), 
29 weeks (p<0.01) and 43 weeks of age (p<0.01) (figure 5.5D). Step length was 
measured by dividing the total distance travelled by total number of touches for 
balance and coordination analysis. The step length of sedentary SH mice was 
significantly higher at 43 weeks of age (p<0.01) in comparison to sedentary GH mice. 
The step length of sedentary GH mice decreased significantly with advancing age 




As part of the first aim of this study, it was observed that the total distance moved, 
total number of touches and step length was significantly higher in sedentary 
PolgAmut/mut SH mice in comparison to sedentary PolgAmut/mut GH mice. This could 
indicate that sedentary PolgAmut/mut SH mice are more active within a 5 minute period 
of testing time from 15 weeks of age and move with longer step length to retain their 
gait and balance stable. This is interesting because sedentary PolgAmut/mut GH mice 
experience a significant decline in their total distance travelled, total number of 
touches and step length with advancing age. As animals get older, their locomotive 
activity reduce proportionally with age. Sedentary PolgAmut/mut GH mice showed 
reduced step length with age (p<0.001). This could mean that GH mice move less 
but without having to take longer steps or they are more confident and are familiar 
with the arena during the testing time, since longer step lengths indicate the state of 
imbalance and unfamiliarity of mice with the apparatus. Reduced number of touches 
in sedentary GH mice indicate their reduced movement. Interestingly sedentary GH 
mice showed significantly higher velocity of movements at 29 weeks in comparison to 
15 weeks of age indicating that despite less movements, GH mice were faster in 






Figure 5.5. Open field testing in sedentary GH and SH PolgAmut/mut mice. A) Total 
distance moved was significantly higher in sedentary SH mice (****p<0.0001) in 
comparison to sedentary GH mice at 43 weeks of age. B) Average velocity. C) 
Rearing frequency was significantly higher in sedentary SH mice (**p<0.01) in 
comparison to GH mice at 43 weeks of age. D) Total number of touches was 
significantly greater in sedentary SH mice at 43 weeks (**p<0.01) in comparison to 
sedentary GH mice. E) Step length was significantly higher in sedentary SH mice in 







B.  Sedentary compared with Exercised SH PolgAmut/mut mice  
OFT was performed on sedentary PolgAmut/mut SH (n=5) and exercised PolgAmut/mut 
SH mice (n=5) in order to find out whether exercise has any behavioural and 
locomotive effect on solitary housed mice in comparison to non-exercised solitary 
housed mice (figure 5.6). The total distance moved in exercised SH mice was 
significantly reduced with advancing age from 15 weeks to 43 weeks (p<0.01) and 
from 29 weeks to 43 weeks (p<0.0001). However at 29 weeks of age, exercised SH 
mice moved significantly further than sedentary SH mice (p<0.05) (figure 5.6A). 
There was no significant difference between the velocity and rearing frequency of 
both groups at any time point and with advancing age (figure 5.6B and 5.6C 
respectively). Total number of touches was reduced significantly in exercised SH 
group with advancing age (p<0.001). However, in sedentary SH mice this remained 
unchanged with age (figure 5.6D). The step length was reduced significantly in 
exercised SH group with advancing age from 29 weeks to 43 weeks (p<0.01), 
however no significant difference were seen between the groups at any time point as 
shown by figure 5.6E. As part of the second aim of this study, I have shown that 
exercised PolgAmut/mut SH mice moved significantly less with advancing age which 
reflects on their lower overall number of touches. The exercised mice also had 





Figure 5.6. Open field testing in exercised GH and SH PolgAmut/mut mice. A) Total 
distance moved was significantly reduced in exercised SH mice with advancing ggae 
(**p<0.01). B) Average velocity. C) Rearing frequency. D) Total number of touches 
were significantly reduced in exercised SH mice with advancing age (***p<0.001). E) 








C. Exercised GH compared with SH PolgAmut/mut mice 
OFT was carried out on exercised PolgAmut/mut GH mice (n=10) and exercised 
PolgAmut/mut SH mice (n=5) in order to find out whether housing condition affect 
behavioural and locomotive activity of exercised PolgAmut/mut mice. The total distance 
moved in exercised SH mice was significantly higher at 15 weeks (p<0.05) and 29 
weeks of age (p<0.01) compared with exercised GH mice (figure 5.7A). Exercised 
SH mice also showed a significant reduction in distance moved from 15 weeks to 43 
weeks (p<0.01) and from 29 to 43 weeks of age (p<0.01) (figure 5.7A). The average 
velocity of exercised GH mice was significantly increased with advancing age 
(p<0.01) but was significantly higher at 15 weeks in exercised SH mice (p<0.05) 
(figure 5.7B). The rearing frequency of exercised SH mice increased significantly with 
advancing age (p<0.05) (figure 5.7C). Total number of touches was significantly 
higher in the exercised SH mice at 15 weeks (p<0.05) in comparison to exercised GH 
mice and decreased significantly with advancing age in exercised SH mice from 15 
weeks to 43 weeks (p<0.01) and 29 weeks to 43 weeks (p<0.01) (figure 5.7D). The 
average step length was significantly higher in exercised SH mice at 29 weeks and in 
comparison to exercised GH mice (p<0.01) and reduced significantly in exercised SH 





Figure 5.7. Open field testing in exercised GH and SH PolgAmut/mut mice. A) Total 
distance moved was significantly reduced in exercised SH mice with advancing age 
(**p<0.01). B) Average velocity was significanty increased in exercised GH mice with 
advancing age (**p<0.01). C) Rearing frequency. D) Total number of touches was 
significanrly reduced in exercised SH mice with advancing age (**p<0.01). E) Step 







5.3.4  Organ weights in PolgAmut/mut mice 
Organ weights in sedentary PolgAmut/mut GH (n=10), sedentary PolgAmut/mut SH (n=5), 
exercised GH (n=10) and exercised SH (n=5) mice were measured after organ 
harvest (detailed chapter 2 section 2.17). Figures 5.8 shows organ weight 
comparisons between different cohorts (unpaired t-test). Figures 5.9 shows organ 
weights normalised to body weight (BW) (unpaired t-test). Organ weight to body 
weight ratio was measured in order to eliminate the effects of weight change in 
overall organ weight. 
Pancreas weight (p<0.003) and pancreas: BW ratio (p=0.004) was significantly 
higher in sedentary PolgAmut/mut SH mice in comparison to GH mice (figure 5.8A and 
5.9A respectively). Liver: BW (p=0.007) and lung: BW (p=0.03) ratios were also 
significantly higher in sedentary PolgAmut/mut SH mice (figure 5.9A). Considering that 
the body weight of Sedentary SH mice was in general lower than GH mice, it’s clear 
that sedentary SH mice had significant hypertrophy in the stated organs. Organ 
hypertrophy seen in sedentary PolgAmut/mut SH mice could be pathological or 
adaptation to function. There was no significant difference between the organ 
weights of sedentary and exercised SH mice. However left kidney and right kidney 
weights were significantly higher in exercised GH mice in comparison to exercised 






Figure 5.8. Organ weights in PolgAmut/mut mice. A) Pancreas weight was significantly higher in sedentary SH mice in comparison 
to GH mice (**p<0.01). B) Organ weights in sedentary and exercised SH mice. C) Right kidney and left kidney weights were 
significantly higher in exercised GH mice in comparison to exercised SH mice (*p<0.05). (Unpaired t-test). Error bars represent 







Figure 5.9. Normalised organ weights in PolgAmut/mut mice. A) Liver: BW (**p<0.01), lungs: BW (*p<0.05) and pancreas: BW 
(**p<0.01) ratios were significantly higher in sedentary SH mice in comparison to sedentary GH mice. B) Normalised organ weights 




5.3.5  Cardiac apoptosis in PolgAmut/mut mice  
Cardiac apoptosis was assessed in fixed 4μm cardiac right ventricular sections 
(detailed chapter 2 section 2.23.2) from sedentary GH (n=10), sedentary SH (n=5), 
exercised GH (n=10) and exercised SH (n=5) PolgAmut/mut mice by active cleaved-
caspase 3 (CC3) immunohistochemistry. Images were obtained by Aperio Scanner 
(Leica) and the percentage of cardiac apoptosis was quantified using the nuclear v 
algorithm on Genie software (Leica Biosystems). Dark brown circular regions 
represent the expression of active form of Caspase-3. The percentage of apoptosis 
was quantified by the ratio of total nuclei count to total apoptotic nuclei count. 
CC3 immunohistochemistry revealed that the percentage of apoptotic nuclei was 
significantly higher in the cardiac muscle of sedentary PolgAmut/mut SH mice in 
comparison to sedentary PolgAmut/mut GH mice (p=0.007, unpaired t-test) (figure 
5.10A). Cardiac apoptosis has already been documented in sedentary PolgAmut/mut 
GH mice in comparison to sedentary PolgA+/+ GH mice in chapter 3. This is 
exacerbated in the sedentary PolgA mut/mut SH mice suggesting that solitary housing 
conditions are detrimental to the phenotype. 
Cardiac apoptosis was also quantified in sedentary (n=5) and exercised (n=5) 
PolgAmut/mut SH mice right ventricular muscle (figure 5.10B). No significant difference 
(unpaired t-test) between the rates of cardiac apoptosis of both groups were seen, 
indicating that singly-housing exacerbates cardiac apoptosis which is not rescued 
following endurance exercise. 
Cardiac apoptosis was measured in exercised PolgAmut/mut GH (n=10) and SH (n=5) 
mice right ventricular muscle. Figure 5.10C shows that the rate of cardiac apoptosis 
was significantly higher in exercised SH mice in comparison to exercised GH mice 
(p=0.0071, unpaired t-test), confirming that single housing is detrimental to the 





Figure 5.10. Rate of apoptosis in PolgAmut/mut mice. A) Rate of cardiac apoptosis is significantly higher in sedentary PolgAmut/mut 
SH mice in comparison to sedentary GH mice (***p=0.007). B) There was no significant difference in the percentage of apoptosis 
between the sedentary SH and exercised SH mice (p=0.6). C) Exercised SH mice have significantly higher rate of apoptotic nuclei 




5.3.6  Cardiomyocyte width and cardiac fibrosis in PolgAmut/mut mice 
Cardiomyocyte width and cardiac fibrosis was assessed in 4μm fixed right ventricular 
cardiac muscle sections in sedentary GH (n=10), sedentary SH (n=5), exercised GH 
(n=10) and exercised SH (n=5) PolgAmut/mut mice by Haematoxylin and Eosin (H&E) 
staining (detailed chapter 2 section 2.20) and Masson trichrome staining (detailed 
chapter 2 section 2.22) respectively. 
H&E staining is used to morphologically assess the structure of cardiomyocytes and 
determine any alteration in their shape and size. Five random snapshots of x20 
magnification images were obtained using Zeiss microscopy and the width of 50 
transverse cardiomyocytes were analysed from each image to make a total of 250 
fibres from each mouse. Zen (v2.5) analysis software (Zeiss) was used to measure 
cardiomyocyte width. 
Similarly, cardiac fibrosis was assessed in both cohorts by Masson trichrome staining 
to assess the presence of collagenous tissue to identify cardiac fibrosis. Images were 
obtained from Nikon Tie widefield microscope and analysed using NIS elements 
software. The percentage of fibrosis was assessed by using RGB general analysis in 
which each dye is separated by RGB thresholding and the area of collagen to total 
tissue section was quantified to determine the percentage of fibrosis. Cardiomyocyte 





Figure 5.11. Cardiomyocyte width and cardiac fibrosis in PolgAmut/mut mice. 
H&E histochemistry was used to visualise cardiomyocyte width (magnification x20, 
Scale bars=100μm) and Masson trichrome staining was carried out to visualise 





Cardiomyocyte width was shown to be significantly higher in GH PolgAmut/mut mice 
from chapter 3 in comparison to PolgA+/+ mice. Cardiomyocyte width was significantly 
higher (5.78μm greater in average) in the sedentary GH mice in comparison to SH 
mice (p=0.003, unpaired t-test) meaning that solitary housing condition alleviate 
enlarged cardiomyocyte width in PolgAmut/mut mouse (figure 5.12A). Cardiac fibrosis 
was proven to be significantly higher in GH PolgAmut/mut mice from chapter 3, but does 
not seem to be affected by singly-housing (figure 5.12D). Since cardiomyocytes have 
high density of mitochondria to allow for more efficient ATP synthesis, larger 
cardiomyocytes which normally lead to hypertrophy also normalises wall tension 
during the conditioning process. In the setting of inactive lifestyle however 
cardiomyocyte hypertrophy could be pathological. However the difference in the 
hypertrophy level could be due to the small sample size in the SH cohort.  
No significant differences were seen in percentage of cardiac fibrosis and 
cardiomyocyte width between the sedentary and exercised SH mice (unpaired t-test), 
meaning that exercise in the context of single-housing has no impact on 
cardiomyocyte width and the level of cardiac fibrosis in PolgAmut/mut mice (figures 
5.12B and 5.12E respectively). These findings are similar to the findings of chapter 4 
figure 4.4 where exercise in the context of group-housing in PolgAmut/mut mice did not 
affect cardiomyocyte hypertrophy and cardiac fibrosis observed in PolgAmut/mut mice. 
Similarly, exercise in the context of singly-housing in PolgAmut/mut SH mice did not 
change cardiomyocyte width and the level of cardiac fibrosis as shown in figures 
5.12C and 5.12F respectively. This could simply mean that exercise and housing 
condition do not have an impact on the levels of cardiac fibrosis and cardiomyocyte 
hypertrophy in exercised cohort and only the housing condition have an impact on 
cardiomyocyte width in sedentary cohort. Although in comparison to PolgA+/+ mice a 






Figure 5.12. Cardiomyocyte width and cardiac fibrosis in PolgAmut/mut mice. A) 
Cardiomyocyte width is significantly higher in sedentary GH mice in comparison to 
SH mice (***p=0.003, unpaired t-test). B, E) There is no significant difference in 
cardiomyocyte width (p=0.9) and percentage of cardiac fibrosis in SH sedentary and 
exercised mice. C, F) There was no significant difference between the cardiomyocyte 
width (p=0.3) and cardiac fibrosis in exercised GH and SH mice (unpaired t-test). 









5.3.7  Mitochondrial complex I (NDUFB8) and complex IV (MTCOI) expression 
levels in PolgAmut/mut mice hearts 
Cardiac mitochondrial ETC complex I (CI) NDUFB8 subunit and complex IV (CIV) 
MTCOI subunit expression levels were quantified by immunofluorescence (detailed 
chapter 2 section 2.24.2). Paraffin fixed right ventricular cardiac sections (4μm) from 
sedentary GH (n=10), sedentary SH (n=5), exercised GH (n=10) and exercised SH 
(n=5) PolgAmut/mut mice were subjected for detection of NDUFB8, MTCOI, VDAC 
(mitochondrial mass marker) and laminin (myocardial basal membrane protein 
marker). A mitochondrial mass marker was used to confirm genuine mitochondrial 
signal. Images were acquired using Nikon LSM800 microscope (figure 5.13). The 
expression levels of two complexes were normalised to Porin levels and quantified by 
an in-house immuno-analyser software. Five random snapshots of x10 magnification 
were selected from each mouse for analysis. Laminin was used to semi-automatically 
detect and outline transverse cardiomyocytes for analysis. Analysed cardiomyocytes 
were categorised into positive, intermediate positive, intermediate negative and 
negative expression levels of NDUFB8 and MTCOI based on their z-scores. 
Mitochondrial respiratory chain graphs (MRC) were generated as shown in figures 
5.14. Percentage of CI and CIV expression levels were also quantified in each group 
and compared in figure 5.15. Porin Z-scores were used to classify fibres into very low 
(Z-scores <-3SD), low (Z-scores between -3SD and -2SD), normal (Z-scores 
between -2SD and +2SD), high (Z-scores between +2SD and +3SD) and very high 
(Z-scores >+3SD) (detailed chapter 2 table 2.4). Porin expression levels as z-score 





Figure 5.13. Mitochondrial NDUFB8 (CI) and MTCOI (CIV) subunit expression levels. Representative images of right 
ventricular cardiac muscle for immuno detection of NDUFB8 (complex I), MTCOI (complex IV), Porin (mitochondrial mass marker) 






Figure 5.14. MRC plots from sedentary and exercised, GH and SH PolgAmut/mut 
mice. A) Sedentary GH. B) Exercised GH. C) Sedentary SH. D) Exercised SH mice. 
Each dot represent a cardiomyocyte. Solid yellow lines represent SD limits for the 
classification of cardiomyocytes. Yellow dashed lines represent mean expression 
level of cardiomyocytes with normal CI and CIV. Each cardiomyocyte was colour 








Figure 5.15. Percentage of cardiomyocytes with MTCOI and NDUFB8 
expression levels (unpaired t-test). A) Sedentary GH and SH mice. B) Sedentary 
and exercised SH mice. C) Exercised GH and SH mice hearts. Unpaired t-test in 





Figure 5.16. Porin Z-scores in: A) sedentary GH and SH mice. B) Sedentary and 
exercised SH mice. C) Exercised GH and SH mice. Error bars represent mean ±SD. 
 
The percentage of cardiomyocytes with intermediate negative NDUFB8 and MTCOI 
expression levels were significantly higher in the right ventricular cardiac muscle of 
sedentary PolgAmut/mut SH mice in comparison to sedentary PolgAmut/mut GH mice 
(p<0.01 and p<0.0001 respectively) (figures 5.15A1, A2). Interestingly, the 
percentage of cardiomyocytes with intermediate positive expression levels of 
NDUFB8 was significantly higher in sedentary GH mice in comparison to SH mice 
(p<0.05, unpaired t-test) (figure 5.15A). 
Unpaired t-test between the different categories revealed that the percentage of 
cardiomyocytes with positive and intermediate positive expression of NDUFB8 and 
intermediate positive expression of MTCOI was significantly higher in exercised 
PolgAmut/mut SH mice in comparison to sedentary PolgAmut/mut SH mice (p<0.001) 
(figure 5.15B1 and B2) Whereas percentage of cardiomyocytes with intermediate 
negative MTCOI and NDUFB8 as well as negative MTCOI expression was 
significantly higher in sedentary PolgAmut/mut SH mice in comparison to exercised 
PolgAmut/mut SH mice. The negative shift in the expression levels of MTCOI and 
NDUFB8 in sedentary SH cohort may be an indication of decreased cellular 
respiration in the cardiac muscle of sedentary SH mice. These findings although 
confirm the presence of enzymes but do not account for the activity of subunits. 
An unpaired t-test was performed to analyse NDUFB8 and MTCOI expression in 




cardiac muscle (figures 5.15C1, C2). Exercised PolgA mut/mut GH mice had 
significantly higher percentage of cardiomyocytes with intermediate positive 
expression levels (p<0.01) as well as intermediate negative MTCOI expression 
(p<0.05), whereas exercised PolgAmut/mut SH mice had significantly higher percentage 
of cardiomyocytes with negative expression of NDUFB8 and MTCOI (p<0.01).  
Figures 5.16 represent mitochondrial mass marker expression levels. Porin z-scores 
were generated through immunoanalyser software and were within the normal range 
in all four cohorts of mice, indicating that porin levels were not affected by exercise 
and singly-housing in mice.  
 
5.3.8  COX activity in PolgAmut/mut mice hearts  
Mitochondrial complex IV (COX) activity was quantified by COX/SDH histochemistry 
in left ventricular cardiac muscle sections from sedentary GH (n=10), sedentary SH 
(n=5), exercised GH (n=10) and exercised SH (n=5) mice. COX deficient cells stain 
blue by reduction of NBT, allowing for the visualisation of nuclear encoded succinate 
dehydrogenase. Images were acquired by Nikon Tie microscope and the percentage 
of blue staining was measured in comparison to total tissue area. Five random 
snapshots of x10 magnification per mouse was selected for analysis through NIS 
elements software where RGB general analysis algorithm was used to set a 
threshold for each channel. The percentage of COX deficiency was calculated by the 
ratio of total tissue area to total blue staining region. An unpaired t-test was 
performed to statistically analyse the difference in COX activity between groups.  
In order to visualise the effects of housing condition on cardiac COX activity of 
sedentary PolgAmut/mut mice, both sedentary GH and sedentary SH mice cardiac 
sections were assessed for COX/SDH histochemistry (figure 5.17). Interestingly, 
percentage of COX deficiency was significantly higher in sedentary SH PolgAmut/mut 
mice hearts in comparison to sedentary GH mice (5.18A). 
COX activity was also measured in sedentary and exercised PolgA mut/mut SH mice 
(figure 5.18B). The percentage of cardiomyocytes with COX deficiency was not 
significantly different between the two cohorts, indicating that exercise in the setting 




COX activity was also determined in exercised PolgAmut/mut GH and SH mice in order 
to find out whether singly-housing has any effect on the mitochondrial function of 
exercised mice. There was no significant difference between the levels of COX 
activity between the two groups (figure 5.18C).  
I have confirmed in chapter 4 section 4.3.9 that group-housed PolgAmut/mut mice 
whether sedentary or exercised had similar levels of COX activity. Similarly singly-
housed PolgAmut/mut mice have non-significant levels of COX deficiency whether 
sedentary or exercised. COX deficiency analysis in all groups indicate that singly-
housed inactive PolgAmut/mut mice, have compromised COX activity as shown in 
figure 5.18A. These findings purely show that the effects of singly-housing is more 





Figure 5.17. Representative micrographs of mitochondrial COX, SDH activity and COX/SDH histochemistry in PolgAmut/mut 
mice. A mosaic pattern of COX deficiency is seen within the left ventricular cardiac muscle of all groups with COX/SDH 





Figure 5.18. COX deficiency in PolgAmut/mut mice hearts. A) The percentage of COX deficiency is significantly higher in the left 
ventricular cardiac muscle of SH cohort (***p=0.0005, unpaired t-test) in comparison to GH mice. B) There is no significant 
difference between the level of COX activity of sedentary and exercised SH mice (p=0.06, unpaired t-test). C) There is no significant 




5.3.9  NBTx and laminin immunofluorescence in PolgAmut/mut mice hearts 
NBTx assay and laminin immunofluorescence was performed in left ventricular 
cardiac muscle of sedentary PolgAmut/mut GH (n=10), sedentary PolgAmut/mut SH (n=5), 
exercised PolgAmut/mut GH (n=10) and exercised PolgA mut/mut SH (n=5) mice in order 
to visualise and quantify COX deficiency based on NBTx activity only through the 
technique described in chapter 3 section 3.3.10.  
Left ventricular cardiac sections were stained for cytochrome c oxidase and NBTx 
activity followed by laminin immunofluorescence. COX functional cells remain 
transparent through NBTx assay where NBT is not reduced and deposited inside 
cells by SDH. COX dysfunctional cells however turn blue and the amount of blue 
deposition inside cells i.e. depth of blue, determines the degree of deficiency. Five 
random snapshots of x10 magnification Images were obtained and analysed through 
an in-house immunoanalyzer software. 500 transverse cardiomyocytes per mouse 
were semi-automatically selected through laminin immunofluorescence and analysed 
through the software. The darker the blue staining, the more COX deficient the cells 
were; however this was observed in black through the monochrome camera (figure 
5.19). An arbitrary z-scoring was used (Chapter 2 section 2.24.1) to categorise 
cardiomyocytes into groups of positive, intermediate and negative according to the 





Figure 5.19. NBTx assay and laminin immunofluorescence in PolgAmut/mut mice. Images were obtained from LSM800 




In order to observe changes in COX activity of inactive mice within different housing 
conditions, sedentary GH (n=10) and sedentary SH (n=5) mice were compared 
(figure 5.20). Sedentary GH mice had significantly higher percentage of 
cardiomyocytes with positive and intermediate COX activity (figure 5.20A) (p<0.001) 
and sedentary SH mice had a significantly higher percentage of COX negative 
cardiomyocytes in comparison to GH mice. Percentage of COX intermediate 
cardiomyocytes were significantly higher in exercised SH mice cohort in comparison 
to sedentary SH group (p<0.01, unpaired t-test) (figure 5.20B). Exercised SH mice 
have significantly higher percentage of COX negative cardiomyocytes (p<0.001, 
unpaired t-test) and exercised GH mice have significantly higher COX positive 





Figure 5.20. Complex IV activity by NBTx assay in PolgAmut/mut GH mice. A) 
Sedentary GH mice had significantly higher percentage of cardiomyocytes with 
positive and intermediate COX activity (***p<0.001, unpaired t-test) however SH mice 
had significantly higher percentage of cardiomyocytes with negative COX activity. B) 
SH Exercised cohort had greater percentage of cardiomyocytes with intermediate 
COX activity in comparison to SH sedentary mice (**p<0.01, unpaired t-test). C) SH 
exercised mice had significantly higher percentage of cardiomyocytes with negative 
COX activity in comparison to exercised GH mice (*p<0.05) and exercised GH mice 




comparison to exercised GH mice (****p<0.0001, unpaired t-test). Error bars 
represent mean± SD. 
 
5.3.10 MtDNA copy number in PolgAmut/mut mice hearts 
Mitochondrial DNA (mtDNA) copy number was quantified by qRT-PCR through 
amplification of genes encoding for mitochondrial encoded protein (ND1) and 
nuclear-encoded protein (β-actin). The ratio of ND1: B-actin ratio in the left ventricular 
muscle of sedentary GH (n=10), sedentary SH (n=5), exercised GH (n=10) and 
exercised SH (n=5) mice determined mtDNA copy number (detailed chapter 2 
section 2.26).  
There was no significant difference between the mtDNA copy numbers of any of the 
groups (unpaired t-test) confirming that different housing conditions do not have an 






Figure 5.21. Mitochondrial DNA copy number in PolgAmut/mut mice hearts. A) There is no significant difference between the 
cardiac mtDNA copy number of sedentary GH and sedentary SH cohorts (p=1, unpaired t-test). B) There is no significant difference 
between the mtDNA copy number of sedentary and exercised SH cohort (p=0.06). C) There is no significant difference between the 




5.4 Discussion  
I have shown in previous chapters that PolgAmut/mut mice suffer from premature 
ageing phenotypes and that endurance exercise did not alleviate progeroid 
phenotypes and mitochondrial dysfunction in the setting of singly-housing. This is in 
stark contrast to the findings of Safdar et al (2011) who showed that endurance 
exercise was able to extend lifespan, improve mitochondrial function and completely 
reverse the premature ageing phenotype. To try and understand the different 
outcomes of the two studies, I looked in detail for any major differences in the way 
that the two studies had been conducted. The main difference between the studies 
that I discovered was the housing conditions. In my study, the mice were group-
housed, whereas Safdar et al (2011) housed single mice in individual cages. It is 
well-known that housing conditions can have a significant effect on both the welfare 
of the animals and experimental outcomes. Kamakura et al (2016) showed that 
solitary housed C57BL/6J mice had significantly lower levels of corticosterone levels 
in comparison to group-housed mice. They reported that this stress inducer hormone 
level increases due to territory-related aggression in group-housed mice. A study by 
Kalliokoski et al (2014) reported that BALB/c mice singly-housed for three weeks 
showed marked hypothermia due to their altered serotonin activity. They emphasised 
the importance of social housing in mice and that mice with deprived social contact 
develop depressive-like behaviours. Leraci et al (2016) have also demonstrated that 
nine weeks old individually housed C57BL/6J male mice showed higher locomotive 
activity and that anxiety and depressive characteristics were induced by social 
isolation and downregulation of neuroplasticity-related genes.  
Similar to the findings of my study and Laraci et al (2016), another work by Febigner 
et al (2014) also reported that C57BL/6J mice which were housed in individual cages 
have significantly higher locomotive activity than group-housed mice. They also 
showed that group-housed mice have shorter-bouts of rapid eye movement during 
sleep, meaning that their sleep is much more disturbed than singly-housed mice and 
are more alert possibly due to tension between mice within a cage. This may also 
have a direct effect on the level of activity of group-housed mice during the day when 
the open field test was performed.  
The mouse model I have studied has the PolgA mut/mut genotype on a C57BL/6J 




underling the differences between our study and that of Safdar et al. For this reason, 
I conducted a pilot study to examine the effects of single or group housing mice on 
the baseline PolgAmut/mut phenotype and on their physiological, behavioural and 
biochemical response to exercise. 
Data on previous research showed that the median lifespan of group-housed 
sedentary PolgAmut/mut mice was 336 days by Trifunovic et al (2004) and 416 days by 
Kujoth et al (2005). Safdar et al (2011) found that singly-housed PolgAmut/mut mice had 
a further reduction of lifespan to ~230 days. Considering they had a very small 
sample size and that out of 18 mice that they culled, only 4 were included in their 
lifespan curve with no clear reason for the selection process. They have combined 
the data obtained from male and female mice to draw conclusion in their study or at 
least they have not segregated/ specified their observations in male and female mice. 
Human studies reveal that females in general live longer than males due to lower 
cardiovascular risks from the action of endogenous estradiol levels and the 
differences in their chromosomal constitution and genome composition (Eskes and 
Haanen, 2007). However in mice there is large genetic contribution and broad 
distribution within strains that determine the total lifespan in males and females (The 
Jackson laboratory, 1964). One of the first studies by Asdell et al in 1967 showed 
that female mice lived longer, highlighting the effects of sex hormones upon 
longevity. Therefore, it’s fair to conclude that studies on mice should not combine 
observations from male and female. Combination of genetic (sex-differences) and 
environmental (singly-housing) factors may be a reason why Safdar et al (2011) have 
detected such shortening of lifespan in PolgAmut/mut mice. Steptoe et al (2013) have 
documented that social isolation in humans is associated with increased mortality 
rate. It’s also reported that social relationships are crucial in maintenance of health 
especially during older age and is linked to mental and physical health (Holt-Lunstad, 
Smith and Layton, 2010). Socially isolated individuals are also at a higher risk of 
developing CV disease (Barth et al, 2010), cognitive deterioration (Bassuk et al, 
1999) and infections (Cohen, 1997). 
Safdar et al (2011) have shown that endurance exercise completely reversed the 
shortening of lifespan in PolgA mut/mut mice to ~500 days, whereas my data showed 
that exercised mice had a median lifespan of 272 days, very similar to singly-housed 
sedentary mice. The significant difference between the findings of the two studies on 




mice which directly have an impact on the energy state of most organs as 
mitochondria are involved in the longevity pathway. Secondly it could be the fact that 
male and female mice may withstand the social isolation of singly-housing differently. 
My data also showed that the body weight of singly-housed PolgAmut/mut mice 
decreased significantly with age and in comparison to group-housed mice at the end 
of the study. Socially-isolated wild-type mice showed significant reduction in food 
consumption and lower body weight in comparison to socially housed mice. Whereas 
in a mouse model of obesity (BRS-3 deficient mice) single-housing caused a greater 
body weight gain and food consumption (Yamada et al, 2000). Similarly wild-type 
mice exhibited higher social responses in isolation than the mouse model of obesity. 
Schiavone et al (2016) have identified that psychosocial stress such as cage isolation 
in rats is a key regulator in bone homeostasis in male Wistar rats and that social 
housing significantly reduces the body weight of these mice. Another study by 
Katsunori and Yoshitomo (2007) have reported that solitary-housing in mouse model 
of diabetes (KK mouse) is associated with early mortality and morbidity as well as 
accelerated adiposity. It’s therefore crucial to bear in mind that housing conditions 
may affect different strain of mice in various ways. However a pre-disposed disease 
burden may exaggerate the environmental stress such as solitary housing.  
I’ve also shown that the percentage of cardiac apoptosis was significantly higher in 
the singly-housed PolgAmut/mut mice in comparison to group-housed mice. Dai et al 
(2010) and Kujoth et al (2005) have demonstrated cardiac apoptosis in PolgAmut/mut 
mice hearts, but no evidence for the impact of housing condition in cardiac apoptosis. 
Trifunovic et al (2004) have shown that 25 weeks old PolgAmut/mut mouse carry 
marked respiratory chain deficiency in their hearts as a direct consequence of 
impaired respiratory chain complex activity. Similarly, Hiona et al (2010) have 
demonstrated that PolgAmut/mut mice display significant reduction in OXPHOS 
complex expression including complexes I, III and IV. The assembly of complexes, 
activity and mRNA expression of all the complexes as well as the ATP content were 
downregulated in PolgAmut/mut mice skeletal muscle. In chapter 4, I have reported that 
sedentary and exercised group-housed PolgAmut/mut mice had similar levels of COX 
activity however Safdar et al (2011) have documented that the reduction in 
mitochondrial complex I and complex IV activity was rescued with exercise when 




mice to observe whether that is the case and found out that COX activity, Complex I 
and COX expression levels were significantly higher in group-housed PolgA mut/mut 
mice. It seemed as singly-housing skewed cardiomyocytes COX activity and 
expression negatively, meaning that single-housing exacerbates mitochondrial 
dysfunction. 
The second aim of this study was to understand the effects of 6 months of endurance 
treadmill running exercise on singly-housed PolgAmut/mut mice. My data showed that 
exercise had no major effect on the lifespan, body condition, behavioural and 
locomotive activity of singly-housed mice. The exercised cohort however showed 
significantly higher temperatures at 29 weeks of age in comparison to sedentary mice 
and at 29 weeks and 43 weeks of age in comparison to exercised group-housed 
mice which may indicate an attempt made by exercised mice to thermoregulate when 
they are housed in solitude. The body temperature of mice indicate their health and 
metabolic state (Gordon, 2017). It’s also known that body temperature has a positive 
correlation with body weight and a negative correlation with age in C57BL/6J mice 
(Talan, 1984). Swoap and Gutila (2009) have investigated the thermoregulatory 
capacity of mice in different biological and environmental conditions. They have 
shown that core body temperature of mice fluctuates during ad libitum feeding and 
changes into hypothermic state when food is removed from the cage. This 
hypothermic response to calorie restriction is blocked when mice are placed in a 
thermoneutral environment (Koizumi et al, 1992).  
The third aim of this study was to find out whether single-housing would influence 
exercised PolgAmut/mut mice. My data showed that SH exercised mice developed 
significant worsening of body condition at 29 weeks of age in comparison to GH 
exercised mice, however due to low number of SH animals at 43 weeks (n=3) the 
comparison was not the most reliable at 43 weeks. Further analysis of cardiac 
muscle revealed that the percentage of apoptotic cardiomyocytes were significantly 
higher in the sedentary and exercised SH cohort. 
Since both exercised and non-exercised singly-housed PolgAmut/mut mice had 
significantly higher rate of cardiac apoptosis in comparison to group-housed mice 
and with no significance between the two cohorts, it’s sensible to conclude that 
housing conditions have significant impact on the rate of programmed cell death 




as suggested by Vanempel et al (2005). Sabbah (2000) reported elevated levels of 
active CC-3 expression in response to pressure overload in heart failure rodent 
models and myocardial infarction (Agosto et al, 2011). CC-3 overexpression is also 
observed in patients with right ventricular dysplasia which result in cell loss and 
sudden death (Mallat at al, 1996). Mitochondrial function as a measure of COX 
activity was not significantly different between the two cohorts, however further 
classification of cardiomyocytes by NBTx revealed that cardiomyocytes of sedentary 
SH mice appeared to be in COX negative region in comparison to sedentary GH 
mice. 
Although there is no clear answer to whether PolgAmut/mut mice are better off in groups 
or solitary cages and whether exercise has an impact on the progression or 
regression of PolgAmut/mut phenotypes, this study has confirmed that singly-housed 
mice experienced an overall accelerated decline in their body condition and cardiac 
mitochondrial function. 
 
5.5 . Limitations and future work  
In order to make the study statistically more reliable, the next step would be to 
increase the sample size for the singly-housed mice now that significant changes are 
seen with altering housing condition. The future work would be to assess each 
mouse independently for their exercise tolerance level and tailor the exercise 
programme to their individual needs based on their maximal aerobic capacity. Due to 
high variation in biological data, there may be significant and inevitable differences in 
the control group as well. Although previous research has shown that PolgAmut/mut 
mice develop premature ageing phenotypes from around the age of 16 weeks 
onwards, it’s crucial to measure cardiac mitochondrial function in younger cohort of 
mice before they show signs of accelerated ageing to set the baseline values for 










Chapter 6.  The effects of ageing and endurance exercise on 




6.1.1  Age-related cardiovascular changes 
Physiological cardiovascular ageing leads to structural and functional (macroscopic 
and microscopic) changes in the heart and the vasculature. Age-related 
cardiovascular structural changes include increased arterial stiffness, left ventricular 
wall thickness and fibrosis (Scholz et al, 1988; Strait and Lakatta, 2012). These 
changes may lead to diastolic dysfunction and increased afterload (Lakatta and Levy, 
2003). Increased left ventricular stiffness is a result of increased cardiomyocyte size 
and shape (elliptical to spheroid) accompanied by interventricular septum wall 
thickening (Hees et al, 2002). These age-related structural changes have crucial 
implications for cardiac contractile efficiency during increased cardiac workload and 
in development of cardiovascular disease (Strait and Lakatta, 2012).  
Functional age-related changes in the cardiovascular system include a decline in end 
diastolic and end systolic volumes, reduced cardiac contractility, prolonged 
contraction and relaxation which is accompanied by reduced sympathetic signalling 
(Lakatta et al, 2009). At rest, the slower heart rate and decreased inotropic 
competency in the elderly is compensated by an increase in stroke volume to 
maintain cardiac output (Weisfeldt, 1998). The heart’s repair mechanisms also 
become diminished with age leading to pronounced adverse remodelling and 
increased dysfunction (Paneni et al, 2017). Increased collagenous tissues in the 
heart and fat accumulation around the sinoatrial node (SAN) lead to a reduction in 
the number of pacemaker cells with age (Burgess, Mc Crea and Hedrick, 2001). 
Increased calcification on the fibrous cardiac skeleton also reduces the 
atrioventricular node (AVN) signalling and increases the risk of conduction blocking 





6.1.2  Age-related cardiac mitochondrial changes 
Mitochondria are proposed to play an important role in ageing due to an observed 
age-related decline in oxidative phosphorylation (Gomez and Hagen, 2012). Schriner 
et al (2005) investigated the effects of reactive oxygen species (ROS) on longevity 
and cardiac pathology. They showed that mice overexpressing mitochondrial 
targeted catalase (MCAT) had extended lifespan and delayed ROS damage onset in 
the cardiac muscle compared with controls. Mitochondrial DNA (mtDNA) deletion 
levels associated with ROS damage in the cardiac muscle were also found to be 
significantly higher in the ageing cohort and significantly lower in the aged-matched 
MCAT treated group. Similarly, Dai and Rabinovitch (2009) investigated the role of 
mitochondrial oxidative stress in cardiac ageing and determined that protein 
carbonylation which is an indicator of mitochondrial oxidative damage, increased with 
advancing age and decreased with MCAT overexpression in the mouse model. They 
also observed a significant increase in cardiac muscle mtDNA copy number with age 
due to upregulation of PGC-1α and its downstream transcription factors to increase 
biogenesis as a result of mitochondrial oxidative damage with age (Dai and 
Rabinovitch, 2009).  
Further supporting evidence for the role of mitochondria in cardiac ageing stems from 
the study carried out on the PolgAmut/mut mice model of accelerated ageing (detailed 
in chapters 3-5) (Trifunovic et al, 2004; Kujoth et al, 2005). These mice have a 
significantly increased mtDNA point mutation and deletion with age compared with 
age-matched controls, as well as increased cardiac apoptosis, increased left 
ventricular mass index (LVMI) and decreased systolic and diastolic function, most of 
which were attenuated by MCAT overexpression (Schriner et al, 2005).  
Another study implicating the role of mitochondria in cardiac ageing comes from an 
investigation of mice with mutation of cardiac p66shc gene (Migliaccio et al, 1999). 
The p66 shc is an enzyme located in the mitochondrial intermembrane space that 
utilises electrons from the electron transport chain (ETC) to produce H2O2. Mice 
lacking a functional copy of p66shc protein have extended lifespan and attenuated 
ROS-mediated apoptosis. The molecular mechanism underlying the dysfunctional 
p66 shc protein is it’s phosphorylation by PKC-beta and accumulation inside 
mitochondria to activate excessive Ca2+ signalling and apoptosis induction (Pinton et 




protein inhibits left ventricular (LV) hypertrophy through renin-angiotensin induction 
and reduces ROS-mediated damage in cardiac progenitor cells in a diabetic mouse 
model. 
 
6.1.3  Age-related cardiovascular changes with exercise  
Exercise exerts an inducible form of physiological stress on the body which requires 
an organised response from the nervous system and cardiovascular system to 
increase oxygenated blood flow to the working muscle by up to 80% of the total blood 
flow (Roh et al, 2016). Disruption in any of these integrated systems leads to 
diminished exercise capacity and a significant decline in peak cardiac output (Milano 
et al, 2013). The functional capacity of the heart to augment HR during exercise 
progressively declines with advancing age (Kitzman et al, 1991). This is mainly due 
to inadequate oxygen delivery to impaired cardiac reserve and poor oxygen 
extraction efficiency of working muscle in the elderly. The relative increase in stroke 
volume (SV) in response to exercise also diminishes with age mainly due to a 
reduction in maximal heart rate (HRmax) (Gulati et al, 2010).  
The maximal oxygen consumption (VO2 max) or the aerobic capacity is affected by 
age, gender, genetics, weight, temperature and altitude of living environment (Betik 
and Hepple, 2008), with advancing age being the greatest driving force (Pollock et al, 
2015). VO2 max is a gold standard measure of cardiorespiratory fitness and is 
documented to reduce by 10% per decade after the age of 25 years (Robinson, 
1938; Astrand, 1960) which further increases to 15% decline per decade between 50 
and 70 year old individuals (Fitzgerald et al, 1997). The rate of VO2 max decline 
accelerates further after the age of 70 in heart failure patients (Fleg and Strait, 2011). 
It’s documented that regular endurance exercise training enhances the body’s 
aerobic capacity (Bundy and Levaer, 2010). The intensity of exercise is also an 
important factor contributing to increased VO2 max (Talbot, Metter and Fleg, 2000). A 
stress test is a conventional method for assessment of cardiorespiratory fitness. Data 
are used to improve risk stratification and to plan an exercise training (Lemond and 
Hom 2015). It is documented that greatest improvements in aerobic capacity are 
gained when intensity of exercise reaches 90% to 100% of VO2 max (Wender and 




Since rodents share comparable exercise physiology with humans, most short-term 
exercise studies are carried out in mice and rats. Healthy 24 month old C57BL/6 
mice show a 28% decline in VO2 max in comparison to their 12 month old 
counterparts (Schefer and Talan, 1996). Exercise-induced reduction in end-diastolic 
volume (preload) and exercise-induced increase in ejection fraction is less 
pronounced in aged rodents (Lakatta, 1990). 
Epidemiological studies revealed that endurance exercise training reduces the risk of 
chronic diseases, extends lifespan and reduces the chances of developing physical 
disability in later life (Buchner D.M, 2009). Boveris and Navarro (2008) documented 
that moderate endurance exercise in rodents confers cellular and phenotypic 
protection from age-associated diseases and provides systemic metabolic benefits. A 
human pilot study on 538 runners revealed that over a course of 21 years the all-
cause mortality and disability scores were significantly lower in the more active group 
(Booth and Laye, 2010).  
Long term adaptations of the cardiovascular system to exercise in the elderly include 
physical conditioning and improved peak oxygen consumption in part through 
increased maximum cardiac output by augmented stroke volume (SV) and in part by 
increased oxygen utilisation capacity of the body (Nystoriak and Bhatnagar, 2018). 
The augmented SV is due to a reduction in end systolic volume and increased 
ejection fraction with no changes in end diastolic volume. Cardiac performance is 
also diminished with age, and pathological cardiac hypertrophy was suggested to be 
linked to a reduction in mitochondrial Ca2+ ATPase2a (SERCA2a) expression and 
excessive ROS generation. Exercise in the elderly reverses the ROS damage to 
mitochondria as seen with physiological aging (Roh et al, 2016). 
 
6.1.4  Impact of exercise on cardiac mitochondrial function 
Since excessive mitochondrial ROS generation is documented to reduce cardiac 
performance with age (Kornfeld et al, 2015), studies were carried out to evaluate the 
role of exercise in augmenting antioxidant levels such as catalase, superoxide 
dismutase and glutathione peroxidase as ROS scavenging enzymes to provide 
cardioprotective benefits of exercise (Somani, Frank and Rybak, 1995 and Linke et 




mitochondrial biogenesis, was found in the cardiac and skeletal muscle in response 
to endurance exercise (Little et al, 2010). On the other hand, aging is documented to 
be linked to reduced muscle specific PGC-1-α expression coincident with reduced 
mitochondrial function (Ling et al, 2004 and Dillon et al, 2012). A study conducted by 
Moraes team in 2012 showed that increased expression of PGC-1-α in the muscle of 
PolgA mut/mut mice increases mitochondrial biogenesis and improves mitochondrial 
function including mtDNA content and complex IV activity, as well as cardiac 
phenotypes such as improved ejection fraction, without reducing mtDNA mutation 
accumulation. It’s believed that the cardio-protective effects of PGC-1-α are likely to 
be due to its ROS-lowering effects since St-Pierre et al (2006) have suggested that 
PGC-1-α induces ROS-detoxifying enzyme activation such as GP-x1 and SOD2 in 
mouse models of neurodegeneration.  
Yoo et al (2019) investigated the effects of acute exercise on mitochondrial function 
of Fischer rats and concluded that mitochondrial ETC and Ca2+ retention capacity of 
all tissues increased significantly. No changes in H2O2 production of different fibre 
types of skeletal muscle or rate of mitophagy were seen. It’s also been confirmed that 
decreased Ca2+ retention capacity leads to opening of the mitochondrial permeability 
transition pore (mPTP) and further release of pro-apoptotic molecules which initiate 
cell death (Anderson et al, 1981). 
Another study by Menshikova and her team (2006) was performed and showed that 
12 weeks of exercise increased cardiolipins and mitochondrial DNA copy number in 
aged individuals. They also demonstrated that mitochondrial oxidative capacity was 
increased as a measure of ETC complexes II-IV. Conversely, a study carried out by 
Gun-Soo and Seon-Rye (2013) showed adverse effects of 8 weeks of endurance 
exercise training that decreased mitochondrial coupling of phosphorylation and 
respiration due to mitochondrial damage is due to a shift in lipid metabolism. 
Due to the conflicting outcomes of previous studies on the effects of endurance 
exercise on mitochondrial and cardiovascular health in older age, I decided to 
investigate the role of late-life endurance exercise training on cardiac and 





6.1.5  Mouse model  
Since mice age a lot faster than humans, 14-15 month old C57BL/6J (wild-type) mice 
are considered as middle-aged corresponding to 38-47 years old humans. By the 
end of the study mice were 22 month old which corresponded to older individuals of 
61-65 years old (Jackson laboratory, 2007). The C57BL/6J mouse model is one of 
the most common studied in the ageing field due to its well-characterised health-span 
and lifespan as well as having defined normal phenotypes with age (Brewer and 
Treuting, 2011). C57BL/6J mice have an extensively researched database of 
physiological changes with age that correlate closely with that in humans and a well 
characterised system of assessing end points (Burkholder et al, 2012).  
 
6.2 Aims of study 
The two aims of the present study were to understand the effects of age and 
endurance exercise on clinical phenotype, locomotor activity, grip strength and 
haemodynamic measures including maximal oxygen consumption, heart rate, blood 
pressure and cardiac function in wild type (C57BL/6J) male mice. For this reason, I 
aim to characterise the following: 
• Investigate the effects of advancing age on the stated parameters of n=10 
C57BL/6J mice in order to set the baseline characteristics of aged mice prior 
to the exercise intervention. 
• Investigate the impact of six month of endurance treadmill running exercise on 
the stated parameters and to investigate post-mortem cardiac pathology and 




6.3 Results  
6.3.1 Clinical scoring and body weight assessment with age 
14 month old sedentary C57BL/6J mice (Charles River Laboratory) were group-
housed in cages of between two to four and randomly assigned to either the 
sedentary (n=10) or exercised (n=10) groups. Clinical scoring as a determinant of 
lifespan and health span was recorded from the age of 14 months to 22 months 
according to the method detailed in chapter 2 section 2.10. The higher clinical scores 
indicate the worsening of body condition in mice (figure 6.1A). Body weight is also 
recorded as an independent measure of health state in mice at 14, 18 and 22 months 
of age as shown in figure 6.1B. The body condition of mice significantly worsened 
with advancing age from 20 months onwards and the body weight of mice increased 
significantly from 14 months onwards (One way ANOVA repeated measures). 
Monitoring videos are attached to the appendix for observation of phenotypic and 
behavioural changes in mice. 
 
Figure 6.1. Body condition scoring and body weight with age. A) Clinical scoring 
from 14 months to 22 months (****p=0.0001) (One-way ANOVA repeated measures). 
B) Body weight at 14m, 18m and 22 months (***p<0.001) (One-way repeated 
measures ANOVA). Error bars represent mean ±SD. 
 
6.3.2 Clinical scoring and body weight assessment with exercise 
The body condition of sedentary and exercised C57BL6/J mice was compared at 





intervention from fight wounds. The other 10 remaining mice lived up to the end of 
the study (22 months).  
Clinical scoring is a strong indicator of end point and was carried out in sedentary 
(n=10) and exercised (n=10) mice from the age of 14 months (pre-intervention) to 22 
months (post-intervention) (figure 6.2A). There was no significant difference in the 
body condition scoring of sedentary and exercised mice up to 20 months of age. At 
21 months and 22 months of age sedentary mice showed significant deterioration in 
body condition in comparison to exercised mice (p<0.05, Two way ANOVA repeated 
measures). 
Body weight of sedentary and exercised mice was recorded as part of the clinical 
scoring data at 14, 18 and 22 months of age (figure 6.2B). Sedentary mice showed 
significantly higher body weight at 22 months of age (p<0.05) and also with 
advancing age from 14 months onwards, whereas exercised mice maintained a 







Figure 6.2. Body condition scoring and body weight in sedentary and exercised 
mice. A) Clinical scoring of sedentary mice was significantly higher in comparison to 
exercised mice at 21 months (***p<0.0003) and 22 months of age (*p<0.05). B) Body 
weights at 22 months (*p<0.05) (Two-way ANOVA repeated measures). Error bars 
represent mean ±SD. 
 
6.3.3 Open field testing (OFT) with age 
Open field testing (OFT) was carried out over a 5 minute period according to the 
technique explained in chapter 2 section 2.16.1, in order to investigate behavioural 
and locomotive activity of C57BL6/J mice with age from 14 months to 22 months as 




Total distance travelled, average velocity and rearing frequencies were not 
significantly different with advancing age in mice (figures 6.3A, 6.3B and 6.3C). Total 
number of touches were significantly reduced from 14 months to 18 months (p<0.05) 
and from 14 months to 22 months of age (p<0.001) (figure 6.3D) which indicates a 
general decline in locomotive activity with advancing age. Step length was 
significantly decreased from 14 months to 18 months (p<0.001) and from 14 months 
to 22 months of age (p<0001) which indicate deterioration of coordination and 






Figure 6.3.Open field testing in aged sedentary mice. A) Distance moved. B) 
Average velocity. C) Rearing frequency. D) Total number of touches reduced with 
age (***p<0.001). E) Step length reduced with age (***p<0.001) (One-way ANOVA 





6.3.4 Open field testing (OFT) with exercise  
Similarly the locomotive activity and behavioural changes in C57BL6/J exercised 
(n=10) mice was assessed by OFT and compared to the sedentary cohort (n=10). 
Figures 6.4 (A-E) demonstrate quantitative measures obtained from both cohorts of 
mice pre-intervention (14 months), mid-intervention (18 months) and post-
intervention (22 months). A two-way ANOVA repeated measures was carried out 
between groups.  
Total distance moved (figure 6.4A) represent the overall locomotive state of mice 
which was not significantly different between groups pre- and post-intervention. Other 
parameters including average velocity and rearing frequency did not change 
significantly between the two cohorts at different time points. Longer step length is 
either an indication of having to compensate for the alteration in gait and balance or 
the unfamiliarity of the mouse with the open field device which decreased 
significantly with advancing age in both groups, however there was no difference 
between groups pre- and post-intervention. Since both mice have been acclimatised 
to the OFT device to the same extent, it seems as if the decline in step length in both 
groups was an indication of reduced balance and coordination of mice. Total number 
of touches were also reduced significantly with increasing age in both groups but not 
significantly between groups at any time point (figure 6.4E). Reduced step length and 
reduced number of touches may simply be a sign of increasing frailty and poor 
coordination in mice. Step length is a product of total distance moved over total 






Figure 6.4. Open field testing in sedentary and exercised mice at 14, 18 and 22 
months of age. A) Total distance moved at any time point (p>0.05). B) Average 
velocity at any time point (p>0.05). C) Rearing frequency at any time point (p>0.05). 
D) Step length was reduced in both groups with advancing age in both cohorts 
(****p<0.0001). E) Total number of touches was decreased in both groups with 
advancing age (*p<0.05). (Two-way ANOVA repeated measures). Error bars 





6.3.5 Rotarod performance test with age 
The rotarod performance test was carried out in C57BL6/J mice with advancing age 
to assess grip strength, balance and motor coordination according to the technique 
explained in chapter 2 section 2.16.2. Figure 6.5A shows the time mice take to fall off 
the rod during three trials at three time points (14 months, 18 months and 22 months 
of age) known as the latency to fall. The longer the mice stay on the rotarod, the 
more grip strength and coordination they have to hang on the rod at higher speeds.  
Figure 6.5B represent the average of all three trials at 14 month, 18 month and 22 
month of age. Trials number 1 and 2 did not change significantly with advancing age, 
however, the time to fall off the rotating rod on trial number 3 was significantly 
reduced in mice by the end of 18m and 22m (p<0.001). Since trial 1 acts more as an 
acclimatisation and learning stage, most mice behave similar with changes occur in 






Figure 6.5. Rotarod performance in aged mice. The time to fall off the rotating rod 
at 14, 18, and 22 months of age. A) At T#1 and T#2 there was no significant 
difference between the latency to fall in sedentary and exercised mice at any time 
point (p>0.05). At T#3, 14 months vs 18 months (***p<0.001) and 14 months vs 22 
months (***p<0.001). (One-way ANOVA repeated measures). B) Latency to fall at 
three time points. Trials 1-3 are averaged within each time point. Mice take longer to 





6.3.6  Rotarod performance test with exercise  
Similar to above, grip strength, coordination and balance was measured as the 
latency to fall off the accelerating rod using rotarod device in C57BL6/J sedentary 
(n=10) and exercised (n=10) groups at 14 months (pre-intervention), 18 months and 
22 months of age according to the technique explained in chapter 2 section 2.16.2 
(figure 6.6A). Two way ANOVA repeated measures was used to measure significant 
changes between groups pre-, mid- and post-intervention over three trials. 
Sedentary mice at 22 months of age do not seem to be able to remain stable on the 
rod and learn through trial 1 and possibly trial 2, hence very short time to fall off the 
rotating rod. On trial number three, 14 months old sedentary and exercised mice did 
not seem to have significantly different latency to fall however at 22 months of age, 
exercised mice took 324 seconds longer to fall off the rotating rod (p<0.001) in 
comparison to the sedentary cohort who took 26 seconds to fall. This test clearly 
demonstrates that sedentary mice have significantly weaker muscle strength and 
poorer coordination and balance and/or slower learning ability by 22 months of age 
as they fall off the rotating rod quicker than exercised mice.  
Figure 6.6B represent the average of three trials at each time point in order to 
observe the combined effects of all trials. At 14 months of age, the combined effects 
of three trials on exercised mice have a profound effect which makes exercised mice 
stay on the rotating rod significantly longer than sedentary mice (p<0.05, two-way 
ANOVA repeated measures). Although trials 1 and 2 are not significantly higher in 
exercised mice at 14 months of age, but the average of all three trials are 







Figure 6.6. Latency to fall between sedentary and exercised mice at 14, 18 and 
22 month of age. A) #T1, 14 months (p>0.05), 18 months (*p<0.05), 22 months 
(p>0.5). #T2, 14 months (p>0.05), 18 months (***p=0.0011), 22 months (**p=0.01). 
#T3, 14m (p=0.8), 18m (***p=0.0011), 22m (**p=0.0023) (Two-way ANOVA repeated 
measures). B) The average of three trials at 14, 18 and 22 months of age. Exercised 
mice took longer to fall off the rotating tod at 14 months (*p<0.05), 18 months 





6.3.7  Haemodynamics and cardiovascular changes 
6.3.8  Cardiac function test through cardiac Magnetic Resonance Imaging 
(cMRI) with age 
Cardiac Magnetic Resonance Imaging (cMRI) (7-Tesla horizontal bore from Varian 
Inc, Palo Alto, CA, USA) was carried out in C57BL6/J sedentary mice (n=10) at 14 
months and 22 months of age based on the technique described in chapter 2 section 
2.10. ECG-gated cine-MRI scans were analysed in Segment v2.0 
(http://segment.heiberg.se) to measure Left ventricular mass (LVM), and the LV 
functional parameters including the end diastolic volume (LVEDV), end systolic 
volume (LVESV) as well as stroke volume (SV), ejection fraction (EF) and cardiac 
output index (CO).  
An example to illustrate analysis in Segment is included in chapter 2 section 2.12.1, 
figure 2.2. All parameters obtained are presented in figure 6.7. Due to variation in 
body weight between mice, LVM, volume measurements and CO were normalised to 
body weight (figure 6.8). CO was significantly increased with advancing age (p<0.05, 
paired t-test). LVESV was significantly decreased with advancing age (p<0.05, paired 
t-test). LVMI, LVEDVI and LVESVI were all unchanged with advancing age (paired t-






Figure 6.7. Haemodynamic measurements from cardiac MRI. Original MRI 
parameters (paired t-test). A) CO increased significantly with age (*p<0.05). B, C, 
D, E) no significant differences were seen in LVM, LVSV, LVEDV and LVEF. F) 
LVESV decreased significantly with increasing age (*p<0.05). Error bars represent 







Figure 6.8. MRI parameters indexed to body weight (paired t-test). A) Cardiac 
output index (COI) (p=0.23), B) Left ventricular mass index (LVMI) was significantly 
higher in younger mice (*p=0.03). C) Left ventricular stroke volume index (LVSVI) 
(p=0.54). D) Left ventricular end systolic volume index (LVESVI) (*p<0.05). E) Left 







6.3.9  Cardiac function test through cMRI with exercise  
Cardiac MRI was carried out pre- (14 months of age) and post-intervention (22 
months of age) in C57BL6/J sedentary and exercised mice. Similarly cardiac function 
analysis was carried out in Segment as explained in chapter 2 section 2.12.1. 
Figures 6.9 A-F represent original cardiac MRI data and figures 6.10 A-E represent 
cardiac MRI measures normalised to body weight. There was no significant 
difference between cardiac output index (COI) and left ventricular stroke volume 






Figure 6.9. Haemodynamic cardiac function measurements in sedentary and 
exercised mice. LVM and LVEDV did not change in any of the cohorts with age. 
There was no significant difference in any cardiac function parameters between 
groups pre- and post-intervention with exercise (Two-way ANVOA repeated 






Figure 6.10. Normalised haemodynamic cardiac function measurements in 
sedentary and exercised mice. A) Cardiac output index (COI). B) LVMI and C) left 
ventricular systolic volume index (LVSVI) were not significantly different pre- and 
post-intervention. D, E) Left ventricular end systolic volume and end diastolic volume 
index reduced in exercised mice with age (***p<0.001 and **p<0.01 respectively, 




6.3.10 Blood pressure with age 
Arterial blood monitoring is key to the evaluation of phenotypical changes associated 
with cardiovascular pathology and lifestyle interventions. A non-invasive blood 
pressure monitor (NIBP) (Columbus instruments, Ohio, USA) in C57BL6/J mice was 
used to measure blood pressure from the arterial tail and data were recorded in NIBP 
software (Columbus) at 14 months and 22 months of age according to the technique 
shown in chapter 2 section 2.15. As well as mean arterial blood pressure (MABP), 
systolic blood pressure (SBP) and diastolic blood pressure (DBP) were also recorded 
(figures 6.11A-C). Blood pressure did not change with increasing age in sedentary 
mice (paired t-test). 
 
 
Figure 6.11. Blood pressure changes with advancing age. A) Systolic blood 
pressure (SBP) (p=0.077). B) Diastolic blood pressure (DBP) (p=0.05) and C) Mean 
arterial blood pressure (MABP) (p=0.07) (Paired t-test) did not significantly change 





6.3.11 Blood pressure with exercise 
Next I evaluated the effect of exercise on MABP, SBP and DBP using an NIBP 
system in C57BL6/J sedentary (n=10) and exercised (n=10) mice at 14 month (pre-
intervention) and 22 month (post-intervention) of age. BP measurements were 
averaged and plotted in figure 6.12 (A-C). There was no significant differences 




Figure 6.12. Blood pressure changes with exercise. A) Systolic blood pressure 
(SBP) (p>0.05) B) Diastolic blood pressure (DBP) (p>0.05) and C) Mean arterial 
blood pressure (MABP) were not significantly different between the two groups at any 






6.3.12 Heart rate changes with age 
Resting heart rate (HR) was measured during blood pressure measurements using 
an NIBP monitor. All C57BL6/J mice were placed in a restrainer of suitable size at 
the same time and same room temperature. Heart rate was calculated from 
measuring the BP at the peripheral site (tail artery) from each mouse at 14 months 
and 22 months of age in triplicates according to the technique detailed in chapter 2 
section 2.15 and the mean data are presented in figure 6.13. HR was significantly 
reduced in mice with increasing age (p=0.004, paired t-test). 
 
Figure 6.13. Resting heart rate at 14 and 22 months of age. Heart rate has 
significantly decreased in mice with increasing age (**p=0.004) (Paired t-test). Error 
bar represent mean ±SD.  
 
6.3.13 Heart rate changes with exercise 
Resting HR was also measured in C57BL6/J mice pre-intervention at 14 months and 
post-intervention at 22 months of age through non-invasive blood pressure monitor 
according to the method explained in chapter 2 section 2.15. Figure 6.14 
demonstrate the changes in HR as a result of exercise training in aged mice. 
Exercise had no effect on the resting HR in 22 month mice in comparison with 






Figure 6.14. Resting heart rate in sedentary and exercised mice at 14 months 
and 22 months of age. HR was significant reduced in sedentary mice with 
advancing age (*p<0.05), however no differences were seen between groups at any 
time point. (Two-way ANOVA repeated measures). Error bars represent mean ±SD. 
 
6.3.14 Aerobic capacity with age 
Aerobic capacity is measured using the Oxymax system metabolic treadmill 
(Columbus instruments, USA). VO2 peak (peak oxygen consumption) and respiratory 
exchange ratio (RER) during submaximal exercise were measured at three time 
points; 14, 18 and 22 month of age (details in chapter 2 section 2.13). VO2 peak is the 
highest rate of oxygen consumption during incremental exercise and RER is a 
product of VCO2 peak (peak CO2 production during incremental exercise) over VO2 peak 
which is a determinant of anaerobic threshold. The VO2 peak of C57BL6/J mice (n=10) 
declined significantly with advancing age (p<0.0001) (figure 6.15A). No significant 
difference in the rate of RER was seen with age (figure 6.15B) (One-way ANOVA 





Figure 6.15.VO2 peak and RER in response to exercise. A) VO2 peak decreased 
significantly with advancing age in sedentary mice (****p<0.0001). B) RER at 14, 18 
and 22 months (p>0.05). (One-way ANOVA repeated measures). Error bars 
represent ±SD.  
 
6.3.15 Aerobic capacity with exercise 
To see whether six month of endurance exercise affected cardiorespiratory fitness, 
VO2 peak and RER were measured in C57BL6/J sedentary (n=10) and exercised 
(n=10) mice at three time points (14, 18 and 22 months) throughout the intervention 
(figure 6.16). The rate of VO2 peak decline in both groups were measured (figure 6.17). 
Since VO2 peak decreases with advancing age in both groups, the difference in rate of 




sedentary mice was 26.45% and the rate of VO2 peak decline in exercised mice was 
23.84%. There was a trend towards a 2.6% increase in the rate of decline in the 




Figure 6.16. VO2 peak and RER in sedentary and exercised mice at 14m, 18m and 
22m of age. A) VO2 peak was not significantly different between the two groups at 14, 
18 and 22 months of age (p>0.05). B) RER was not significantly different between 
the groups at different time points (p>0.05) (Two-way ANOVA repeated measures). 






Figure 6.17. Rate of VO2 peak decline in sedentary and exercised mice at three 
time points (14, 18 and 22 months). There was no significant difference between 
the rates of decline between the two groups. 
 
6.3.16 Organ weight changes with exercise 
Sedentary (n=10) and exercised (n=10) C57BL6/J mice were culled humaenly at 22 
months of age post cMRI by terminal anaesthesia and organs were harvested 
(details in chapter 2 section 2.17) and harvesting sheet (appendix 2) for further 
biochemical and molecular analysis. Organ weights and normalised organ weights to 
body weight were measured following dissection and organ harvest as shown in 
figures 6.18A and 6.18B respectively. Right kidney weight was significantly higher in 
the exercised cohort (p<0.01) regardless of the body weight. The ratio of right kidney 
(p<0.001), left kidney (p<0.01), heart (p<0.05) and the brain (p<0.05) to body weight 
was also significantly higher in the exercised cohort. Although the underlying 
mechanism for organ hypertrophy is not determined in this chapter, however this may 





Figure 6.18.Organ weights in sedentary and exercised mice. A) Organ weight in 
sedentary and exercised mice. Right kidney weight is significantly higher in exercised 
mice (**p<0.01) in comparison to sedentary mice. B) Organ to body weight ratio is 
significantly higher in the right kidney (***p<0.001), left kidney (**p=0.0043), heart 
(*p=0.02) and the brain (*p=0.037) of the exercised mice in comparison to sedentary 





6.3.17 Cellular and molecular analysis in the heart following exercise 
Mouse hearts were harvested and dissected longitudinally according to table 1 in 
appendix 2. The left side of the heart (left ventricle and left atria) was snap-frozen in 
isopentane cooled in liquid nitrogen and the right side of the heart (right ventricle and 
right atria) were formalin-fixed and embedded in paraffin. 
The LV is under stress in response to exercise especially with advancing age and the 
RV is associated with numerous cardiovascular diseases and its role in vascular and 
RV remodelling is well-known. COX/SDH histochemistry, NBTx analysis and 
mitochondrial DNA copy number were performed on the LV muscle (frozen). 
Haematoxylin and Eosin staining, Masson trichrome staining, cleaved caspase 3 
immunohistochemistry and mitochondrial complex I and complex IV 
immunofluorescence were performed on the RV cardiac muscle (fixed). 
 
6.3.18 Cardiac fibrosis and cardiomyocyte width changes following exercise 
Haematoxylin and Eosin (H&E) staining was carried out to determine right ventricular 
(RV) cardiomyocyte width according to the technique explained in chapter 2 section 
2.20.1. The nuclei were stained dark blue/purple by haematoxylin incubation and 
were subsequently stained in eosin to visualise cellular components such as 
cytoplasm and myocardium in pink. Images were acquired by Zeiss light microscope 
and analysed using Zen analysis software (see chapter 2 section 2.19.2). Five 
random snapshots of x20 magnification were selected from C57BL6/J sedentary 
(n=10) and exercised (n=10) mice and the width of 50 random transverse 
cardiomyocytes were measured from each image (figure 6.19). Cardiomyocyte width 
was significantly higher in the RV cardiac muscle of exercised mice (in average 
25.22μm) in comparison to sedentary mice (in average 16.37μm) (p<0.0001, 
unpaired t-test) (figure 6.19B). 
Cardiac fibrosis was assessed in C57BL6/J sedentary (n=10) ad exercised (n=10) 
mice by Masson trichrome staining in which a three coloured dye was used to stain 
cell nuclei in purple, cytoplasm and cardiomyocytes in red and collagenous 
connective tissue in blue (Figure 6.19A bottom row images) according to the 




were acquired by Nikon Tie microscope and analysed using NIS elements software. 
RGB general analysis algorithm was used to create and set threshold for each RGB 
channel in order to find out the percentage of cardiomyocytes with blue collagenous 
fibrotic areas. The ratio of total tissue area to blue staining determined the 
percentage of cardiac fibrosis (figure 6.19C). Sedentary mice have a significantly 
higher percentage of cardiac fibrosis in comparison to exercised cohort (p=0.008, 
unpaired t-test) which may indicate abnormal thickening of the heart muscle with age 
due to excessive deposition of extracellular matrix in the cardiac tissue. Exercise 









Figure 6.19. Percentage of cardiac fibrosis and cardiomyocyte width in 
sedentary and exercised mice. A) Top row images represent H&E staining 
(Magnification x20. Scale bars=100μm) and bottom row images show trichrome 
staining from sedentary and exercised cohort (Magnification x10. Scale 
bars=200μm).Cardiomyocyte width was significantly bigger in exercised mice 
(****p<0.0001). C) Percentage of cardiac fibrosis was significantly higher in the 
sedentary cohort (**p=0.008, unpaired t-test). Error bars represent mean ±SD. 
 
6.3.19 Cardiac Apoptosis following exercise  
Activated-cleaved caspase 3 immunohistochemistry was carried out in C57BL6/J 
sedentary (n=10) and exercised (n=10) mice hearts to quantify levels of apoptosis 




were taken by Aperio-scanner and analysed through Image-scope analysis software, 
nuclear staining algorithm. The total number of apoptotic nuclei as dark brown 
regions were calculated as the ratio of total number of nuclei (figure 6.20). Sedentary 
mice had significantly higher frequency of apoptotic cells compared with mice in the 
exercised cohort (p=0.04, unpaired t-test). 
 
 
Figure 6.20. Percentage of cardiac apoptosis in sedentary and exercised mice. 
The frequency of apoptotic nuclei is significantly higher in the sedentary mice in 
comparison to exercised mice (*p=0.04). Error bars represent mean ±SD. 
 
6.3.20 Cardiac mitochondrial complex I and complex IV expression levels 
following exercise 
Mitochondrial complex IV (MTCOI) and complex I (NDUFB8) expression levels were 
measured in the RV cardiac muscle of C57BL6/J sedentary (n=10) and exercised 
(n=10) mice using the OXPHOS immunofluorescence assay detailed in chapter 2 
section 2.24.2. Images were obtained by LSM800 microscope and analysed using 
the in-housed immunoanalyzer software. Laminin was used to mark the 
cardiomyocyte boundaries and Porin to normalise complex I and complex IV protein 
levels to. Five random snapshots of x10 magnification were obtained from each 
mouse and the transverse cardiomyocytes were selected for analysis through the 
semi-automated software (figure 6.21). Cardiomyocytes were categorised based on 




3SD), intermediate positive (-4.5<z<-3 SD), intermediate negative (-6<z<-4.5 SD) 
and negative (z<-6 SD) expression levels. Mitochondrial respiratory chain plots 
(MRC) were generated and an example from each group was shown in figure 6.22 
two figures on the left. Each dot represent an individual muscle fibre and is colour 
coded according to the Porin levels. Dotted black lines represent the SD limit for the 
classification of fibres. Percentage of cardiomyocytes with MTCOI (CIV) positive and 
intermediate positive expression levels were significantly higher in the exercised 
cohort (p<0.01) in comparison to sedentary cohort. There was no significant 
difference in any of the CI categories between the two groups (unpaired t-test). 
Mitochondrial mass marker (porin) z-scores were used to categorise mitochondrial 
mass levels. Figure 6.22C shows that porin levels in both sedentary and exercised 





Figure 6.21. RV muscle mitochondrial complex I (NDUFB8) and complex IV 
(MTCOI) expression levels. Fluorescence detection visualised; Porin (mitochondrial 
mass)-green (488nm), complex I subunit (NDUFB8) - red (647nm), complex IV 
subunit (MTCOI)-orange (546nm), laminin (myocardial protein)-blue (405). Merged 







Figure 6.22. Mitochondrial respiratory chain plots (MRC), NDUFB8, MTCOI and 
porin expression levels. Sedentary mouse MRC plot and Exercised mouse MRC 
plot on the left. A) Percentage of cardiomyocytes with complex I subunit (NDUFB8) 
expression. B) Percentage of cardiomyocytes with complex IV (MTCOI) expression 
levels. (Unpaired t-test). C) Porin z-scores determine mitochondrial mass within the 





6.3.21 Cardiac mitochondrial complex IV activity following exercise 
Mitochondrial complex IV (COX) activity was quantified by COX/SDH histochemistry 
in LV cardiac muscle sections from C57BL6/J sedentary (n=10) and exercised (n=10) 
mice (chapter 2 section 2.21). Five random fields of x10 magnification were acquired 
using Nikon Tie microscope and analysed using NIS elements software (figure 6.23). 
The RGB general analysis algorithm was used to set a threshold for different 
channels. The percentage of COX deficiency was determined by the ratio of total 
tissue area to the total blue deficient regions. Individual COX and SDH 
histochemistry was used to distinguish and visualise the heterogeneity of COX 
activity in cells. Figure 6.24 shows the percentage of COX deficiency in sedentary 
and exercised mice by unpaired t-test analysis. There is no significant difference in 





Figure 6.23. Representative COX, SDH and COX/SDH histochemistry in 
sedentary and exercised LV tissue. Top images represent COX staining in brown, 
middle row images show nuclear encoded SDH staining in blue and bottom row show 






Figure 6.24. Percentage of COX deficiency through COX/SDH histochemistry. 
There is no significant difference in the level of COX deficiency between groups 
(unpaired t-test, p=0.44). Error bars represent mean ±SD. 
 
6.3.22 Cardiac COX activity through NBTx assay following exercise 
NBTx assay and laminin immunofluorescence was carried out in LV cardiac muscle 
of C57BL6/J sedentary (n=10) and exercised (n=10) mice. NBTx assay relies on a 
similar theory to COX/SDH in order to visualise and quantitate the degree of COX 
deficiency although only through NBT activity (detailed chapter 2 section 2.24.1). 
COX functional cells remain colourless as there is no NBT reduction by SDH. COX 
deficient cells however stain various degrees of blue depending on the level of 
deficiency. The darker the blue staining, the more deficient the cells were. Laminin 
immunofluorescence was carried out following NBTx assay to allow for easy 
detection and analysis of cardiomyocytes. Images were acquired on LSM800 
microscope and analysed through an in-house immuno-analyser software. 500 
transverse cardiomyocytes per image were analysed. A numbering system was used 
to categorise cardiomyocytes into groups of COX positive, COX intermediate and 
COX negative cardiomyocytes (figure 6.26) based on the activity of COX in young 
C57BL/6J mice hearts. Figure 6.25 shows NBTx staining, laminin 
immunofluorescence in green and merged image consisting of NBTx bright field and 
laminin channel in green overlapping. Figure 6.26 demonstrates that exercised mice 
seemed to have higher percentage of cardiomyocytes in COX positive category 




intermediate (P<0.001) and COX negative (p<0.05) (unpaired t-test). NBTx provided 
more detail of the spread of COX activity of cardiomyocytes whereas COX/SDH 
(figure 6.23) only demonstrated the presence or absence of COX deficiency omitting 






Figure 6.25. Representative immunofluorescence and bright field images of 
sedentary and exercised mice LV muscle. Laminin-green (488), NBTx through 
monochrome camera and bright field to demonstrate the blue nature of reduced NBT. 





Figure 6.26.COX activity levels in sedentary and exercised mice. Percentage of 
cardiomyocytes with positive COX activity was significantly higher in the exercised 
cohort (**p<0.01). Percentage of cardiomyocytes with COX intermediate and COX 
negative activity was significantly higher in the sedentary cohort (****p<0.0001 and 
*p<0.05 respectively, unpaired t-test). Error bars represent mean ±SD.  
 
6.3.23 Exercise-associated skeletal muscle cytokine levels  
In order to quantify markers of inflammation, I performed total cytokine array on the 
skeletal muscle of both cohorts of C57BL6/J mice at the end of intervention when 
mice were 22 month of age. The technique requires a significant volume of tissue 
and since the amount of heart tissue was limited and used extensively in 
histochemical procedures, the skeletal muscle was used a surrogate tissue 
commonly affected by ageing. Total muscle homogenate cytokine levels were 
assessed in sedentary (n=10) and exercised (n=10) mice quadriceps using the V-
PLEX mouse cytokine kit (Meso Scale Discovery, USA) as detailed in chapter 2 
section 2.27. Quadriceps were homogenised and the total cytokine array was carried 
out from protein extracts. Skeletal muscle is an organ under strain during exercise 
especially with advancing age and its repair is associated with key inflammatory 
cytokines. The concentration of 10 cytokines (IFN-γ, IL-10, IL-12p70, IL-2, IL-4, IL-5, 




unpaired t-test was carried out to discern the changes in each cytokine level between 
groups, pre- and post-intervention. Figures 6.27A-B demonstrate that there is no 
significant difference between any of the muscle cytokine in the two cohorts. 
 
 
Figure 6.27. Total muscle homogenate cytokine levels in sedentary and 
exercised mice. No significant changes in the level of muscle cytokines were seen 





6.3.24 Exercise-associated cardiac mitochondrial DNA copy number 
Mitochondrial DNA (mtDNA) copy number was quantified in C57BL6/J sedentary 
(n=10) and exercised (n=10) mice LV cardiac muscle by the ratio of ND1 
(mitochondrial OXPHOS gene) to β-actin (house-keeping nuclear encoded gene). 
Real-time quantitative PCR was used to amplify the genes of interest and the ratio of 
both genes determined the amount of mtDNA present in each cell as detailed in 
chapter 2 section 2.26. There was no significant difference in the cardiac mtDNA 
copy numbers between the two groups (figure 6.28). 
 
Figure 6.28. Mitochondrial DNA copy number in sedentary and exercised mice 
LV cardiac muscle. There is no significant difference between the mtDNA copy 
number of both cohorts (p=0.2) (unpaired t-test). Error bars represent mean ±SD. 
 
6.4 Discussion  
This study has shown that C57BL/6J mice undergo significant phenotypic change, 
worsening of body condition and significant weight gain with advancing age. Their 
inquisitiveness and step length reduced significantly with age indicative of lower 
locomotive activity. A study carried out by Shoji et al (2016) showed that older mice 
present diminished locomotive activity in novel environments. This study did not 




anxiety-like behaviours such as decreased step length and reduced number of 
touches in sedentary mice. I have also shown that sedentary mice have a significant 
decline in grip strength, coordination and balance as they get older. Takeshita et al 
(2017) demonstrated that lower grip strength is associated with neuromuscular 
dysfunction. Interestingly, Xuan et al (2016) showed that reduction in grip strength is 
a predictor of mortality. Cardiac function was assessed in young and aged C57BL6/J 
mice by cMRI technique in this study. There was no significant change in LVM and 
LVEDV with advancing age in sedentary mice. However, left ventricular mass index, 
left ventricular end diastolic volume index and left ventricular end systolic volume 
index decreased significantly with advancing age. Left ventricular mass is an 
independent predictor of myocardial morbidity and mortality according to Verdecchia 
et al (2001). Wiesmann et al (2000) have also shown that LV mass index decreases 
with advancing age. As body weight also increases with age, LV mass indexed to 
body weight would naturally be smaller than in younger counterparts unless LVM 
also significantly increased with age. It is largely known that aging is associated with 
hypertension due to decreased diastolic and increased systolic blood pressures 
(Pinto, 2007). Resting heart rate also decreased significantly with age. Kostis et al 
(1982) have shown that resting heart rate does not change massively with advancing 
age, however the maximum heart rate achieved in response to exercise is reduced 
with age. Aerobic capacity of mice decreased with age as predicted according to 
previous research (Chappell et al, 2003). Fitzgerald et al (1997) have declared that 
the rate of decline in VO2 max is smaller in endurance-trained athletes than those 
with sedentary lifestyle. The Baltimore longitudinal study by Ades and Toth (2005) 
has criticised the previous cross-sectional studies on aerobic capacity where older 
participants selected might have been healthier than younger ones due to their 
selective survival.  
As the baseline traits of sedentary C57BL/6J mice were characterised in the first aim 
of this study, the next step was to investigate the effect of 6 months of endurance 
exercise training on physiological and cardiovascular parameters in the second part 
of this study.  
Since physical ability and cardiovascular plasticity that are required to perform 
endurance exercise becomes limited with age (Wang et al, 2014), it’s crucial to 
devise an exercise regimen to target and improve the multi-organ decline seen 




long endurance training reversed cardiac compliance (as a measure of slop of the 
pressure-volume curve), increased LV mass, improved arterial stiffness and aerobic 
capacity by 19%. However 1 year of progressive vigorous training in sedentary men 
at 65 years of age had little effects on cardiac compliance. The physiological LV 
remodelling observed with exercise included a significant increase in LV mass, 
increase in cardiac output and stoke volume which was accompanied by an overall 
decrease in body weight and heart rate (Fujimoto et al, 2010). As well as 
improvements in aerobic capacity and cardiac function, Zampieri et al (20016) 
showed that physical exercise also increases the mitochondrial calcium uniporter and 
mitochondrial CIV expression levels in aged skeletal muscle. They confirmed a 
complete remodelling of mitochondrial structure and function by exercise training 
possibly due to increased expression of mitochondrial fusion protein OPA1. 
My study has confirmed that cardiac hypertrophy occurred in exercised mice as 
measured by an increase in cardiomyocyte width in the absence of cardiac fibrosis. 
Marvao et al (2015) categorised cardiac hypertrophy without cardiac fibrosis as 
physiological hypertrophy which is also seen during pregnancy and chronic exercise.  
Agarwal et al (2009) have suggested that cardiomyocyte hypertrophy in exercised 
mice is related to anti-inflammatory properties of exercise shown by an increase in 
TNF-α expression, causing reduced rate of cardiac fibrosis. Endurance exercise is 
not only documented to improve cardiac function in normal aging, it is cited to 
mediate CV risk factors in people with stroke as well. Tang et al (2013) suggested 
that high intensity exercise improves the function of right side of the heart and 
myocardial relaxation whereas low intensity exercise was shown to improve glucose 
and inflammatory markers as well as plasma lipid metabolism after stroke. Similarly, 
Roest et al (2004) have shown that exercise training in patients with atrial correction 
for transposition of great arteries have increased right ventricular end diastolic 
volume (EDV) and right ventricular end systolic volume (ESV) without significant 
changes in stroke volume (SV) and ejection fraction (EF). Since ejection fraction (EF) 
is affected by afterload, preload, contractility of the cardiac muscle and heart rate, 
changes in EF may arise from alteration in any of the contributing factors. My data 
show that EF was improved post-exercise however no other parameter was affected 
post-exercise. Paridon et al (1991) showed that a relationship between chronotropic 




association of afterload with increased RVEDV and RVESV in response to physical 
exercise.  
Significant improvements in cardiac mitochondrial function were observed with 
endurance exercise in this study seen that the percentage of cardiomyocytes with 
COX positive expression levels and COX positive activity levels were significantly 
higher in the exercised cohort compared to non-exercised sedentary mice, 
demonstrating a positive shift in mitochondrial function with exercise. Bishop et al 
(2014) have suggested that physical activity increases mitochondrial function but not 
content as was assessed by citrate synthase activity. They have also documented 
that exercise training intensity in mice and rats are the most crucial determinant of 
improvement in mitochondrial function and exercise training repetition strongly 
correlate with improvements in mitochondrial content. They’ve observed that 
mitochondrial improvements were reversed immediately upon withdrawal of physical 
activity, highlighting the plasticity of cardiac and skeletal muscle to exercise training. 
My porin data suggested that mitochondrial mass was not affected with exercise 
since low and very low levels of porin were not detected in any of the cardiomyocytes 
from both groups.  
Interestingly, Lundby and Jacobs (2015) reported that exercise training increases 
intermyofibrillar mitochondrial volume in skeletal muscle by up to 40% due to 
enhanced muscle cross-sectional area and growth. Jacobs et al (2013) have 
reported that six sessions of high intensity interval training in untrained male subjects 
enhanced skeletal muscle’s respiratory capacity by increasing the expression and 
activity of mitochondrial enzymes that facilitate aerobic metabolism. Whereas Lundby 
and Jacobs (2015) demonstrated that low/moderate endurance training improved fat 
oxidation capacity by mitochondria and not necessarily the global respiratory 
capacity. Although most of the research carried out in rodent models may have 
implications in human research, the psychological responses in which mice 
experience during exercise seems to be different to humans (Lehmann and 
Herkenham, 2011). Since decline in mitochondrial content with age in human skeletal 
muscle was documented to be linked to decline in cardiorespiratory fitness (Short et 
al, 2005), Robinson et al (2005) investigated the effects of exercise training on 
isolated mitochondrial from human skeletal muscle at resting and fasting state in 
order to observe the impact of exercise training on the ageing process. They have 




especially those involved in mitochondrial function, muscle growth and insulin 
signalling cascade in older subjects by exercise. High intensity training enabled the 
most robust increase in regulation of transcription and translation of skeletal muscle 
growth and mitochondrial function. 
 
6.5 Conclusion 
In this study, I have confirmed that 6 months of exercise intervention in C57BL/6J 
mice improved functional capacity such as higher locomotive activity, assumed 
stronger muscles and better body conditioning score. Cardiac function was also 
improved in exercised mice as evident by higher percentage of ejection fraction. 
Cardiomyocyte hypertrophy was evident in exercised mice as well as lower 
percentage of cardiac fibrosis and apoptosis. Mitochondrial CIV expression and 
activity was significantly higher in the exercised group. Therefore, this late-life 
exercise intervention strategy was beneficial in attenuating physiological, cardiac and 
mitochondrial decline with age.  
 
6.6 Future work 
Given the current baseline physical, cardiac and mitochondrial characteristics of 
C57BL/6J mice and the impacts of ageing observed in the first aim of this chapter, 
this mouse model would enable the investigation of individual VO2 max testing to 
assess exercise performance and aerobic capacity in each mouse. Younger mice are 
more malleable to exercise training in a way that smaller and more variable training 
responses were observed in the old compared to young subjects (Harber et al, 
2012). It’s advantageous to perform individual exercise intolerance test for each 
mouse and personalise the endurance exercise regimen based on their maximal 









Chapter7. Final Discussion 
The aim of this thesis was to investigate the role of endurance exercise on physical, 
mitochondrial and cardiovascular function of two mouse models, one of accelerated 
and one of normal aging. Understanding the mechanisms underlying the decline in 
cardiovascular and mitochondrial function in aging and whether these changes can 
be modulated with endurance exercise are fundamental if we are going to prescribe 
exercise as a lifestyle intervention in later life. 
The main findings of the PolgAmut/mut mouse study was that endurance exercise did 
not alleviate the physiological and functional decline observed in male PolgAmut/mut 
mice with age and did not mitigate the reduction in cardiac mitochondrial function. 
PolgAmut/mut mice had significant reduction in body condition, weight loss and 
diminished thermoregulatory capacity compared with age-matched WT mice. I 
showed significant age-related decline in physical function in comparison to PolgA+/+ 
mice confirming previous studies (Trifunovic et al, 2004; Kujoth et al, 2005). The 
established decline in cardiac mitochondrial function, cardiomyocyte hypertrophy, 
cardiomyocyte apoptosis and accumulation of cardiac fibrosis in PolgAmut/mut mice 
was not altered with endurance exercise. Solitary-housing in general appeared to 
accelerate the deterioration in body condition and implement a decline in locomotive 
activity from a younger age regardless of the state of physical activity. In contrast with 
the findings of this study, Safdar et al (2011) reported that endurance exercise 
alleviates premature aging phenotypes and induces mitochondrial rejuvenation in 
solitary-housed PolgAmut/mut mice. They have averaged their findings from male and 
female mice and observed significant reduction in lifespan of sedentary mice in 
comparison to exercised mice. This may skew their results since clinical scoring for 
example is influenced by aggression in males and hormonal factors in female mice. 
Interestingly, group-housed exercised and non-exercised PolgAmut/mut mice revealed 
fewer apoptotic cells in the heart in comparison to exercised and non-exercised 
PolgAmut/mut mice housed in solitude. Exercise in the setting of single-housing 
however did not seem to be able to alleviate cardiomyocyte apoptosis in comparison 
to non-exercised cohort. This may mean that housing condition, may partly play a 





Endurance exercise had no effect on CI and CIV expression and CIV activity in the 
cardiac muscle of group-housed PolgAmut/mut mice. CIV activity however was further 
diminished when mice were singly-housed. Again, confirming that housing condition 
may play a role in cardiac mitochondrial function regardless of the status of physical 
activity of PolgAmut/mut mice. My study also showed that exercise and single-housing 
did not have an impact on mitochondrial biogenesis as demonstrated by 
mitochondrial mass (porin) expression levels. Mitochondrial mass in skeletal muscle 
was suggested to be increased with endurance exercise (Koltai et al, 2012) due to 
the higher demand on energy production machinery of working muscle. Vettor et al 
(2014) demonstrated that eNOS plays a significant role in upregulation of 
mitochondrial biogenesis and PGC-1α in the cardiac muscle of rodent models.  
Singly-housed exercised mice appeared to have higher CI and CIV expression levels 
in comparison to singly-housed sedentary mice, however the activity of CIV was non-
significant between the groups. The presence of non-active CIV protein is not enough 
to improve mitochondrial function. Safdar et al (2011) suggested that 6 months of 
endurance exercise attenuated all the symptoms of pre-mature aging previously 
described by Trifunovic et al (2004) and Kujoth et al (2005). They have also found 
that exercise restored mtDNA depletion, reduced the frequency of mtDNA point 
mutations, maintained mitochondrial morphology and increased mitochondrial 
biogenesis by an increase in mitochondrial ETC subunits and CIV activity. The 
methodology by which this research group had conducted their study was unclear. 
For instance, 18 mice from each gender was selected, however molecular data was 
conducted on <5 mice while gender was not stated, which raises the question of 
whether those mice were selected randomly or not. If only four mice lived until 72 
weeks as they have suggested, then statistics will not be as reliable for such strong 
claims. 
In the normal aging C57BL6/J mouse study, I have confirmed that the body condition, 
physical function and muscle strength of mice deteriorates with normal aging. I have 
also observed reduction in LVMI, LVEDVI and LVESVI with age in agreement with a 
study carried out by Fiechter et al (2013). The cardiovascular changes which occur 
with increasing age are suggested to play a major role in the response of the CV 
system to disease. The significant decline in ventricular chamber volume and 
dimension with age could be a compensatory response to the decline in LV muscle 




mice with advancing age, normalisation of cardiac volumes and mass data may at 
least in part mask the changes observed in ventricular volumes observed with aging. 
With increasing body weight, both blood volume and cardiac output increases to 
meet the body’s increased metabolic rate. Therefore, it was necessary to normalise 
cardiac function measurements to each mouse’s body weight as previously 
described (Maceira et al, 2006; fuchs et al, 2016) in order to visualise changes that 
occur as a result of exercise and age and not weight gain. Moreover, I presented 
evidence of decreased resting HR with age. Previous studies have reported an age-
related decline in maximal HR (Fuchi et al, 1989; Hagberg et al, 1985; Rivera et al, 
1989), but not a significant change in resting HR. One of the limitations of obtaining 
haemodynamic measures in this study was a lack of data on the impact of animal 
handling, restraining during the measurements and no alternative method for 
measuring BP and HR. There was a significant animal-to-animal and time-dependent 
variation in tail-cuff method of obtaining BP and HR in mice which may bias the 
results if they’re not taken over many trials. A study published by Wilde et al in 2017 
compared  the telemetry method of obtaining BP non-invasively and the tail-cuff 
method and concluded that the latter underestimates the core blood pressure 
changes during handling and restraining of mice which directly affects cardiovascular 
parameters such as the heart rate and core body temperature. Core body 
temperature can ultimately affect blood pressure i.e. lower temperatures can cause 
dilation of blood vessels to increase blood pressure (Mayo clinic, 2019).  
My study showed a significant reduction in peak oxygen consumption rate (VO2 peak) 
with age in agreement with previous research (Chow et al, 2007). A number of 
studies have reported a 10% decline in VO2 max per decade after the age of 25 which 
increases up to 15% from the age of 50 onwards in non-active healthy individuals 
(Robinson, 1938; Astrand, 1960; Hawkins and Wiswell, 2003). A general decline in 
VO2 max with age is suggested to be a result of declined cardiac output and therefore 
reduced blood supply to the active muscle (Kim et al, 2016). 
In the late-life endurance exercise intervention study, I demonstrated that exercised 
mice had a significantly slower decline in their body condition and significantly lower 
body weight post-intervention in comparison to the sedentary group. The body weight 
of exercised mice remained steady throughout the intervention. Improvements in the 
muscle strength of exercised mice was also observed post-intervention. This finding 




strength was assessed through rotarod testing in old C57BL6/J mice. The authors 
have reported that 8 weeks of progressive exercise training improved the 
regenerative capacity of skeletal muscle in aged male mice. There is also evidence 
that late-life exercise may improve physical function and reduce disability in 
developed countries (Ettinger et al, 1997; Jette et al, 1999; Minor et al, 1989). My 
study suggested there may be a potential improvements in aerobic capacity of 
exercised mice as shown by slower rate of VO2 peak decline with age. A slow decline 
in VO2 max has also been observed in athletes of low-impact sports such as rowing 
with increasing age (Reaburn and Dascombe, 2008). In addition the rate of age-
related VO2 max decline in male master athletes is documented to be approximately 
one-half the rate of decline observed in non-exercised age-matched males (Rogers 
et al, 1990). VO2 peak as a measure of oxidative function was used in this study as an 
important factor in assessing the improvements in the rate of aerobic capacity decline 
with age. 
In agreement with this study, a study carried out by a group of scientists in University 
of Texas on more than 50 participants of between the age of 45-64 have showed that 
moderate aerobic exercise for two years restores LV elasticity and compliance by 
25% and improves VO2 max by 18%, reducing the chances of developing heart 
failure in later life (Erin et al, 2018). They also found that LVEDV was increased with 
exercise, contributing to greater stroke volume for any filling pressure. A study by 
Hawkins and Wiswell (2003) reported that it is harder to reduce VO2 max loss with 
regular exercise in older men and women rather than middle-aged individuals, due to 
both central and peripheral adaptations with age.  
Another study conducted by Zhao and Ma (2016) revealed that a swimming 
intervention in male C57BL6/J mice for 8 weeks developed cardioprotection against 
apoptosis by reducing the apoptosis-related microRNAs (miRNAs) and enhancing 
Bcl-2/Bax ratio in the cardiac muscle of exercised mice. Similarly, 4 weeks of 
swimming exercise in an AMPK-/- mouse model revealed attenuation of isoproterenol-
induced cardiac fibrosis by inhibiting NADPH oxidase-ROS pathway mediated AMPK 
activation (Ma et al, 2015). Isoproterenol was used as a non-selective β-AR agonist 
to induce cardiac fibrosis. One study suggests that miRNAs respond to exercise by 
inhibiting excessive collagen formation, increasing angiogenesis and regulating the 




cardiomyocyte size growth was found to be associated with a series of miRNAs with 
cardioprotective roles. 
I have also observed a significant reduction in cardiac apoptosis in exercised mice in 
comparison to sedentary mice. Interestingly, a study by Kwak, Song and Lawler 
(2006) reported an age-related increase in mitochondrial Bax/Bcl-2 ratio and 
exercise-induced amelioration of mitochondrial mediated apoptosis with age, leading 
to diminished DNA fragmentation. A study by Nakajima et al (2010) showed that 
chronic endurance exercise in older people increases the methylation of pro-
inflammatory apoptosis-related speck-like protein caspase (ASC) genes in circulatory 
blood which otherwise decrease with advancing age. These group of ASC proteins 
are responsible for modulating IL-18 and IL-1B cytokines. Nakajima et al (2010) 
reported that exercise is associated with attenuation of the age-related increase in 
pro-inflammatory cytokines. However, no significant exercise-induced changes in the 
level of muscle cytokines were observed in my study. Also, the balance in the 
number and distribution of cardiomyocytes and fibroblasts is disturbed with age, 
leading to inflammation and cardiac fibrosis (Kyselvic and Leddy, 2017). I have 
demonstrated that endurance exercise in a normal ageing mouse model reduces 
cardiac fibrosis in agreement with the study carried out Kyselvic and Leddy in 2017. 
Fibroblasts secrete extracellular collagen chains under physiological conditions which 
assemble into cross-links of fibrils in the interstitium. The authors concluded that 
cardiac remodelling through exercise is beneficial, decreasing cardiac fibrosis, 
increasing PI3K activity, improving calcium handling and endothelial function from 
increases in nitric oxide (NO) production. Similarly, Xu et al (2008) have shown that 
the levels of angiotensin-II were significantly reduced in ischaemic patients that 
underwent exercise training. This resulted in reduced fibrogenesis as a measure of 
decreased expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) which 
promotes accumulation of myocardial fibrosis (Takawale et al, 2017) with unchanged 
expression of matrix metalloproteinase-1 which attenuates the development of 
myocardial fibrosis (Foronjy et al, 2008). Xu et al (2008) have also documented a 
significant reduction in collagenous tissue in LV cross-sections of exercised mice in 
comparison to non-active mice suggesting that myocardial fibrosis is attenuated in 
infarcted hearts with endurance exercise. Giannuzzi et al (2003) have shown that 




attenuated abnormal cardiac remodelling and improved exercise tolerance and 
quality of life. 
The effects of endurance exercise on mitochondrial OXPHOS function has also been 
extensively researched in the past. Lundby and Jacos (2015) have shown that with 
exercise training, the population of intermyofibrillar mitochondrial volume density 
increases significantly as well as mitochondrial proteins that facilitate aerobic 
metabolism. These adaptations and the magnitude of change was suggested to be 
dependent on both exercise intensity and duration. In my study, the proportion of 
cardiomyocytes with positive mitochondrial OXPHOS complex IV expression and 
activity was significantly higher in the exercised mice, demonstrating a positive shift 
in the expression and activity of complex IV with endurance exercise. 
 
7.1 Use of mouse models 
The premature mouse model of ageing known as PolgAmut/mut mice was used in the 
first part of this study to investigate the effects of the accumulation of mitochondrial 
dysfunction on the ageing phenotype with a particular focus on the CV system, and 
whether endurance exercise could ameliorate this phenotype. One advantage of this 
mouse model was the development of early ageing phenotypes for a relatively quick 
study with large number of samples. In addition, humans are known to accumulate 
mtDNA mutations with age whereas C57BL6 mice do not to the same extent so it is a 
good model to use to see if exercise can improve mitochondrial function due to 
somatic mutations.  
An advantage of using C57BL6/J mouse model of normal healthy ageing is that the 
maturation phase of mice is 45 times faster over the age of 5 months in comparison 
to human ageing which enables studies to be carried out in short period of time. A 
disadvantage of using mice as subjects of this study is the fact that mice do not live 
in their natural environment therefore their mental and physiological state may not 





7.2 Implications of this research on human interventions  
Now that the beneficial effects of exercise in aged mouse heart have been 
characterised, clinical trials on human studies would be carried out more confidently. 
Although there are still large unknown areas, an obvious finding is that the later the 
endurance exercise begins in the lifetime of a healthy individual, the less the 
beneficial effects will be. There are obvious differences in the environmental 
conditions and physiology of mice and humans therefore care should be taken when 
designing an appropriate clinical intervention study and human subjects should be 
closely monitored.  
 
7.3 Future work 
An advantage of the PolgAmut/mut mouse study was recruitment of a large number of 
samples. However, due to limited procedures that could be carried out on mice under 
the license of which the two studies were part of, mice were not allowed to perform 
an exercise intolerance test to reach their maximal aerobic capacity (VO2 max) for a 
more tailored exercise regime. Since the molecular mechanism underlying normal 
age-related changes vary to that of premature age-related changes, I have observed 
no improvements in PolgAmut/mut mitochondrial and cardiac function but promising 
improvements in mouse model of normal ageing with exercise (C57BL6/J mice).  
Future work would include taking into account the external factors such as 
microenvironment, diet, housing conditions, thermoregulation, stress, social 
interactions, and genetics of mice whom respond better to exercise interventions. 
Using an optimal ageing systems where exercise may be more beneficial on long 
term interventions is also an important point to consider. There is more control in 
rodent models over genetics, external factors such as housing, diet and level of 
exercise they undergo. However, in humans there is more control over how much 
one can tolerate exercise and that communication makes interventions easier both 
for the researcher and the subjects. A downfall of performing a research on rodents 
is that monitoring and scoring of clinical conditions are assessed using a human-
based scoring system. Mice are tested throughout the intervention without them 
having any understanding of the procedure and that may exert extra stress on mice 





7.4 Final conclusion  
This research has successfully assessed the baseline characteristics, cardiac 
pathology and mitochondrial function in accelerated ageing PolgAmut/mut mouse model 
and normal ageing C57BL6/J mouse model. 
The normal aging process has an impact on ventricular ESV and EDV as well as LV 
mass in healthy aged mice. Exercise in part has managed to alleviate the cardiac 
fibrosis and apoptosis that is normally seen within aged heart. C57BL6/J mice as 
normal ageing mouse model were more successful in benefiting from the exercise 
regime than the PolgAmut/mut mice. This could be due to the fact that mutator mice 
experience higher mtDNA mutation burden from younger age. Single-housing in 
these subset of mice seems to be able to shift the manifestation of disease to 
younger age since solitary housed mice show accelerated decline in body condition 
straight after their cage separation pre-intervention at 14 weeks of age. My data 










Chapter 8.  Appendices 
Appendix 1. Mouse monitoring criteria, used to assess clinical phenotypes of 
PolgAmut/mut and C57BL/6J mice for severity and progression of body condition states 


















Table 8.1. Mouse monitoring recording sheet for PolgAmut/mut mice. One score of three, three scores of two, 20% body weight 








Mouse ID       RFID transponder         Notch        Cage         DOB              Harvest Date  
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Appendix 2. Mouse Harvesting sheet. Used for PolgAmut/mut and C57BL6/J mice. 
Cage: Date: 
Mouse No: Storage Location: 
Harvest Number: Final Urine & Faeces location: 
 
Weighing and Measurements: 
Remove any fat from tissue before weighing 
Body weight g 
Liver g 
Spleen g 
Kidney R g 




Skeletal Muscle g 
Fat g 
Brain g 







1. Dissection kit:  
2. Scalpels 
3. Formalin 
4. Liquid nitrogen  
5. 70% Ethanol spray  
6. Labelled tubes and cassettes (blue and white) 
7. Needles and syringes for blood collection and pinning the mouse 
8. Ice 
9. Dry ice for transport 
10. PBS for perfusion of organs  
11. Gloves, blue roll, yellow bag for body disposal 
12. Ruler 
13. Petri dishes for small intestine pinning  
14. Scales 
15. Weighing boats 
16. Isopentane 
17. Isoflurane 
18. Dissection sheet guidelines 
19. Body/Organ harvest sheet 
20. Biopsy pads 
21. Microscope 
Dissection Protocol: 
1. Weigh the mouse. 
2. Spray the mouse with 70% EtOH, and cut open from the tail to the neck. 
3. Aspirate blood from the heart and place it in ice (serum is collected from the 
supernatant after centrifugation at 8000rpm for 10mins). 
4. Weigh each mouse tissue prior to dividing for fixing or freezing. 
a. Fixing 10% formalin 










1. Right Kidney – Cut longitudinal, half is fixed, half is frozen. 
2. Left Kidney – Cut transverse, half is fixed, half is frozen. 
3. Skin – Shave skin from back, use paper towel to cut 2 slivers. One is fixed, the 
other is frozen 
4. Brain – Cut between hemispheres. Left hemisphere is fixed, the right 
hemisphere is frozen. 
5. Fat – follow the protocol for fat dissection (fat dissolves in formalin). 
6. Muscle –Muscle is dunked in isopentane first. The isolated skeletal muscles 
include quadriceps, EDL, TA, gastrocnemius and soleus muscles from both 
legs. The left leg muscles were fixed, and the right leg muscle was frozen. 
Quadriceps of right leg was homogenised for protein extraction. 
7. Lung – Left lung (2lobes) is fixed, the right lung is frozen. 
8. Heart – Cut longitudinal, right side is fixed and left side is slowly cooled in 
isopentane. 
9. Spleen - Half the spleen goes into the tissue cassette with the Liver. The other 
half of the spleen gets frozen. 
10. Liver– Triangular lobe of liver goes into tissue cassette. Cut a capsule off the 
bilobulated lobe and discard. Cut a sliver from the exposed capsule and place 
into tissue cassette. Cut a capsule off the large lobe and discard. Cut a sliver 
from the exposed capsule. Cut two squares from this sliver, one gets frozen for 
RNA, the other gets frozen for protein. The rest of the liver gets frozen.  
11. Pancreas – This is located wrapped around the proximal SI next to the stomach. 
It is hard to distinguish from fat, however, if required, the pancreas sinks and fat 
floats in water. Half the pancreas is fixed, the other half is frozen. 
12. SI – Measure the SI its contents are then collected. 2 ends of the SI are frozen. 





13. Colon – The contents of the colon is collected. 2 ends of the colon are frozen. 
The rest is fixed. 
14. Caecum – The contents of the caecum is collected. 
15. Stomach – The contents of the stomach is emptied. The stomach is rolled up. 






Appendix 3. Expanded RM3 chow diet composition. Used for PolgAmut/mut and 
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